Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT

OF 1934

For the quarterly period ended June 30, 2024

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

ACT OF 1934

For the transition period from ______________ to _____________

Commission file number: 001-41252

T Stamp Inc. (D/B/A Trust Stamp)

(Exact name of registrant as specified in its charter)

Delaware

7372

81-3777260

(State or Other Jurisdiction of Incorporation or Organization)

(Primary Standard Industrial Classification Number)

(IRS Employer Identification Number)

3017 Bolling Way NE, Floor 2, Atlanta, Georgia 30305

(Address of registrant’s principal executive offices) (Zip code)

Registrant’s telephone number, including area code (404) 806-9906

Securities registered under Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange on which registered

Class A Common Stock, $0.01 par value per share

IDAI

The NASDAQ Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act: None.

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No x

Indicate by check mark whether the issuer (1) has filed reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 USC. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. o

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. o

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

As of August 12, 2024, there were 16,780,931 shares of Class A Common Stock, par value $0.01 per share, of the registrant outstanding.

Table of Contents

T STAMP INC.

TABLE OF CONTENTS


		Page
PART I	FINANCIAL INFORMATION

Item 1.	Financial Statements	3
	Condensed Consolidated Balance Sheets as of June 30, 2024 (Unaudited) and December 31, 2023	3
	Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2024 and 2023 (Unaudited)	4
	Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2024 and 2023 (Unaudited)	5
	Condensed Consolidated Statements of Stockholders’ Equity for the three and six months ended June 30, 2024 and 2023 (Unaudited)	6
	Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2024 and 2023 (Unaudited)	8
	Notes to Condensed Consolidated Financial Statements (Unaudited)	10
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	27
Item 3.	Quantitative and Qualitative Disclosures About Market Price	41
Item 4.	Controls and Procedures	41

PART II	OTHER INFORMATION

Item 1.	Legal Proceedings	42
Item 1A.	Risk Factors	42
Item 2.	Unregistered Sale of Equity Securities and Use of Proceeds	42
Item 3.	Defaults Upon Senior Securities	42
Item 4.	Mine Safety Disclosures	42
Item 5.	Other Information	42
Item 6.	Exhibits	44
	Signatures	47

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements.

T STAMP INC.

CONDENSED CONSOLIDATED BALANCE SHEETS


	June 30, 2024		December 31, 2023
	(unaudited)
ASSETS
Current Assets:
Cash and cash equivalents	$	659,533	$	3,140,747
Accounts receivable, net (includes unbilled receivables of $4,440 and $143,219 as of June 30, 2024 and December 31, 2023, respectively)	517,380		686,327
Related party receivables	24,921		44,087
Prepaid expenses and other current assets	726,612		826,781
Total Current Assets	1,928,446		4,697,942
Capitalized internal-use software, net	1,509,180		1,472,374
Goodwill	1,248,664		1,248,664
Intangible assets, net	192,619		223,690
Property and equipment, net	43,512		56,436
Operating lease right-of-use assets	229,370		164,740
Other assets	41,567		29,468
Total Assets	$	5,193,358	$	7,893,314
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	$	1,104,638	$	1,232,118
Related party payables	53,087		82,101
Accrued expenses	1,539,378		1,143,890
Deferred revenue	182,000		10,800
Income tax payable	—		1,975
Short-term operating lease liabilities	123,431		81,236
Short-term financial liabilities	—		162,130
Total Current Liabilities	3,002,534		2,714,250

Warrant liabilities	251,668		256,536
Notes payable, including accrued interest of $28,808 and $40,317, as of June 30, 2024 and December 31, 2023, respectively	953,799		953,877
Long-term operating lease liabilities	73,520		53,771
Total Liabilities	4,281,521		3,978,434

Commitments, Note 10

Stockholders’ Equity:
Common stock $0.01 par value, 50,000,000 shares authorized, 11,384,139 and 9,198,089 shares issued, and 11,384,139 and 9,143,355 outstanding at June 30, 2024 and December 31, 2023, respectively	113,841		91,434
Treasury stock, at cost: 0 and 54,734 shares held as of June 30, 2024 and December 31, 2023, respectively	—		—
Additional paid-in capital	56,591,713		54,375,622
Accumulated other comprehensive income	175,059		139,670
Accumulated deficit	(56,130,215)		(50,853,285)
Total T Stamp Inc. Stockholders’ Equity	750,398		3,753,441
Non-controlling interest	161,439		161,439
Total Stockholders’ Equity	911,837		3,914,880
Total Liabilities and Stockholders’ Equity	$	5,193,358	$	7,893,314

The accompanying notes to the unaudited condensed consolidated financial statements are an integral part of these statements.

Table of Contents

T STAMP INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)


	For the three months ended June 30,				For the six months ended June 30,
	2024		2023		2024		2023
Net revenue	$	500,395	$	460,804	$	1,074,071	$	919,438
Operating Expenses:
Cost of services (exclusive of depreciation and amortization shown separately below)	247,435		203,928		542,033		420,887
Research and development	564,736		574,397		1,016,578		1,206,766
Selling, general, and administrative	2,132,395		1,877,616		4,624,088		3,847,173
Depreciation and amortization	181,195		187,272		365,996		406,454
Total Operating Expenses	3,125,761		2,843,213		6,548,695		5,881,280
Operating Loss	(2,625,366)		(2,382,409)		(5,474,624)		(4,961,842)
Non-Operating Income (Expense):
Interest expense, net	(16,773)		(9,793)		(35,322)		(19,994)
Change in fair value of warrant liability	2,408		6,955		4,868		5,615
Other income	41,739		217,605		234,852		261,547
Other expense	(369)		(2,726)		(6,704)		(3,144)
Total Other Income (Expense), Net	27,005		212,041		197,694		244,024
Net Loss before Taxes	(2,598,361)		(2,170,368)		(5,276,930)		(4,717,818)
Income tax expense	—		—		—		—
Net loss before non-controlling interest	(2,598,361)		(2,170,368)		(5,276,930)		(4,717,818)
Net loss attributable to non-controlling interest	—		—		—		—
Net loss attributable to T Stamp Inc.	$	(2,598,361)	$	(2,170,368)	$	(5,276,930)	$	(4,717,818)
Basic and diluted net loss per share attributable to T Stamp Inc.	$	(0.21)	$	(0.32)	$	(0.47)	$	(0.80)
Weighted-average shares used to compute basic and diluted net loss per share	12,227,476		6,757,320		11,169,735		5,897,089

The accompanying notes to the unaudited condensed consolidated financial statements are an integral part of these statements.

Table of Contents

T STAMP INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(unaudited)


	For the three months ended June 30,				For the six months ended June 30,
	2024		2023		2024		2023
Net loss including non-controlling interest	$	(2,598,361)	$	(2,170,368)	$	(5,276,930)	$	(4,717,818)
Other Comprehensive Income (Loss):					—		—
Foreign currency translation adjustments	3,698		(7,604)		35,389		(49,046)
Total Other Comprehensive Income (Loss)	3,698		(7,604)		35,389		(49,046)
Comprehensive loss	(2,594,663)		(2,177,972)		(5,241,541)		(4,766,864)
Comprehensive loss attributable to non-controlling interest	—		—		—		—
Comprehensive loss attributable to T Stamp Inc.	$	(2,594,663)	$	(2,177,972)	$	(5,241,541)	$	(4,766,864)

The accompanying notes to the unaudited condensed consolidated financial statements are an integral part of these statements.

Table of Contents

T STAMP INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(unaudited)

FOR THE THREE MONTHS ENDED JUNE 30, 2024 AND 2023


	Common Stock			Additional Paid-In Capital	Treasury Stock			Accumulated Other Comprehensive Income		Accumulated Deficit		Non-controlling Interest		Total
	Shares	Amount			Shares	Amount
Balance, March 31, 2023	5,121,607	$	51,216	39,479,741	—	$	—	$	195,810	$	(41,847,176)	$	161,439	$	(1,958,970)
Exercise of prefunded warrants to common stock	1,553,250	15,533		(13,979)	—	—		—		—		—		1,554
Exercise of options to common stock	1,740	17		(17)	—	—		—		—		—		—
Issuance of common stock, prefunded warrants, and common stock warrants, net of fees	1,312,468	13,124		7,451,188	—	—		—		—		—		7,464,312
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary	(16,821)	(168)		52,707	16,821	—		—		—		—		52,539
Stock-based compensation	—	—		97,737	—	—		—		—		—		97,737
Currency translation adjustment	—	—		—	—	—		(7,604)		—		—		(7,604)
Net loss attributable to T Stamp Inc.	—	—		—	—	—		—		(2,170,368)		—		(2,170,368)
Balance, June 30, 2023	7,972,244	$	79,722	47,067,377	16,821	$	—	$	188,206	$	(44,017,544)	$	161,439	$	3,479,200


	Common Stock			Additional Paid-In Capital		Treasury Stock			Accumulated Other Comprehensive Income		Accumulated Deficit		Non-controlling Interest		Total
	Shares	Amount				Shares	Amount
Balance, March 31, 2024	10,099,672	$	100,997	$	54,641,448	—	$	—	$	171,361	$	(53,531,854)	$	161,439	$	1,543,391
Exercise of prefunded warrants to common stock	542,100	5,421		(5,421)		—	—		—		—		—		—
Issuance of common stock in relation to vested restricted stock units and grants	242,377	2,423		(36,919)		—	—		—		—		—		(34,496)
Issuance of common stock, prefunded warrants, and common stock warrants, net of fees	499,990	5,000		1,685,480		—	—		—		—		—		1,690,480
Stock-based compensation	—	—		307,125		—	—		—		—		—		307,125
Currency translation adjustment	—	—		—		—	—		3,698		—		—		3,698
Net loss attributable to T Stamp Inc.	—	—		—		—	—		—		(2,598,361)		—		(2,598,361)
Balance, June 30, 2024	11,384,139	$	113,841	$	56,591,713	—	$	—	$	175,059	$	(56,130,215)	$	161,439	$	911,837

The accompanying notes to the unaudited condensed consolidated financial statements are an integral part of these statements.

Table of Contents

T STAMP INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(unaudited)

FOR THE SIX MONTHS ENDED JUNE 30, 2024 AND 2023


	Common Stock			Additional Paid-In Capital		Treasury Stock			Stockholders’ Notes Receivable		Accumulated Other Comprehensive Income		Accumulated Deficit		Non-controlling Interest		Total
	Shares	Amount				Shares	Amount
Balance, January 1, 2023	4,854,302	$	48,543	$	39,496,183	56,513	$	—	$	(18,547)	$	237,252	$	(39,299,726)	$	161,439	$	625,144
Exercise of warrants to common stock	1,553,250	15,533		(13,979)		—	—		—		—		—		—		1,554
Exercise of options to common stock	1,740	17		1,983		—	—		—		—		—		—		2,000
Issuance of common stock, prefunded warrants, and common stock warrants, net of fees	1,312,468	13,124		7,451,188		—	—		—		—		—		—		7,464,312
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary	245,725	2,457		(25,261)		(39,692)	—		—		—		—		—		(22,804)
Reverse stock split rounding	4,759	48		(48)		—	—		—		—		—		—		—
Repayment of shareholders loan through in-kind services	—	—		—		—	—		18,547		—		—		—		18,547
Stock-based compensation	—	—		157,311		—	—		—		—		—		—		157,311
Currency translation adjustment	—	—		—		—	—		—		(49,046)		—		—		(49,046)
Net loss attributable to T Stamp Inc.	—	—		—		—	—		—		—		(4,717,818)		—		(4,717,818)
Balance, June 30, 2023	7,972,244	$	79,722	$	47,067,377	16,821	$	—	$	—	$	188,206	$	(44,017,544)	$	161,439	$	3,479,200


	Common Stock			Additional Paid-In Capital		Treasury Stock			Accumulated Other Comprehensive Income		Accumulated Deficit		Non-controlling Interest		Total
	Shares	Amount				Shares	Amount
Balance, January 1, 2024	9,143,355	$	91,434	$	54,375,622	54,734	$	—	$	139,670	$	(50,853,285)	$	161,439	$	3,914,880
Exercise of prefunded warrants to common stock	1,424,100	14,241		(14,241)		—	—		—		—		—		—
Issuance of common stock in relation to vested restricted stock units and grants	316,694	3,166		(60,159)		(54,734)	—		—		—		—		(56,993)
Issuance of common stock, prefunded warrants, and common stock warrants, net of fees	499,990	5,000		1,685,480		—	—		—		—		—		1,690,480
Stock-based compensation	—	—		605,011		—	—		—		—		—		605,011
Currency translation adjustment	—	—		—		—	—		35,389		—		—		35,389
Net loss attributable to T Stamp Inc.	—	—		—		—	—		—		(5,276,930)		—		(5,276,930)
Balance, June 30, 2024	11,384,139	$	113,841	$	56,591,713	—	$	—	$	175,059	$	(56,130,215)	$	161,439	$	911,837

The accompanying notes to the unaudited condensed consolidated financial statements are an integral part of these statements.

T STAMP INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)


	For the six months ended June 30,
	2024		2023
Cash flows from operating activities:
Net loss attributable to T Stamp Inc.	$	(5,276,930)	$	(4,717,818)
Net loss attributable to non-controlling interest	—		—
Adjustments to reconcile net loss to cash flows used in operating activities:
Depreciation and amortization	365,996		406,454
Stock-based compensation	605,011		157,311
Change in fair value of warrant liability	(4,868)		(5,615)
Repayment of shareholder loan through in-kind services	—		18,547
Impairment of assets	1,112		16,819
Gain on sale of property and equipment	—		(216,189)
Non-cash interest	28,808		19,904
Non-cash lease expense	78,964		109,879
Non-cash write off of mobile hardware	(162,130)		(15,775)
Loss on retirement of equipment	2,955		17,589
Changes in assets and liabilities:
Accounts receivable	168,947		521,685
Related party receivables	19,166		(1,551)
Prepaid expenses and other current assets	100,169		83,041
Other assets	(12,099)		(9,063)
Accounts payable	(127,480)		(171,183)
Accrued expense	395,488		(437,365)
Related party payables	(29,014)		(134,824)
Deferred revenue	171,200		887,218
Income tax payable	(1,975)		(5,616)
Operating lease liabilities	(80,248)		(104,817)
Net cash flows from operating activities	(3,756,928)		(3,581,369)
Cash flows from investing activities:
Proceeds from sale of property, plant and equipment	—		377,360
Capitalized internally developed software costs	(315,192)		(356,892)
Patent application costs	(38,810)		(37,717)
Purchases of property and equipment	(9,084)		—
Net cash flows from investing activities	(363,086)		(17,249)
Cash flows from financing activities:
Proceeds from exercise of warrants to common stock	—		1,554
Proceeds from exercise of options to common stock	—		2,000
Proceeds from common stock, prefunded warrants, and common stock warrants, net of fees	1,690,480		7,464,312
Forfeited common stock shares to satisfy taxes	(56,993)		(22,804)
Principal payments on financial liabilities	—		(29,715)
Net cash flows from financing activities	$	1,633,487	$	7,415,347
Effect of foreign currency translation on cash	5,313		(35,809)
Net change in cash and cash equivalents	(2,481,214)		3,780,920
Cash and cash equivalents, beginning of period	3,140,747		1,254,494
Cash and cash equivalents, end of period	$	659,533	$	5,035,414

T STAMP INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)


Supplemental disclosure of cash flow information:
Cash paid during the period for interest	$	2,356	$	570

Supplemental disclosure of non-cash activities:
Adjustment to operating lease right-of-use assets related to renewed leases	$	143,594	$	82,185
Adjustment to operating lease operating lease liabilities related to renewed leases	$	142,192	$	83,298
Adjustment to operating lease right-of-use assets related to terminated leases	$	—	$	82,095
Adjustment to operating lease liabilities related to terminated leases	$	—	$	77,648
Prepaid rent expense reclassified upon termination of leases	$	—	$	5,335

The accompanying notes to the unaudited condensed consolidated financial statements are an integral part of these statements.

T STAMP INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

1. Description of Business, Summary of Significant Accounting Policies, and Going Concern

Description of Business — T Stamp Inc. was incorporated in the State of Delaware on April 11, 2016. T Stamp Inc. and its subsidiaries (“Trust Stamp”, “we”, “us”, “our” or the “Company”) develops and markets artificial intelligence-powered software solutions for enterprise and government partners and peer-to-peer markets.

Trust Stamp develops proprietary artificial intelligence-powered solutions, researching and leveraging machine learning, artificial intelligence, biometric science, cryptography, and data mining, to deliver insightful identity and trust predictions that identify and defend against fraudulent identity attacks, protect sensitive user information, and extend the reach of digital services through global accessibility. We utilize the power and agility of technologies such as GPU processing, edge-computing, neural networks, and large language models to process and protect data faster and more effectively than has ever previously been possible in order to deliver results at a disruptively low cost for usage across multiple industries, including:

•Banking/FinTech

•KYC/AML Compliance

•Humanitarian and Development Services

•Government and Law Enforcement, including Alternative to Detention programs

•Cryptocurrency and Digital Assets

•Biometrically Secured Email and Digital Communications

•P2P Transactions, Social Media, and Sharing Economy

•Real Estate, Travel, and Healthcare

As our portfolio of intellectual property and solutions has developed, we have started to seek applications for our technology outside our traditional focus on identity and trust. We anticipate licensing our technology in numerous fields, typically through established partners who will integrate our technology into field-specific applications.

Reverse Split — On February 15, 2023 our Board of Directors approved and, as of February 20, 2023, the holders of a majority of our voting capital stock approved an amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation and approved to effect a reverse split of our issued and outstanding shares of Class A Common Stock at a ratio of one share for every five shares currently held, rounded up to the nearest whole share – whereby every five (5) outstanding shares of Class A Common Stock was combined and became one (1) share of Class A Common Stock, rounding up to the nearest whole number of shares (the “Reverse Split”). All share and per share amounts have been updated to reflect the Reverse Split in these unaudited condensed consolidated financial statements. The Reverse Split was effective for trading on the market opening of Nasdaq on March 23, 2023. The Reverse Stock Split effective March 23, 2023, was ratified by the Company’s stockholders by written consent pursuant to a definitive proxy statement filed with the Securities and Exchange Commission on April 13, 2023. Written consent from the majority of stockholders was received as of May 13, 2023.

Amended and Restated Certificate of Incorporation — On July 6, 2023, the Company received confirmation of the acceptance of its Third Amended and Restated Certificate of Incorporation (the "Third Restated Certificate") from the Secretary of State of Delaware. The Third Restated Certificate was approved by the Company’s stockholders by written consent pursuant to a definitive proxy statement filed with the Securities and Exchange Commission on April 13, 2023. Written consent from the majority of stockholders was received as of May 13, 2023. The Third Restated Certificate maintained the 50,000,000 authorized shares of Common Stock and eliminated the authorized Preferred Stock. The Third Restated Certificate also created a classified Board of Directors of the Company with three classes of directors who will stand for election in staggered years.

Going Concern — The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company is a business that has not yet generated profits, with a net loss during the six months ended June

30, 2024 of $5.28 million, negative net operating cash outflows of $3.76 million for the same period, working capital of negative $1.07 million and an accumulated deficit of $56.13 million as of June 30, 2024.

The Company’s ability to continue as a going concern in the next twelve months following the date the unaudited condensed consolidated financial statements were available to be issued is dependent upon its ability to produce revenues and/or obtain financing sufficient to meet current and future obligations and deploy such to produce profitable operating results. Management has evaluated these conditions and plans to generate revenue and raise capital as needed to satisfy the Company’s capital needs. While the negotiation of significant additional revenue is well advanced, it has not reached a stage that allows it to be factored into a going concern evaluation. In addition, although the Company has previously been successful in raising capital as needed and has already made plans to do so as well as restructuring expenses to meet the Company’s cash needs, no assurance can be given that the Company will be successful in its capital raising efforts. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period.

On July 13, 2024, T Stamp Inc. entered into a Securities Purchase Agreement (the “SPA”) with a certain investor (the “Purchaser”). Pursuant to the terms of the SPA, the Purchaser agreed, at the closing of the SPA (the “Closing”) and upon the terms and subject to the conditions set forth in the SPA, to purchase from the Company 4,597,701 shares of Class A Common Stock, par value $0.01 of the Company (the “Class A Common Stock”) at $0.435 per share, which was equal to the closing price of the Company’s Class A Common Stock on the Nasdaq Stock Market on July 11, 2024. The total purchase price for the shares was agreed to be paid pursuant to three promissory notes issued by the Purchaser to the Company comprised of (i) a $500,000 promissory note payable on July 31, 2024, which was paid on July 25, 2024; (ii) a $500,000 promissory note payable on August 31, 2024; and (iii) a $1,000,000 promissory note payable within three (3) trading days of an effective resale registration statement as contemplated by the Registration Rights Agreement. The Company filed a resale registration statement on Form S-3 for this purpose on July 18, 2024 (File No.: 333-280884), which is currently under review by the Commission. As of the date of this Quarterly Report on Form 10-Q, the resale registration statement is not yet effective. None of the promissory notes accrue interest, and each may be repaid before their respective due dates.

On July 13, 2024 (the “Closing Date”), the Closing of the SPA occurred, and the Company issued 4,597,701 shares of Class A Common Stock to the Purchaser at $0.435 in exchange for the three promissory notes described above, totaling $2,000,000 in combined principal. The Closing of the SPA was subject to a number of customary closing conditions, including, but not limited to, the Company’s entry into a Registration Rights Agreement, the execution of which were conditions to the Closing of the SPA. Additionally, as part of the Closing of the SPA, the Purchaser executed a Voting Limitation Agreement.

Basis of Presentation — The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with US Generally Accepted Accounting Principles (“US GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The accompanying unaudited condensed consolidated financial statements have been prepared on a basis which assumes that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.

Basis of Consolidation — The accompanying unaudited condensed consolidated financial statements reflect the activity of the Company and its subsidiaries, Trusted Mail Inc. (“Trusted Mail”), Finnovation LLC (“Finnovation”), Trust Stamp Malta Limited (“Trust Stamp Malta”), AIID Payments Limited, Biometric Innovations Limited (“Biometrics”), Trust Stamp Rwanda Limited, Metapresence Limited, Trust Stamp Denmark ApS, Quantum Foundation, TSI GovTech Corporation, Global Server Management Inc., Cheltenham AI LTD, and Trust Stamp Nigeria Limited. All significant intercompany transactions and accounts have been eliminated.

Further, we continue to consolidate Tstamp Incentive Holdings (“TSIH”) which we consider to be a variable interest entity.

In the opinion of management, these condensed consolidated financial statements reflect all adjustments necessary (which adjustments are of a normal and recurring nature) for the fair presentation of the Company's financial position as of June 30, 2024 and December 31, 2023, and the results of operations for the three and six months ended June 30, 2024 and 2023. The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of results expected for the full year. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with GAAP have been omitted pursuant to the rules and regulations of the SEC. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial

statements and the notes to consolidated financial statements in the Company's Annual Report on Form 10-K for the year ended December 31, 2023. The accounting policies employed are substantially the same as those shown in note 1 of the notes to consolidated financial statements included therein.

Variable Interest Entity — On April 9, 2019, management created a new entity, TSIH. Furthermore, on April 25, 2019, the Company issued 320,513 shares of Class A Common Stock to TSIH, for the purpose of providing a pool of shares of Class A Common Stock of the Company that the Company’s Board of Directors (the “Board”) could use for employee stock awards and were recorded initially as Treasury stock. Since establishing TSIH, 264,000 shares were transferred to various employees as a stock award that were earned and outstanding. On February 15, 2023, Trust Stamp issued 206,033 shares of Class A Common Stock to TSIH to be used to satisfy vested employee stock awards. As of June 30, 2024, no shares of Class A Common Stock are held by TSIH as all shares have been issued pursuant to employee Restricted Stock Units.

The Company does not own any of the shares of Class A Common Stock of the Company held by TSIH. The Company considers this entity to be a variable interest entity (“VIE”) because it is thinly capitalized and holds no cash. Because the Company does not own shares in TSIH, management believes that this gives the Company a variable interest. Further, management of the Company also acts as management of TSIH and is the decision-maker as management grants shares held by TSIH to employees of the Company. As this VIE owns only shares in the Company and no other liabilities or assets, the Company is the primary beneficiary of TSIH and will consolidate the VIE.

Major Customers and Concentration of Risks — Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of Cash and cash equivalents, and Accounts receivable. We maintain our Cash and cash equivalents with high-quality financial institutions, mainly in the United States; the composition of which are regularly monitored by us. The Federal Deposit Insurance Corporation covers $250,000 for substantially all depository accounts. The Company from time to time may have amounts on deposit in excess of the insured limits. As of June 30, 2024 and December 31, 2023, the Company had $206,821 and $2,620,765 in U.S. bank accounts, respectively, which exceeded these insured amounts. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts.

For Accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit and maintain reserves for potential credit losses based upon the expected collectability of Accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of credit worthiness and applying other credit risk monitoring procedures.

Three customers represented 95.42% or 48.95%, 38.80%, and 7.67% of the balance of total Accounts receivable as of June 30, 2024 and three customers represented 91.11% or 53.55%, 30.43%, and 7.13% of the balance of total Accounts receivable as of December 31, 2023. The Company seeks to mitigate its credit risk with respect to Accounts receivable by contracting with large commercial customers and government agencies, and regularly monitoring the aging of Accounts receivable balances. As of June 30, 2024 and December 31, 2023, the Company had not experienced any significant losses on its Accounts receivable.

During the three months ended June 30, 2024, the Company sold to primarily three customers which made up approximately 96.21% of total Net revenue, and consisted of 67.33%, 17.38%, and 11.50% from an S&P 500 Bank, Mastercard and Triton, respectively.

Additionally, during the three months ended June 30, 2023, the Company sold to primarily three customers which made up approximately 90.67% of total Net revenue, and consisted of 48.97%, 31.33%, and 10.37% from an S&P 500 Bank, Mastercard, and Triton, respectively.

During the six months ended June 30, 2024, the Company sold to primarily three customers which made up approximately 95.37% of total Net revenue, and consisted of 62.39%, 22.72%, and 10.26% from an S&P 500 Bank, Mastercard and Triton, respectively.

Additionally, during the six months ended June 30, 2023, the Company sold to primarily four customers which made up approximately 92.73% of total Net revenue, and consisted of 44.57%, 28.21%, 10.22%, and 9.73% from an S&P 500 Bank, Mastercard, FIS, and Triton, respectively.

Property and Equipment, Net — Property and equipment, net is stated at cost less accumulated depreciation. Depreciation is recognized using the straight-line method over the estimated useful lives of the respective assets. Maintenance and

repairs that do not improve or extend the useful lives of the assets are expensed when incurred, whereas additions and major improvements are capitalized. Upon sale or retirement of assets, the cost and related accumulated depreciation are derecognized from the consolidated balance sheet and any resulting gain or loss is recorded in the consolidated statements of operations in the period realized.

Accounting for Impairment of Long-Lived Assets — Long-lived assets with finite lives include Property and equipment, net, Capitalized internal-use software, Operating lease right-of-use assets, and Intangible assets, net subject to amortization. The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of assets held and used is measured by comparison of the carrying amount of an asset or an asset group to estimated undiscounted future net cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset exceeds these estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the assets exceeds the fair value of the asset or asset group. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.

As of June 30, 2024, the Company determined that $1 thousand of Capitalized internal-use software were impaired. The impaired Capitalized internal-use software was expensed to Research and development during the six months ended June 30, 2024. As of December 31, 2023, the Company determined that $19 thousand of Capitalized internal-use software and $12 thousand of Intangible assets was impaired. The impaired Capitalized internal-use software was expensed to Research and development during the year ended December 31, 2023.

Goodwill — Goodwill is accounted for in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 350, Intangibles—Goodwill and Other. The Company allocates the cost of an acquired business to the assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. The excess of the purchase consideration transferred over the fair value of the net assets acquired, including other Intangible assets, net, is recorded as Goodwill. Goodwill is tested for impairment at the reporting unit level at least quarterly or more frequently when events or circumstances occur that indicate that it is more likely than not that an impairment has occurred. In assessing Goodwill for impairment, the Company first assesses qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. In the qualitative assessment, the Company considers factors including economic conditions, industry and market conditions and developments, overall financial performance and other relevant entity-specific events in determining whether it is more likely than not that the fair value of the reporting unit is less than the carrying amount. Should the Company conclude that it is more likely than not that the recorded Goodwill amounts have been impaired, the Company would perform the impairment test. Goodwill impairment exists when a reporting unit’s carrying value exceeds its fair value. Significant judgment is applied when Goodwill is assessed for impairment. There were no impairment charges to Goodwill as of June 30, 2024 and December 31, 2023.

Remaining Performance Obligations — The Company’s arrangements with its customers often have terms that span over multiple years. However, the Company generally allows its customers to terminate contracts for convenience prior to the end of the stated term with less than twelve months’ notice. Revenue allocated to remaining performance obligations represents non-cancelable contracted revenue that has not yet been recognized, which includes deferred revenue and, in certain instances, amounts that will be invoiced. The Company has elected the practical expedient allowing the Company to not disclose remaining performance obligations for contracts with original terms of twelve months or less. Cancellable contracted revenue, which includes customer deposit liabilities, is not considered a remaining performance obligation. As of June 30, 2024 and December 31, 2023, the Company did not have any related performance obligations for contracts with terms exceeding twelve months.

Disaggregation of Revenue


	For the three months ended June 30,				For the six months ended June 30,
	2024		2023		2024		2023
Professional services (over time)	$	414,145	$	385,804	$	901,571	$	769,438
License fees (over time)	86,250		75,000		172,500		150,000
Total Revenue	$	500,395	$	460,804	$	1,074,071	$	919,438

Recent Accounting Pronouncements Not Yet Adopted — In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) – Improvements to Income Tax Disclosures. ASU 2023-09 requires enhancements and further transparency to certain income tax disclosures, most notably the tax rate reconciliation and income taxes paid. This ASU is effective for fiscal years beginning after December 15, 2024 on a prospective basis and retrospective application is

permitted. The Company is currently evaluating the impacts of the new standard but does not expect a material impact to its unaudited condensed consolidated financial statements or related disclosures.

In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. The amendments in this ASU clarify that an entity should measure the fair value of an equity security subject to contractual sale restriction the same way it measures an identical equity security that is not subject to such a restriction. The FASB said the contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, should not affect its fair value. The ASU is effective for public entities for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect this guidance to have a material impact to its unaudited condensed consolidated financial statements or related disclosures.

2. Borrowings

Promissory Notes Payable


	June 30, 2024		December 31, 2023
Malta loan receipt 3 – June 3, 2022	$	491,680	$	507,035
Malta loan receipt 2 – August 10, 2021	303,582		313,063
Malta loan receipt 1 – February 9, 2021	62,325		64,271
Interest added to principal	67,404		29,191
Total principal outstanding	924,991		913,560
Plus: accrued interest	28,808		40,317
Total promissory notes payable	$	953,799	$	953,877

In May 2020, the Company formed a subsidiary in the Republic of Malta, Trust Stamp Malta, with the intent to establish a research and development center with the assistance of potential grants and loans from the Maltese government. As part of the creation of this entity, we entered into an agreement with the government of Malta for a potentially repayable advance of up to €800 thousand or $858 thousand to assist in covering the costs of 75% of the first 24 months of payroll costs for any employee who begins 36 months from the execution of the agreement on July 8, 2020. On February 9, 2021 the Company began receiving funds and as of June 30, 2024, the balance received was $858 thousand which includes changes in foreign currency rates.

The Company will pay an annual interest rate of 2% over the European Central Banks (ECB) base rate as set on the beginning of the year in review. If the ECB rate is below negative 1%, the interest rate shall be fixed at 1%. The Company will repay a minimum of 10% of Trust Stamp Malta’s pre-tax profits per annum capped at 15% of the amount due to the Corporation until the disbursed funds are repaid. At this time, Trust Stamp Malta does not have any revenue-generating contracts and therefore, we do not believe any amounts shall be classified as current. The Malta loan interest rate increased from 4.5% for the six months ended June 30, 2023 to 6.5% for the six months ended June 30, 2024 due to the increased interest rate noted by the ECB.

3. Warrants

Liability Classified Warrants

The following table presents the change in the liability balance associated with the liability classified warrants, which are classified in Level 3 of the fair value hierarchy from January 1, 2023 to June 30, 2024:


	Warrants ($)
Balance as of January 1, 2023	$	261,569
Additional warrants issued	—
Change in fair value	(5,033)
Balance as of December 31, 2023	$	256,536
Additional warrants issued	—
Change in fair value	(4,868)
Balance as of June 30, 2024	$	251,668

As of June 30, 2024, the Company has issued a customer a warrant to purchase up to $1.00 million of capital stock in a future round of financing at a 20% discount of the lowest price paid by another investor. The warrant was issued on November 9, 2016. There is no vesting period, and the warrant expires on November 30, 2026. The Company evaluated the provisions of ASC 480, Distinguishing Liabilities from Equity, noting the warrant should be classified as a liability due to its settlement being for a variable number of shares and potentially for a class of shares not yet authorized. The warrant was determined to have a fair value of $250 thousand which was recorded as a Deferred contract acquisition asset and to a Warrant liability during the year ended December 31, 2016 and was amortized as a revenue discount prior to the current periods presented. The fair value of the warrant was estimated on the date of grant by estimating the warrant’s intrinsic value on issuance using the estimated fair value of the Company as a whole and has a balance of $250 thousand as of June 30, 2024.

On December 16, 2016, the Company issued an investor warrant to purchase $50 thousand worth of shares of our Class A Common Stock. The warrants have no vesting period and expires on December 16, 2026. The warrant agreement states that the investor is entitled to the “number of shares of Common Stock with a Fair Market Value as of the Determination Date of $50,000”. The determination date is defined as the “date that is the earlier of (A) the conversion of the investor’s Note into the equity interests of the Company or (B) the maturity date of the Note.” The investor converted the referenced Note on June 30, 2020, therefore, defining the determination date. The number of shares to be purchased is settled as 6,418 shares as of June 30, 2020. The exercise price of the warrants is variable until the exercise date.

The Company used a Black-Scholes-Merton pricing model to determine the fair value of the warrants and uses this model to assess the fair value of the warrant liability. As of June 30, 2024, the warrant liability is recorded at $2 thousand which is a $5 thousand decrease, recorded to Change in fair value of warrant liability, from the balance of $7 thousand as of December 31, 2023.

The following assumptions were used to calculate the fair value of the warrant liability during the six months ended June 30, 2024:


Fair Value of Warrants	$0.26 — $0.64
Exercise price	$0.43 — $0.49
Risk free interest rate	4.38%— 4.50%
Expected dividend yield	—	%
Expected volatility	79.25% — 79.59%
Expected term	3 years

Equity Classified Warrants


Warrant Issuance Date	Strike Price		June 30, 2024	December 31, 2023
November 9, 2016	$	3.12	80,128	80,128
January 23, 2020	$	8.00	186,442	186,442
January 23, 2020	$	8.00	524,599	524,599
April 18, 2023	$	1.34	—	775,330
June 5, 2023	$	1.34	1,173,030	1,279,700
December 21, 2023	$	1.34	3,600,000	3,600,000
April 3, 2024	$	—	957,910	—
April 3, 2024	$	0.97	2,000,000	—
April 3, 2024	$	1.06	1,600,000	—
Total warrants outstanding			10,122,109	6,446,199

November 9, 2016

The Company has issued a customer a warrant to purchase 80,128 shares of Class A Common Stock with an exercise price of $3.12 per share. The warrant was issued on November 9, 2016. There is no vesting period, and the warrant expires on November 30, 2026.

January 23, 2020

In January 2020, the Company issued REach®, a related party, a warrant to purchase 186,442 shares of the Company’s Class A Common Stock at an exercise of $8.00 per share in exchange for the cancellation of a $100 thousand SAFE issued on August 18, 2017 by the Company’s affiliate Trusted Mail Inc. with a value of $125 thousand. The warrants were issued on January 23, 2020. There is no vesting period, and the warrants expire on December 20, 2024.

January 23, 2020

In January 2020, the Company issued SCV, a related party, a warrant to purchase 932,111 shares of the Company’s Class A Common Stock at a strike price of $8.00 per share in exchange for $300 thousand in cash and “Premium” sponsorship status with a credited value of $100 thousand per year for 3 years totaling $300 thousand. This “premium” sponsorship status provides the Company with certain benefits in marketing and networking, such as the Company being listed on the investor’s website, as well as providing the Company certain other promotional opportunities organized by the investor. The warrants were issued on January 23, 2020. There is no vesting period, and the warrants expire on December 20, 2024.

On December 21, 2021, SCV executed a Notice of Exercise for certain of its warrants to purchase 407,512 shares of Class A Common Stock at an exercise price of $8.00 per share for a total purchase price of $3.26 million. The closing occurred on January 10, 2022 and resulted in total cash proceeds of $3.26 million to the Company for the warrant exercise.

The warrants to purchase the remaining 524,599 shares of the Company’s Class A Common Stock remain outstanding as of June 30, 2024.

April 18, 2023

On April 14, 2023, the Company entered into a securities purchase agreement (“SPA”) with Armistice Capital Master Fund Ltd. Pursuant to which the Company agreed to issue and sell to the investor (i) in a registered direct offering, 563,380 shares of Class A Common Stock, par value $0.01 per share of the Company at a price of $3.30 per share, and pre-funded warrants to purchase up to 1,009,950 shares of Class A Common Stock, at a price of $3.299 per prefunded warrant, at an exercise price of $0.001 per share of Class A Common Stock, and (ii) in a concurrent private placement, common stock purchase warrants, exercisable for an aggregate of up to 1,573,330 shares of Class A Common Stock, at an exercise price of $3.30 per share. On April 18, 2023, the Company sold 563,380 shares of Class A Common Stock to the institutional investor at a price of $3.30 per share for total proceeds $1,859,154. Additionally, on same date, the institutional investor purchased and exercised the 1,009,950 pre-funded warrants, for total proceeds to the Company of $3,332,835, resulting in

an aggregate issuance by the Company of 1,573,330 shares of Class A Common Stock for net proceeds of $4,778,550 from the registered direct offering after deducting placement fee and legal expense of $363,439 and $50,000, respectively.

On December 21, 2023, the Company entered into an Inducement Agreement with Armistice Capital Master Fund Ltd. Pursuant to the terms of the Inducement Agreement, the exercise price for the warrants to purchase the remaining 1,573,330 shares of Class A Common Stock of the Company was reduced to $1.34 for a total purchase price of $2,108,262.

On December 21, 2023, the remaining 1,573,330 common stock purchase warrants to purchase shares of Class A Common Stock of the Company at a price of $1.34 per warrant were exercised for total proceeds of $2,108,262.

As of December 31, 2023, the Company had received Notice to Exercise for 798,000 common stock purchase warrants resulting in an issuance by the Company of 798,000 shares of Class A Common Stock. Due to the beneficial ownership limitation provisions in the Inducement Agreement, as of December 31, 2023 the remaining 775,330 common stock purchase warrants exercised on December 21, 2023 were unissued and held in abeyance for benefit of the institutional investor until notice from the institutional investor that the shares may be issued in compliance with the beneficial ownership limitation. On February 7, 2024 and February 27, 2024, the Company issued 320,000 and 455,330 shares, respectively.

All warrants related to this investment have been exercised and are no longer outstanding as of June 30, 2024.

June 5, 2023

On June 1, 2023, the Company entered into a securities purchase agreement (“SPA”) with an Armistice Capital Master Fund Ltd. Pursuant to which the Company agreed to issue and sell to the investor (i) in a registered direct offering, 736,400 shares of Class A Common Stock, par value $0.01 per share of the Company at a price of $2.30 per share, and pre-funded warrants to purchase up to 543,300 shares of Class A Common Stock, at a price of $2.299 per prefunded warrant, at an exercise price of $0.001 per share of Class A Common Stock, and (ii) in a concurrent private placement, common stock purchase warrants, exercisable for an aggregate of up to 1,279,700 shares of Class A Common Stock, at an exercise price of $2.30 per share. On June 5, 2023, the Company sold 736,400 shares of Class A Common Stock to the institutional investor at a price of $2.30 per share for total proceeds of $1,693,720. Additionally, on same date, the institutional investor purchased the 543,300 pre-funded warrants at a price of $2.299 per prefunded warrant, for total proceeds to the Company of $1,249,047, resulting in an issuance by the Company of 736,400 shares of Class A Common Stock for net proceeds of $2,686,773 from the registered direct offering after deducting placement fee and legal expense of $205,994 and $50,000, respectively.

On June 12, 2023, the institutional investor exercised 322,300 pre-funded warrants at a price of $0.001 per prefunded warrant, resulting in an issuance by the Company of 322,300 shares of Class A Common Stock for total proceeds of $322. Additionally, on June 23, 2023, the institutional investor exercised 221,000 pre-funded warrants at a price of $0.001 per prefunded warrant, resulting in an issuance by the Company of 221,000 shares of Class A Common Stock for total proceeds of $221.

On December 21, 2023, the Company entered into an Inducement Agreement with Armistice Capital Master Fund Ltd. Pursuant to the terms of the Inducement Agreement, the exercise price for the common stock purchase warrants to purchase the remaining 1,279,700 shares of Class A Common Stock of the Company was reduced to $1.34 for a total purchase price of $1,714,798.

On December 21, 2023, the institutional investor exercised 106,670 warrants to purchase shares of Class A Common Stock of the Company at a price of $1.34 per warrant for total proceeds of $142,938.

As of December 31, 2023, due to the beneficial ownership limitation provisions in the Inducement Agreement, the 106,670 warrants were unissued and held in abeyance for benefit of the institutional investor until notice from the institutional investor that the shares may be issued in compliance with the beneficial ownership limitation. These shares were subsequently issued on February 27, 2024.

The common stock purchase warrants to purchase 1,173,030 shares of the Company’s Class A Common Stock remain outstanding as of June 30, 2024.

December 21, 2023

On December 21, 2023, the Company entered into a warrant exercise agreement (the “WEA”) with a certain existing institutional investor, pursuant to which the institutional investor agreed to exercise (the “Exercise”) (i) a portion (106,670) of the warrants issued to the institutional investor on June 5, 2023, which, as of December 21, 2023, were exercisable for 1,279,700 shares of the Company’s Class A Common Stock, par value $0.01 per share (“Class A Common Stock”) with a current exercise price of $2.30 per share (the “June 2023 Warrants”), (ii) all of the warrants issued to the institutional investor on September 14, 2022, as amended on June 5, 2023, which are exercisable for 120,000 shares of Class A Common Stock, with a current exercise price of $2.30 per share (the “September 2022 Warrants”), and (iii) all of the warrants issued to the institutional investor on April 18, 2023, which are exercisable for 1,573,330 shares of Class A Common Stock, with a current exercise price of $3.30 per share (the “April 2023 Warrants” and collectively with all of the June 2023 Warrants and the September 2022 Warrants, the “Existing Warrants”). In consideration for the immediate exercise of 1,800,000 of the Existing Warrants for cash, the Company agreed to reduce the exercise price of all of the Existing Warrants, including any unexercised portion thereof, to $1.34 per share, which was equal to the most recent closing price of the Company’s Class A Common Stock on The Nasdaq Stock Market prior to the execution of the WEA. As of June 30, 2024, the institutional investor had submitted an Exercise Notice for all 1,800,000 Existing Warrants, in two batches, 918,000 and 882,000, respectively, and the shares of Class A Common Stock were issued to the warrant holders.

In addition, in consideration for such Exercise, the Selling Stockholder received new unregistered warrants to purchase up to an aggregate of 3,600,000 shares of Class A Common Stock, equal to 200% of the shares of Class A Common Stock issued in connection with the Exercise, with an exercise price of $1.34 per share (the “New Warrants”) in a private placement pursuant to Section 4(a)(2) of the Securities Act of 1933 (the “Securities Act”).

All 3,600,000 of the New Warrants remain outstanding as of June 30, 2024.

April 3, 2024

On April 3, 2024, the Company closed a Securities Purchase Agreement with a certain institutional investor. Pursuant to the terms of the Securities Purchase Agreement, the investor agreed to purchase from the Company 499,990 shares of Class A Common Stock, par value $0.01 of the Company and pre-funded warrants to purchase 1,500,010 shares of Class A Common Stock of the Company ("Warrant A") at a purchase price of $0.968 per share resulting in a total purchase price of $1,936,000. The Company paid offering costs of $245,520 resulting in net proceeds of $1,690,480.

Additionally, pursuant to the Securities Purchase Agreement, as additional consideration for the share and Warrant A purchase described above, the Company agreed to issue to the Selling Stockholder a stock purchase warrant for the purchase of 2,000,000 shares of the Company’s Class A Common Stock at an exercise price of $0.968 per share (“Warrant B”), and a stock purchase warrant for the purchase of 1,600,000 shares of the Company’s Class A Common Stock at an exercise price of $1.06 per share (“Warrant C”).

On May 24, 2024, the institutional investor exercised 542,100 pre-funded warrants from Warrant A to purchase shares of Class A Common Stock of the Company at an exercise price of $0.000 per warrant for total proceeds of $0.

As of June 30, 2024, 957,910 warrants of Warrant A, 2,000,000 warrants of Warrant B, and 1,600,000 warrants of Warrant C remain outstanding.

Subsequent to June 30, 2024, the institutional investor exercised an additional 799,091 pre-funded warrants from Warrant A to purchase shares of Class A Common Stock of the Company at an exercise price of $0.000 per warrant for total proceeds of $0 to the Company.

4. Balance Sheet Components

Prepaid expenses and other current assets

Prepaid expenses and other current assets as of June 30, 2024 and December 31, 2023 consisted of the following:


	June 30, 2024		December 31, 2023
Prepaid operating expenses	$	270,332	$	216,875
Rent deposit	30,333		28,400
Value added tax receivable	49,455		116,095
Tax credit receivable (short-term)	25,045		102,151
Miscellaneous receivable	351,447		363,260
Prepaid expenses and other current assets	$	726,612	$	826,781

Capitalized internal-use software, net

Capitalized internal-use software, net as of as of June 30, 2024 and December 31, 2023 consisted of the following:


	Useful Lives	June 30, 2024		December 31, 2023
Internally developed software	5 Years	$	4,215,099	$	3,901,801
Less: Accumulated depreciation		(2,705,919)		(2,429,427)
Capitalized internal-use software, net		$	1,509,180	$	1,472,374

Amortization expense is recognized on a straight-line basis and during the three months ended June 30, 2024 and 2023 totaled $139 thousand and $138 thousand, respectively. Amortization expense during the six months ended June 30, 2024 and 2023 totaled $278 thousand and $279 thousand, respectively.

Property and equipment, net

Property and equipment, net as of as of June 30, 2024 and December 31, 2023 consisted of the following:


	Useful Lives	June 30, 2024		December 31, 2023
Computer equipment	3-4 Years	$	146,596	$	152,014
Furniture and fixtures	10 Years	33,937		28,052
Property and equipment, gross		180,533		180,066
Less: Accumulated depreciation		(137,021)		(123,630)
Property and equipment, net		$	43,512	$	56,436

Depreciation expense is recognized on a straight-line basis and during the three months ended June 30, 2024 and 2023 totaled $9 thousand and $11 thousand, respectively. Depreciation expense during the six months ended June 30, 2024 and 2023 totaled $19 thousand and $53 thousand, respectively.

Accrued expenses

Accrued expenses as of June 30, 2024 and December 31, 2023 consisted of the following:


	June 30, 2024		December 31, 2023
Compensation payable	$	552,133	$	377,403
Commission liability	20,454		26,863
Accrued employee taxes	909,171		624,525
Other accrued liabilities	57,620		115,099
Accrued expenses	$	1,539,378	$	1,143,890

5. Goodwill and Intangible Assets, Net

There were no changes in the carrying amount of Goodwill for the six months ended June 30, 2024.

Intangible assets, net as of June 30, 2024 and December 31, 2023 consisted of the following:


	Useful Lives	June 30, 2024		December 31, 2023
Patent application costs	3 Years	$	522,845	$	484,035
Trade name and trademarks	3 Years	68,312		70,446
Intangible assets, gross		591,157		554,481
Less: Accumulated amortization		(398,538)		(330,791)
Intangible assets, net		$	192,619	$	223,690

The Company added 5 new issued patents during the six months ended June 30, 2024. The patents issued during the six months ended June 30, 2024 increased our total number of patents to 22 and include:

•On January 2, 2024, the Company received Notice of Issuance for a patent that is a continuation of “Systems and Processes for Lossy Biometric Representation.” This patent is a continuation addresses a long-felt but unresolved need for a system or process that can transform size-variant, personally-identifying biometric templates into fixed-size, privacy-secured representations, while maintaining sufficiently accurate biometric matching capabilities.

•On January 30, 2024, the Company received Notice of Issuance for a patent that is a continuation of “Systems and Processes for Lossy Biometric Representation.” This technology provides a system or process that can transform size-variant, personally-identifying biometric templates into fixed-size, privacy-secured representations, while maintaining sufficiently accurate biometric matching capabilities.

•On March 19, 2024, the Company received Notice of Issuance for a patent entitled “Systems and Methods for Enhanced Hash Transforms.” Conventional cryptographic hashing techniques generally include functions that generate unique signatures given a piece of data, accepting binary strings of characters as an input, and producing a string (e.g., a digital signature) as an output. Our new patent addresses the need for improved techniques for securely handling sensitive data.

•On April 23, 2024, the Company received Notice of Issuance for a patent entitled “Face Cover-compatible Biometrics and Processes for Generating and Using Same.” which allows for enrollment of biometric information from individuals wearing face coverings such that subsequent biometric identification and verification processes may not require the individuals to remove their face coverings.

•On April 30, 2024, the Company received Notice of Issuance for a patent entitled “Systems and Methods for Liveness-verified, Biometric-based Encryption.” This patent fulfills a long-felt but unresolved need for a system or method that permits encryption/decryption based on liveness-verified biometric data that cannot be stolen or spoofed.

Intangible asset amortization expense is recognized on a straight-line basis and during the three months ended June 30, 2024 and 2023 totaled $33 thousand and $38 thousand, respectively. Intangible asset amortization expense during the six months ended June 30, 2024 and 2023 totaled $70 thousand and $75 thousand, respectively.

Estimated future amortization expense of Intangible assets, net is as follows:


Years Ending December 31,	Amount
2024	$	60,076
2025	87,980
2026	41,505
2027	3,058
Total future amortization	$	192,619

6. Net Loss per Share Attributable to Common Stockholders

The following table presents the calculation of basic and diluted net loss per share:


	For the three months ended June 30,				For the six months ended June 30,
	2024		2023		2024		2023
Numerator:
Net loss attributable to common stockholders	$	(2,598,361)	$	(2,170,368)	$	(5,276,930)	$	(4,717,818)

Denominator:
Weighted average shares used in computing net loss per share attributable to common stockholders	12,227,476		6,757,320		11,169,735		5,897,089

Net loss per share attributable to common stockholders	$	(0.21)	$	(0.32)	$	(0.47)	$	(0.80)

The following potentially dilutive securities were excluded from the computation of diluted net loss per share calculations for the periods presented because the impact of including them would have been anti-dilutive:


	As of June 30,
	2024	2023
Options, RSUs, and grants	1,323,580	642,927
Warrants	12,817,277	5,017,180
Total	14,140,857	5,660,107

7. Stock Awards and Stock-Based Compensation

From time to time, the Company may issue stock awards in the form of Class A Common Stock grants, Restricted Stock Units (RSUs), or Class A Common Stock options with vesting/service terms. Stock awards are valued on the grant date using the Company’s common stock share price quoted on an active market. Stock options are valued using the Black-Scholes-Merton pricing model to determine the fair value of the options. We generally issue our awards in terms of a fixed monthly value, resulting in a variable number of shares being issued, or in terms of a fixed monthly share number.

During the three months ended June 30, 2024 and 2023, the Company entered into agreements with advisory board members and other external advisors to issue cash payments and stock awards in exchange for services rendered to the Company monthly. The total granted stock-based awards to advisory board members and other external advisors during the three months ended June 30, 2024 and 2023 included grants totaling, $9 thousand and $0, respectively, options totaling $0, and RSUs totaling $1 thousand and $6 thousand, respectively.

In addition to issuing stock awards to advisory board members and other external advisors, during the three months ended June 30, 2024 and 2023, the Company granted stock-based awards to multiple employees. The total granted stock-based

awards to employees during the three months ended June 30, 2024 and 2023 included grants totaling, $8 thousand and $21 thousand, respectively, options totaling $1 thousand and $3 thousand, respectively, and RSUs totaling $288 thousand and $68 thousand, respectively.

During the six months ended June 30, 2024 and 2023, the Company entered into agreements with advisory board members and other external advisors to issue cash payments and stock awards in exchange for services rendered to the Company monthly. The total granted stock-based awards to advisory board members and other external advisors during the six months ended June 30, 2024 and 2023 included grants totaling, $18 thousand and $0, respectively, options totaling $0, and RSUs totaling $2 thousand and $9 thousand, respectively.

In addition to issuing stock awards to advisory board members and other external advisors, during the six months ended June 30, 2024 and 2023, the Company granted stock-based awards to multiple employees. The total granted stock-based awards to employees during the six months ended June 30, 2024 and 2023 included grants totaling, $20 thousand and $47 thousand, respectively, options totaling $4 thousand and $7 thousand, respectively, and RSUs totaling $562 thousand and $95 thousand, respectively.

Stock Options

The following table summarizes stock option activity for the three and six months ended June 30, 2024:


	Options Outstanding	Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (years)	Aggregate Intrinsic Value
Balance as of January 1, 2023	387,109	$	6.40	1.45	$	—
Options granted	11,890	2.28
Options exercised	(1,230)	3.25
Options canceled and forfeited	(4,186)	5.73
Balance as of December 31, 2023	393,583	6.27		1.95	—
Options granted	3,825	1.57
Options exercised	—	—
Options canceled and forfeited	(1,425)	4.21
Balance as of March 31, 2024	395,983	6.24		1.72	—
Options granted	4,375	1.37
Options exercised	—	—
Options canceled and forfeited	(510)	3.92
Balance as of June 30, 2024	399,848	$	6.19	1.49	$	—
Options vested and exercisable as of June 30, 2024	399,848	$	6.19	1.49	$	—


	Options Outstanding	Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (years)	Aggregate Intrinsic Value
Balance as of January 1, 2024	393,583	$	6.27	1.95	$	—
Options granted	8,200	1.46
Options exercised	—	0
Options canceled and forfeited	(1,935)	4.13
Balance as of June 30, 2024	399,848	$	6.19	1.49	—
Options vested and exercisable as of June 30, 2024	399,848	$	6.19	1.49	$	—

The aggregate intrinsic value of options outstanding, exercisable, and vested is calculated as the difference between the exercise price of the underlying options and the fair value of the Company’s common stock. The aggregate intrinsic value of options exercised during the six months ended June 30, 2024 and 2023 was $0.

The weighted average grant-date fair value of options granted during the six months ended June 30, 2024 and 2023 was $0.43 and $1.48 per share, respectively. The total grant-date fair value of options that vested during the six months ended June 30, 2024 and 2023 was $4 thousand and $7 thousand, respectively.

The following assumptions were used to calculate the fair value of options granted during the six months ended June 30, 2024:


Fair value of Class A Common Stock	$0.17 — 0.72
Exercise price	$1.32 — 1.64
Risk free interest rate	4.11 — 4.71%
Expected dividend yield	0.00	%
Expected volatility	77.54 — 79.80%
Expected term	3 Years

As of June 30, 2024, the Company had 399,848 stock options outstanding of which all are fully vested options.

Stock Grants

As of June 30, 2024, the Company has 60,270 common stock grants outstanding of which 45,502 were vested but not issued and 14,768 were not yet vested. All granted and outstanding common stock grants will fully vest by June 30, 2025. The Company had unrecognized stock-based compensation related to common stock grants of $7 thousand as of June 30, 2024.

RSU

As of June 30, 2024, the Company had 863,462 RSUs outstanding of which 37,175 were vested but not issued and 826,287 were not yet vested. All granted and outstanding RSUs will fully vest by January 2, 2025. The Company had unrecognized stock-based compensation related to RSUs of $584 thousand as of June 30, 2024.

During the six months ended June 30, 2024 the Company issued 54,734 of Class A Common Stock to employees that were designated for employee stock awards and were previously recorded as treasury stock.

A summary of outstanding RSU activity as of June 30, 2024 is as follows:


			RSU Outstanding Number of Shares
Balance as of January 1, 2023			292,564
Granted			410,516
Vested (issued)			(159,776)
Forfeited			(97,202)
Balance as of December 31, 2023			446,102
Granted			812,050
Vested (issued)			(318,812)
Forfeited			(75,878)
Balance as of June 30, 2024			863,462

Stock-based compensation expense

Our consolidated statements of operations include stock-based compensation expense as follows:


	For the three months ended June 30,				For the six months ended June 30,
	2024		2023		2024		2023
Cost of services	$	—	$	161	$	262	$	656
Research and development	6,094		12,766		14,210		31,620
Selling, general, and administrative	301,031		84,810		590,539		125,035
Total stock-based compensation expense	$	307,125	$	97,737	$	605,011	$	157,311

8. Related Party Transactions

Related party payables of $53 thousand and $82 thousand as of June 30, 2024 and December 31, 2023, respectively, primarily relate to amounts owed to 10Clouds, the Company’s contractor for software development and investor in the Company, and smaller amounts payable to members of management as expense reimbursements. Total costs incurred in relation to 10Clouds for the three months ended June 30, 2024 and 2023, totaled approximately $7 thousand and $242 thousand, respectively. Total costs incurred in relation to 10Clouds for the six months ended June 30, 2024 and 2023, totaled approximately $111 thousand and $535 thousand, respectively.

Mutual Channel Agreement

On November 15, 2020, the Company entered into a Mutual Channel Agreement with Vital4Data, Inc., a company at which one of our Directors serves as Chief Executive Officer. Pursuant to the agreement, the Company engaged Vita4Data, Inc. as a non-exclusive sales representative for the Company’s products and services. Vital4Data, Inc. is entitled to compensation in the form of commissions, receiving a 20% of commission-eligible on net revenue from sales generated by Vital4Data, Inc. in the first year of the contract term, which is reduced to 10% in the second year, and 5% in the third year. The Company has not earned or expensed any commissions pursuant to the Vital4Data, Inc. agreement to date. As of June 30, 2024 and December 31, 2023, the Vital4Data, Inc. commission due was $0.

9. Malta Grant

During July 2020 the Company entered into an agreement with the Republic of Malta that would provide for a grant of up to €200 thousand or $251 thousand as reimbursement for operating expenses over the first twelve months following Trust Stamp Malta’s incorporation in the Republic of Malta. The Company must provide an initial capital amount of €50 thousand or $62 thousand, which is matched with a €50 thousand or $62 thousand grant. The remaining €150 thousand or $190 thousand are provided as reimbursement of operating expenses twelve months following incorporation.

U.S. GAAP does not provide authoritative guidance regarding the receipt of economic benefits from government entities in return for compliance with certain conditions. Therefore, based on ASC 105-10-05-2, non-authoritative accounting guidance from other sources was considered by analogy in determining the appropriate accounting treatment, the Company elected to apply International Accounting Standards 20 – Accounting for Government Grants and Disclosure of Government Assistance and recognizes the expected reimbursements from the Republic of Malta as deferred income. As reimbursable operating expenses are incurred, a receivable is recognized (reflected within “Prepaid expenses and other current assets” in the consolidated balance sheets) and income is recognized in a similar systematic basis over the same periods in the consolidated statements of operations. During the six months ended June 30, 2023, the Company incurred $0 in expenses that are reimbursable under the grant. As of June 30, 2024, all amounts provided for under this grant were received.

On January 25, 2022, the Company entered into an additional agreement with the government of Malta for a grant of up to €100 thousand or $107 thousand, in terms of the ‘Investment Aid to produce the COVID-19 Relevant Product’ program, to support the proposed investment. The estimated value of the grant is €137 thousand or $146 thousand, at an aid intensity of 75% to cover eligible wage costs incurred after February 1, 2022 in relation to new employees engaged specifically for the implementation of the project. On September 22, 2022, the Company entered into an amendment agreement that enables the Company to submit eligible employee expenses for reimbursement by October 31, 2022. The grant was approved in January 2022, however, the request for payment was not approved and management abandoned the agreement. Hence,

during the six months ended June 30, 2024 and 2023, the Company incurred $0, respectively, in expenses that are reimbursable under the grant. As of June 30, 2024, no amounts provided under this grant were received.

10. Leases and Commitments

Operating Leases — The Company leases office space in Atlanta, Georgia, which serves as its corporate headquarters, office space in Malta, which serves as its research and development facility, and vehicles in Malta that are considered operating lease arrangements under ASC 842 guidance. In addition. the Company contracts for month-to-month coworking arrangements in other office spaces in North Carolina, Denmark, Poland, and Rwanda to support its dispersed workforce. As of June 30, 2024, there were no minimum lease commitments related to month-to-month lease arrangements.

Initial lease terms are determined at commencement date, the date the Company takes possession of the property, and the commencement date is used to calculate straight-line expense for operating leases. Certain leases contain renewal options for varying periods, which are at the Company’s sole discretion. For leases where the Company is reasonably certain to exercise a renewal option, such option periods have been included in the determination of the Company’s Operating lease right-of-use assets and Operating lease liabilities. The Company’s leases have remaining terms of 1 to 5 years. As the Company’s leases do not provide an implicit rate, the present value of future lease payments is determined using the Company’s incremental borrowing rate based on information available at the commencement date.


Lease term and discount rate	June 30, 2024
Weighted average remaining lease term	2.01 years
Weighted average discount rate	5.0	%

During the six months ended June 30, 2024, the Company did terminated one operating lease, one office located in the United States. The lease was terminated upon the conclusion of the agreed upon lease term, therefore, there were no termination fees, Right-of-use assets derecognized, Lease liabilities derecognized, or losses recognized.

Balance sheet information related to leases as of as of June 30, 2024 and December 31, 2023 was as follows:


	June 30, 2024		December 31, 2023
Operating lease right-of-use assets
Operating lease right-of-use assets	$	229,370	$	164,740

Operating lease liabilities
Short-term operating lease liabilities	$	123,431	$	81,236
Long-term operating lease liabilities	73,520		53,771
Total operating lease liabilities	$	196,951	$	135,007

Future maturities of ASC 842 lease liabilities as of June 30, 2024 are as follows:


Years Ending December 31,	Principal Payments		Imputed Interest Payments		Total Payments
2024	$	71,229	$	4,184	$	75,413
2025	86,673		3,608		90,281
2026	22,390		1,130		23,520
2027	8,493		602		9,095
2028	8,166		171		8,337
Total future maturities	$	196,951	$	9,695	$	206,646

Total lease expense, under ASC 842, was included in Selling, general, and administrative expenses in our consolidated statement of operations for the three and six months ended June 30, 2024 and 2023 as follows:


	For the three months ended June 30,				For the six months ended June 30,
	2024		2023		2024		2023
Operating lease expense – fixed payments	$	37,976	$	46,402	$	77,853	$	129,436
Short term lease expense	12,284		15,620		24,220		37,552
Total lease expense	$	50,260	$	62,022	$	102,073	$	166,988

Supplemental cash flows information related to leases was as follow:


	For the six months ended June 30,
	2024		2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	(80,248)	$	(104,817)

During the six months ended June 30, 2024, the Company did not incur variable lease expense.

Financial Liability Obligation — The Company’s financial liability totaled $0 and $162 thousand as of June 30, 2024 and December 31, 2023, respectively, for an executed agreement with a telecommunications company for acquiring mobile hardware. On March 3, 2023, the Company provided a 30-day termination notice to the telecommunications company which terminates the mobile hardware data service. Under the contract terms with the telecommunications company, upon termination of the data service the Company must pay the remaining financial liability during the final data service billing period. The remaining financial liability was resolved with a settlement and no further payment is due as of June 30, 2024.

Litigation — The Company is not currently involved with and does not know of any pending or threatening litigation against the Company or any of its officers or directors in connection with its business.

11. Subsequent Events

Promissory Note Agreement — On July 9, 2024, the Company entered into a subordinated secured promissory note with Agile Lending, LLC as lead lender (“Agile”) and Agile Capital Funding, LLC as collateral agent, which provides for a term loan to the Company of $453,600 with the principal amount of $315,000 and interest of $138,600. Commencing July 18, 2024, the Company is required to make weekly payments of $16,200 until the due date, January 23, 2025. The loan may be prepaid subject to a prepayment fee. An administrative agent fee of $15,000 was paid on the loan. In connection with the loan, Agile was issued a subordinated secured promissory note, dated July 9, 2024, in the principal amount of $315,000 which note is secured by all of the Borrower’s assets, including receivables.

Boumarang License Agreement — On August 6, 2024, the Company entered into a License Agreement (the “Agreement”) with Boumarang Inc. (“Boumarang”), a developer, manufacturer, and seller of hydrogen-powered UAV and USV drones. Pursuant to the Agreement, the Company agreed to grant a non-exclusive license to Boumarang to exploit certain of the Company’s patents for the purpose of producing, selling, marketing, and distributing drones. As consideration for the grant of the non-exclusive license, Boumarang agreed to pay the Company a non-refundable license fee of $5,000,000 in the form of a prepaid warrant issued by Boumarang to the Company for 5,000,000 shares of common stock of Boumarang at $1.00 per share (the “Prepaid Warrant”).

Boumarang Subscription Agreement — On August 6, 2024, Trust Stamp executed a Subscription Agreement with Boumarang to participate in a Regulation D offering being conducted by Boumarang, subscribing for 100,000 shares of Boumarang's common stock at a price per share of $1.00. The Company made the $100,000 subscription payment on August 6, 2024.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and the accompanying notes thereto included elsewhere in this Quarterly Report on Form 10-Q and with our audited consolidated financial statements and the accompanying notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2023, as previously filed with the Commission. This discussion contains forward-looking statements based upon current plans, expectations, and beliefs, involving risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements. Our historical results are not necessarily indicative of the results that may be expected for any period in the future.

Overview

Trust Stamp was incorporated under the laws of the State of Delaware on April 11, 2016 as “T Stamp Inc.” T Stamp Inc. and its subsidiaries (“Trust Stamp”, “we”, or the “Company”) develop and market identity authentication software for enterprise and government partners and peer-to-peer markets.

Trust Stamp develops proprietary artificial intelligence-powered identity and trust solutions at the intersection of biometrics, privacy, and cybersecurity. These solutions enable organizations to protect themselves and their users while empowering individuals to retain ownership of their identity data and prevent fraudulent activity using their identity.

Trust Stamp tackles industry challenges including data protection, regulatory compliance, and financial accessibility, with cutting-edge technology including biometric science, cryptography, and machine learning. Our core technology irreversibly transforms identity information to create tokenized identifiers that enable accurate authentication without storing or sharing sensitive data. By retaining the usefulness of biometric-derived data while minimizing the risk, we allow businesses to adopt biometrics and other anti-fraud initiatives while protecting personal information from hacks and leaks.

Trust Stamp’s key sub-markets are identity authentication for account opening, access, and fraud detection, tokenized digital identities to facilitate financial and societal inclusion, and in-community case management software for alternatives to detention and other governmental uses.

As biometric solutions proliferate, so does the need to protect biometric data. Stored biometric images and templates represent a growing and unquantified financial, security, and PR liability and are the subject of governmental, media, and public scrutiny since biometric data cannot be “changed” once they are hacked, as they are directly linked to the user’s physical features and/or behaviors. Privacy concerns around biometric technology have led to close attention from regulators, with multiple jurisdictions placing biometrics in a special or sensitive category of personal data and demanding much stronger safeguards around collection and safekeeping.

To address this unprecedented danger and increased cross-industry need to establish trust quickly and securely in virtual environments, Trust Stamp has developed its Irreversibly Transformed Identity Token, or IT2 TM, solutions. These solutions replace biometric templates with a cryptographic hash that can never be rebuilt into the original data and cannot be used to identify the subject outside the environment for which it is designed.

Trust Stamp’s data transformation and comparison technology is vendor and modality-agnostic, allowing organizations including other biometric services providers to benefit from our proprietary tokenization process's increased protection, efficiency, utility. With online and offline functionality, Trust Stamp technology is effective in even the most remote locations in the world.

Trust Stamp also offers end-to-end solutions for multi-factor biometric authentication for account access and recovery, KYC/AML compliance, customer onboarding, and more, which allow organizations to approve more genuine users, keep bad actors from accessing systems and services and retain existing users with a superior user experience.

Markets

Trust Stamp has evaluated the market potential for its services in part by reviewing the following reports, articles, and data sources, none of which were commissioned by the Company, and none of which are to be incorporated by reference:

Data Security and Fraud

•According to the “2021 Year End Report: Data Breach QuickView” published by Flashpoint, 4,145 publicly disclosed breaches exposed over 22 billion records in 2022.

•The cumulative merchant losses to online payment fraud between 2023 and 2027 will exceed $343 billion globally according to a 2022 report titled “Fighting Online Payment Fraud in 2022 & Beyond” published by Juniper Research.

Trust Stamp addresses this market with biometric identity verification and biometric authentication solutions. These solutions offer Trust Stamp’s proprietary irreversible identity token to perform biometric-based matching in a secure and tokenized domain, matching tokenized personally identifiable information while implementing liveness detection.

The Company recently announced the development of a biometric authentication process for wire transfers and other high value transactions, a product of particular and immediate relevance to financial institutions concerned about the potential of deep fake attacks on existing authentication systems. The Company currently has three new banking clients who have indicated willingness to participate in a trial of the product scheduled for Q3 of 2024.

Biometric Authentication

•According to a 2022 report titled “Mobile Payment Biometrics,” published by Juniper Research, the value of biometrically authenticated remote mobile payments will reach $1.2 trillion globally by 2027.

•The global biometric system market size is valued at $41.1 billion per annum in 2023, with a forecast compound growth of 20.4% from 2023 to 2030 with a 2030 revenue forecast of $150.6 billion according to the 2023 report titled “Biometric Technology Market Size, Share & Trends Analysis Report By Component, By Offering, By Authentication Type, By Application, By End-use, By Region, And Segment Forecasts, 2023 — 2030” published by Grand View Research.

Trust Stamp addresses this market through its biometric authentication and liveness detection products. These products offer our proprietary IT2 token to perform biometric matching in a secure and tokenized domain. This permits biometric authentication without the risk of storing pictures and biometric templates.

In addition to identity authentication, the Company’s deep learning algorithms can be used to identify specific criteria from facial biometric captures and it has been developing and testing age-estimation software for the rapidly growing age verification market. The new age estimation software is expected to go live with a first commercial client in Q3 of 2024.

Financial and Societal Inclusion

•According to the “Global Findex Database 2021,” published by the World Bank, 1.4 billion people were unbanked as of 2021.

•131 million small and medium-sized enterprises in emerging markets lack access to finance, limiting their ability to grow and thrive (UNSGSA Financial Inclusion Webpage, Accessed March 2023).

•The global market for Microfinance is estimated at $157 Billion in the year 2020, and is projected to reach $342 billion by 2026 according to the 2022 report titled “Microfinance - Global Market Trajectory & Analytics” published by Global Industry Analysts, Inc.

Trust Stamp’s biometric authentication, liveness detection, and information tokenization enable individuals to verify and establish their identities using data derived from biometrics. While individuals in this market lack traditional means of identity verification, Trust Stamp provides a means to authenticate identity that preserves an individual’s privacy and control over that identity.

Alternatives to Detention (“ATD”)

•The ATD market includes Federal, State, and Municipal agencies for both criminal justice and immigration purposes. Trust Stamp addresses the ATD market with applications built on Trust Stamp’s privacy-preserving solutions allowing individuals to comply with ATD requirements using ethical and humane technology methodologies. Trust Stamp has developed innovative patented technologies for use in the ATD market encompassing biometrics, geolocation, and tokenization as well as a proprietary, tamper-resistant, battery-free “Tap-In-Band” that can complement or replace biometric check-in requirements and provide a lower-cost and more humane alternative to traditional “ankle bracelet” technology.

Other Markets

The Company is developing products and working with partners and industry organizations in other sectors that offer significant market opportunities and has entered into go-to-market or licensing agreements, including global data location services, healthcare, IoT, automotive dealer services, and computer vision for UAV operations. We anticipate licensing our technology in numerous fields, typically through established partners who will integrate our technology into field-specific applications.

Principal Products and Services

Trust Stamp’s most important technology is the Irreversibly Transformed Identity Token or IT2, which is combined with a data architecture that can use one or multiple sources of biometric or other identifying data. Once a “hash translation” algorithm is created, like-modality hashes are comparable regardless of their origin. The IT2 protects against system and data redundancy, providing a lifelong “digital-DNA” that can store (or pivot to) any type of KYC or relationship data with fields individually hashed or (salted and) encrypted, facilitating selective data sharing. Products utilizing the IT2 are Trust Stamp’s primary products, accounting for the majority of its revenues during the six months ended June 30, 2024.

We adhere to the best practices outlined in the National Institute of Standards and Technology (“NIST”) and International Organization for Standardization (“ISO”) frameworks, and our policies and procedures in managing personally identifiable information (“PII”) comply with General Data Protection Regulation (“GDPR”) requirements wherever such requirements are applicable.

Key Customers

The Company’s initial business consisted of developing proprietary privacy-first identity solutions and implementing them through custom applications built and maintained for a few key customers. In 2022, the Company added to its product offerings a modular and highly scalable SaaS model with low-code or no implementation (“the Orchestration Layer”). Although the Company remains open to significant opportunities to deliver custom solutions, sales of Orchestration Layer products are the primary focus of the Company’s sales and development initiatives. This strategic pivot in the Company’s go-to-market approach negatively impacted revenue in 2023 but we believe it will substantially increase potential revenue.

Historically, the Company generated most of its income through long-term partnerships, comprising a relationship with an S&P 500 bank with services provided pursuant to a Master Software Agreement entered into in 2017, together with a relationship with Mastercard International (“Mastercard”) with services provided under the terms of a five-year technology services agreement entered into in March 2019 and extended in March 2024 to April 2027 (the "TSA”). Both of those relationships remain strong, and the Company anticipates future revenue growth from the two relationships.

Under the TSA, IT2 technology is being implemented by Mastercard for Humanitarian & Development purposes as a core element of its Community Pass and Inclusive Identity offerings. Use cases include financial services for individuals and businesses and empowering people and communities to meet basic needs, such as nutritious food, clean water, housing, education, and healthcare. The Company is paid to develop and host software solutions utilizing the IT2 and to support Mastercard’s implementations. In addition, the Company is paid on a “per user per year” basis for all transactions utilizing its technology. In December of 2022, the Company entered into a modification of the agreed pricing schedule with Mastercard to move from a per-use to a per-user-year model to broaden the range of potential use cases. The TSA may be terminated by either party in the event of a material breach by the other party that remains uncured within thirty days after notice is received of such a breach. Either party may terminate the TSA if the other party becomes, including, but not limited to, insolvent, subject to bankruptcy, dissolved, or liquidated. Unless the TSA is terminated, the TSA will automatically renew for additional one-year periods in perpetuity unless either party provides ninety days' written notice of

intent not to renew. To date, the Company has received guaranteed minimum annual payments on account of usage. According to the October 2023 interview of Mastercard Executive Vice President and Founder of the Community Pass from the article titled “Mastercard’s Community Pass founder says digital ID platform improving lives, digital inclusion,” published by Biometric Update. Mastercard’s Community Pass program currently serves approximately 3.5 million users and is targeting 30 million users by 2027. Based on information provided to us by Mastercard, we anticipate user-based revenue will start in 2024 and grow year-on-year thereafter.

In 2022, the Company expanded its key customer base to include a relationship with FIS, which was focused on implementing our Orchestration Layer and underlying technologies in FIS’ Global KYC product offering.

The Orchestration Layer is a low-code platform designed to be a one-stop shop for Trust Stamp services and provides easy integration to our products, which are chargeable on a per-user basis. The Orchestration Layer utilizes the Company’s next-generation identity package, offering rapid deployment across devices and platforms, with custom workflows that seamlessly orchestrate trust across the identity lifecycle for a consistent user experience in processes for onboarding and KYC/AML, multi-factor authentication, account recovery, fraud prevention, compliance, and more. The Orchestration Layer facilitates no-code and low-code implementations of the Company’s technology, making adoption and updating faster and more cost-effective for a broader range of potential customers.

In the third quarter of 2022, the Company acquired its first 2 new customers on the Orchestration Layer through its partnership with FIS, and in the fourth quarter of 2022, 4 additional FIS customers onboarded. As of June 30, 2024, a total of 54 financial institutions with over $345 billion in assets have been onboarded via FIS, bringing the total number of (FIS and non-FIS) customers either fully implemented or are currently implementing the Orchestration Layer to 62. The first (non-FIS) client onboarded to the Orchestration Layer in the third quarter of 2022 has generated $343 thousand of revenue for the Company to date including $110 thousand during the six months ended June 30, 2024. Although each institution onboarded via FIS pays a small onboarding fee, given the typical time a financial institution takes to test, implement, and roll out any new technology, the Company does not anticipate significant revenue from the new FIS customers until late 2024.

Reinforced by the product-market fit indicated by the FIS rollout, the Company is building an internal direct sales force to offer the Orchestration Layer to non-FIS institutions. This expansion into direct sales is a work in progress, and the Company is dynamically adapting its approach based on progress toward acceptable success metrics.

In Management's opinion, while the unanticipated loss of any one of our current customers, including our channel partnership with FIS, could adversely affect the Company’s financial position, it would not prevent us from continuing our operations.

Key Business Measures

In addition to the measures presented in our unaudited condensed consolidated financial statements, we use the following key non-GAAP business measures to help us evaluate our business, identify trends affecting our business, formulate business plans and financial projections, and make strategic decisions.

Adjusted EBITDA

This discussion includes information about Adjusted EBITDA that is not prepared in accordance with U.S. GAAP. Adjusted EBITDA is not based on any standardized methodology prescribed by U.S. GAAP and is not necessarily comparable to similar measures presented by other companies. A reconciliation of this non-GAAP measure is included below.

Adjusted EBITDA is a non-GAAP financial measure that represents U.S. GAAP net income (loss) adjusted to exclude (1) other expense, (2) other income, (3) gain on sale of mobile hardware, (4) interest expense, (5) interest income, (6) stock-based compensation, (7) change in fair value of warrant liabilities (8) impairment of assets, (9) non-cash expenses for in-kind services, (10) depreciation, and (11) certain other items management believes affect the comparability of operating results.

Management believes that Adjusted EBITDA, when viewed with our results under U.S. GAAP and the accompanying reconciliations, provides useful information about our period-over-period results. Adjusted EBITDA is presented because management believes it provides additional information with respect to the performance of our fundamental business

activities and is also frequently used by securities analysts, investors and other interested parties in the evaluation of comparable companies. We also rely on Adjusted EBITDA as a primary measure to review and assess the operating performance of our Company and our management, and it will be a focus as we invest in and grow the business.

Adjusted EBITDA has limitations as an analytical tool and should not be considered in isolation from, or as a substitute for, analysis of our results as reported under GAAP. Some of these limitations are:

•Adjusted EBITDA does not reflect our cash expenditures or future requirements for capital expenditures or contractual commitments.

•Adjusted EBITDA does not reflect changes in, or cash requirements for our working capital needs.

•Although Depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements.

•Adjusted EBITDA does not include the impact of certain charges or gains resulting from matters we consider not to be indicative of our ongoing operations.

Due to these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business. We compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted EBITDA only as a supplement to our U.S. GAAP results.

Reconciliation of Net Loss to Adjusted EBITDA


	For the three months ended June 30,				For the six months ended June 30,
	2024		2023		2024		2023
Net loss before taxes	(2,598,361)		(2,170,368)		(5,276,930)		(4,717,818)
Add: Other expense	(369)		(2,726)		6,704		3,144
Less: Other income	(41,739)		(4,723)		(234,852)		(48,665)
Less: Gain on sale of mobile hardware	—		(212,882)		—		(212,882)
Add: Interest expense, net	16,773		9,793		35,322		19,994
Add: Stock-based compensation	307,125		97,737		605,011		157,311
Add: Change in fair value of warrant liability	2,408		6,955		4,868		5,615
Add: Impairment loss of assets	1,112		16,819		1,112		16,819
Add: Non-cash expenses for in-kind services	—		—		—		18,547
Add: Depreciation and amortization	181,195		187,272		365,996		406,454
Adjusted EBITDA loss (non-GAAP)	$	(2,131,118)	$	(2,072,123)	$	(4,492,769)	$	(4,351,481)

Adjusted EBITDA loss (non-GAAP) for the three months ended June 30, 2024, increased by 2.85%, to $2.13 million from $2.07 million for the three months ended June 30, 2023. The overall increase in Adjusted EBITDA loss (non-GAAP) was driven primarily by the increase in Selling, general, and administrative expenses for the three months ended June 30, 2024 when compared to the three months ended June 30, 2023. See “Results of Operations” below for further discussion on the drivers behind the increase in Adjusted EBITDA loss (non-GAAP) during the three months ended June 30, 2024.

Adjusted EBITDA loss (non-GAAP) for the six months ended June 30, 2024, increased by 3.25%, to $4.49 million from $4.35 million for the six months ended June 30, 2023. The overall increase in Adjusted EBITDA loss (non-GAAP) was driven primarily by the increase in Selling, general, and administrative expenses for the six months ended June 30, 2024 when compared to the six months ended June 30, 2023. See “Results of Operations” below for further discussion on the drivers behind the increase in Adjusted EBITDA loss (non-GAAP) during the six months ended June 30, 2024.

Results of Operations

The following table summarizes our consolidated statements of operations for the three and six months ended June 30, 2024 and 2023:


	For the three months ended June 30,				For the six months ended June 30,
	2024		2023		2024		2023
Net revenue	$	500,395	$	460,804	$	1,074,071	$	919,438
Operating Expenses:
Cost of services (exclusive of depreciation and amortization shown separately below)	247,435		203,928		542,033		420,887
Research and development	564,736		574,397		1,016,578		1,206,766
Selling, general, and administrative	2,132,395		1,877,616		4,624,088		3,847,173
Depreciation and amortization	181,195		187,272		365,996		406,454
Total Operating Expenses	3,125,761		2,843,213		6,548,695		5,881,280
Operating Loss	(2,625,366)		(2,382,409)		(5,474,624)		(4,961,842)
Non-Operating Income (Expense):
Interest expense, net	(16,773)		(9,793)		(35,322)		(19,994)
Change in fair value of warrant liability	2,408		6,955		4,868		5,615
Other income	41,739		217,605		234,852		261,547
Other expense	(369)		(2,726)		(6,704)		(3,144)
Total Other Income (Expense), Net	27,005		212,041		197,694		244,024
Net Loss before Taxes	(2,598,361)		(2,170,368)		(5,276,930)		(4,717,818)
Income tax expense	—		—		—		—
Net loss before non-controlling interest	(2,598,361)		(2,170,368)		(5,276,930)		(4,717,818)
Net loss attributable to non-controlling interest	—		—		—		—
Net loss attributable to T Stamp Inc.	$	(2,598,361)	$	(2,170,368)	$	(5,276,930)	$	(4,717,818)
Basic and diluted net loss per share attributable to T Stamp Inc.	$	(0.21)	$	(0.32)	$	(0.47)	$	(0.80)
Weighted-average shares used to compute basic and diluted net loss per share	12,227,476		6,757,320		11,169,735		5,897,089

Comparison of the Three Months Ended June 30, 2024 and 2023

Net revenue


	For the three months ended June 30,
	2024		2023		$ Change		% Change
Net revenue	$	500,395	$	460,804	$	39,591	8.59	%

During the three months ended June 30, 2024, Net revenue increased to $500 thousand, or an 8.59% increase from the Net revenue of $461 thousand for the three months ended June 30, 2023. During the three months ended June 30, 2024, the $500 thousand in Net revenue consisted of $331 thousand from an S&P 500 bank, $84 thousand from Mastercard, and various other customers for the remaining $85 thousand. The majority of the increase in net revenue during the three months ended June 30, 2024 compared to the prior period is the result of an S&P 500 bank adopting the Orchestration Layer, which increased gross revenues earned during the three months ended June 30, 2024 by $189 thousand.

During the three months ended June 30, 2024, the Company generated $317 thousand total revenue from customers using the Orchestration Layer. This includes implementing the Orchestration Layer platform for 6 new enterprise customers through FIS on the Software-as-a-Service (SaaS) platform during the three months ended June 30, 2024. In comparison, during the three months ended June 30, 2023, the Company generated $112 thousand total revenue from Orchestration

Layer customers. Since its launch in the third quarter of 2022, there have been 62 enterprise customers on the Orchestration Layer platform, including 54 financial institutions, as of June 30, 2024. Additionally, revenue from the Orchestration Layer's flagship enterprise customer grew 20.47% between the comparative periods as a result of transitioning and launching the customer on the Orchestration Layer platform. Orchestration Layer's flagship enterprise customer is already in full production and generating monthly recurring revenue with gross margins in excess of 83.15%. Finally, the Company S&P 500 bank customer complete its transition to an augmented version of the SaaS platform during the three months ended June 30, 2024.

The Orchestration Layer is designed to be a one-stop-shop for Trust Stamp services and provides for easy integration to our products; chargeable on a per-use basis and is accelerating the Company’s evolution from being exclusively a custom solutions provider to also offering a modular and highly scalable SaaS model with low-code implementation.

Cost of services


	For the three months ended June 30,
	2024		2023		$ Change		% Change
Cost of services	$	247,435	$	203,928	$	43,507	21.33	%

Cost of services (“COS”) increased by $44 thousand or 21.33% for the three months ended June 30, 2024, compared to the three months ended June 30, 2023. The increase during this period was primarily driven by costs of $40 thousand for the expansion of our proof of identity solutions using a third-party as required for proof of identity contracts. The solution was not considered a cost of sale until the third quarter of 2023, thus, there were no expenses for this solution during the three months ended June 30, 2023.

Research and development


	For the three months ended June 30,
	2024		2023		$ Change		% Change
Research and development	$	564,736	$	574,397	$	(9,661)	(1.68)	%

Research and development (“R&D”) expenses decreased by $10 thousand, or 1.68% for the three months ended June 30, 2024, compared to the three months ended June 30, 2023. The decrease in R&D expense during the three months ended June 30, 2024 was primarily driven by the decrease in outsourced software development as the Company continued to transition this work internally which results in cost savings as internal work is more cost effective. Comparatively, outsourced software development costs decreased by 97.19% when comparing the three months ended June 30, 2024 to the three months ended June 30, 2023. In both periods, R&D expenses mainly were related to R&D payroll and other R&D compensation expenses.

Selling, general, and administrative


	For the three months ended June 30,
	2024		2023		$ Change		% Change
Selling, general, and administrative	$	2,132,395	$	1,877,616	$	254,779	13.57	%

Selling, general, and administrative expense (“SG&A”) increased by $255 thousand, or 13.57%, for the three months ended June 30, 2024, compared to the three months ended June 30, 2023. The increase in SG&A expense was driven by a $468 thousand increase in salaries, stock-based compensation, payroll costs, and sales commissions during the three months ended June 30, 2024. Headcount increased by 3.75%, from 80 full-time employees ("FTE") as of June 30, 2023, compared to 83 FTE as of June 30, 2024 due to reinforcing our sales resources and bringing in-house technical positions that were previously outsourced. Included in the $468 thousand was an increase of $216 thousand during the three months ended June 30, 2024 due to the timing of stock-based compensation awards.

The increases in SG&A were offset by notable reductions in SG&A for the three months ended June 30, 2024 including a total reduction of $302 thousand in professional fees, marketing, office rent, and other operating costs.

In both periods, SG&A expenses were primarily comprised of payroll and other compensation expenses to our Company's workforce.

Depreciation and amortization


	For the three months ended June 30,
	2024		2023		$ Change		% Change
Depreciation and amortization	$	181,195	$	187,272	$	(6,077)	(3.25)	%

Depreciation and amortization (“D&A”) decreased by $6 thousand, or 3.25% for the three months ended June 30, 2024, compared to the three months ended June 30, 2023. The primary driver for the decrease in D&A is due to fully depreciating the Pixelpin (a company we acquired in March 2021) intangible asset during the three months ended March 31, 2024. There was $0 of Pixelpin amortization expense during the three months ended June 30, 2024 compared to $6 thousand during the three months ended June 30, 2023.

Operating loss


	For the three months ended June 30,
	2024		2023		$ Change		% Change
Operating loss	$	(2,625,366)	$	(2,382,409)	$	(242,957)	10.20	%

The Company’s Operating loss increased by $243 thousand or 10.20% for the three months ended June 30, 2024, compared to the three months ended June 30, 2023. The increase in Operating loss was mostly related to the increase of $283 thousand or 9.94% rise in operating expenses as a result of bolstering our sales resources and bringing in-house technical positions that outpaced Net revenue growth.

Interest expense, net


	For the three months ended June 30,
	2024		2023		$ Change		% Change
Interest expense, net	$	(16,773)	$	(9,793)	$	(6,980)	71.28	%

Interest expense, net increased by $7 thousand, or 71.28% for the three months ended June 30, 2024, compared to the three months ended June 30, 2023.The increase in interest expense is primarily due to an increase of $5 thousand as a result of the Malta loan interest rate increasing from 4.5% for the three months ended June 30, 2023 to 6.5% for the three months ended June 30, 2024. Interest earned decreased by $105 to $50 for the three months ended June 30, 2024 from $155 for the three months ended June 30, 2023.

Change in fair value of warrant liability


	For the three months ended June 30,
	2024		2023		$ Change		% Change
Change in fair value of warrant liability	$	2,408	$	6,955	$	(4,547)	(65.38)	%

The Company recognized a gain in Change in fair value of warrant liability during the three months ended June 30, 2024 of $2 thousand compared to a gain of $7 thousand during the three months ended June 30, 2023. This change is based on the fair value assessment and adjustment for one warrant liability as described in Note 3 to the unaudited condensed consolidated financial statements provided under Item 1 of this report.

Other income


	For the three months ended June 30,
	2024		2023		$ Change		% Change
Other income	$	41,739	$	217,605	$	(175,866)	(80.82)	%

Other income decreased by $176 thousand for the three months ended June 30, 2024, compared to the three months ended June 30, 2023. The decrease was primarily due to a $213 thousand gain on the sale of certain mobile hardware assets that occurred during the three months ended June 30, 2023, which was a one-time event and did not recur during the three months ended June 30, 2024. Likewise, during the three months ended June 30, 2024 Trust Stamp received $41 thousand from the University of Malta for a grant program, "Fusion; Technology Development Programme", aiming to provide state financing in the form of grants for research, development and innovation in science and technology. The Company received 50% of the applicable grant in May 2024. The Company expects to receive and recognize the remaining funds once the project is completed.

Other expense


	For the three months ended June 30,
	2024		2023		$ Change		% Change
Other expense	$	(369)	$	(2,726)	$	2,357	(86.46)	%

Other expense decreased by $2 thousand for the three months ended June 30, 2024, compared to the three months ended June 30, 2023. The Company incurred $0 and $3 thousand in unrealized loss on foreign currency translation expense for the three months ended June 30, 2024 and three months ended June 30, 2023, respectively, for intercompany transactions between the parent company, T Stamp Inc., and its subsidiaries, Trust Stamp Rwanda Limited with currencies denominated in United States Dollars and Rwandan Franc. Likewise, the Company incurred a $369 loss for fixed asset disposal for the three months ended June 30, 2024.

Comparison of the Six Months Ended June 30, 2024 and 2023

Net revenue


	For the six months ended June 30,
	2024		2023		$ Change		% Change
Net revenue	$	1,074,071	$	919,438	$	154,633	16.82	%

During the six months ended June 30, 2024, Net revenue increased by $155 thousand, or a 16.82% increase from the Net revenue of $919 thousand for the six months ended June 30, 2023. During the six months ended June 30, 2024, the $1.07 million in Net revenue consisted of $658 thousand from an S&P 500 bank, $238 thousand from Mastercard, and various other customers for the remaining $178 thousand. The majority of the increase in net revenue during the six months ended June 30, 2024 compared to the prior period is the result of an S&P 500 bank adopting the Orchestration Layer, which increased gross revenue by $405 thousand during the six months ended June 30, 2024.

During the six months ended June 30, 2024, the Company generated $614 thousand total revenue from customers using the Orchestration Layer including implementing the Orchestration Layer platform for 14 new enterprise customers added during the six months ended June 30, 2024 through FIS on the Software-as-a-Service (SaaS) platform. In comparison, during the six months ended June 30, 2023, the Company generated $219 thousand total revenue from Orchestration Layer customers. Since its launch in the third quarter of 2022, there have been 62 enterprise customers on the Orchestration Layer platform, including 54 financial institutions, as of June 30, 2024. Additionally, revenue from the Orchestration Layer's flagship enterprise customer grew 23.16% between the comparative periods as a result of transitioning and launching the customer on the Orchestration Layer platform. Orchestration Layer's flagship enterprise customer is already in full production and generating monthly recurring revenue with gross margins in excess of 83.30%. Finally, the Company's S&P 500 bank customer completed its transition to an augmented version of the SaaS platform during the six months ended June 30, 2024.

Cost of services


	For the six months ended June 30,
	2024		2023		$ Change		% Change
Cost of services	$	542,033	$	420,887	$	121,146	28.78	%

Cost of services (“COS”) increased by $121 thousand or 28.78% for the six months ended June 30, 2024, compared to the six months ended June 30, 2023. The increase during this period was primarily driven by costs of $100 thousand for the expansion of our proof of identity solutions using a third-party as required for proof of identity contracts. The solution was not considered a cost of sale until the third quarter of 2023, thus, there were no expenses for this solution during the six months ended June 30, 2023.

In addition, the Company saw an increase in service requests during the six months ended June 30, 2024 resulting in an increase of $22 thousand when compared to the six months ended June 30, 2023. Apart from an increase in service requests, more development hours were charged directly to cost of sales for the six months ended June 30, 2024 when compared to the six months ended June 30, 2023.This increase was mainly due to a specific request made, by one of our main customers, for our development team to work on a specific project during the six months ended June 30, 2024.

Research and development


	For the six months ended June 30,
	2024		2023		$ Change		% Change
Research and development	$	1,016,578	$	1,206,766	$	(190,188)	(15.76)	%

Research and development (“R&D”) expenses decreased by $190 thousand, or 15.76% for the six months ended June 30, 2024, compared to the six months ended June 30, 2023. The decrease in R&D expense during the six months ended June 30, 2024 was primarily driven by the decrease in outsourced software development as the Company continued to transition this work internally which results in cost savings as internal work is more cost effective. Comparatively, outsourced software development costs decreased by 79.34% when comparing the six months ended June 30, 2024 to the six months ended June 30, 2023. In both periods, R&D expenses mainly were related to R&D payroll and other R&D compensation expenses.

Selling, general, and administrative


	For the six months ended June 30,
	2024		2023		$ Change		% Change
Selling, general, and administrative	$	4,624,088	$	3,847,173	$	776,915	20.19	%

Selling, general, and administrative expense (“SG&A”) increased by $777 thousand, or 20.19%, for the six months ended June 30, 2024, compared to the six months ended June 30, 2023. The increase in SG&A expense was driven by a $1.07 million increase in salaries, stock-based compensation, payroll costs, and sales commissions during the six months ended June 30, 2024. Headcount increased by 3.75%, from 80 FTE for the six months ended June 30, 2023, compared to 83 FTE for the six months ended June 30, 2024 due to reinforcing our sales resources and bringing in-house technical positions that were previously outsourced. Included in the $1.07 million increase is an increase of $466 thousand in SG&A during the six months ended June 30, 2024 due to the timing of stock-based compensation awards. In addition, the Company had an increase in dues and subscriptions, due to continued business development and growth, of $84 thousand during the six months ended June 30, 2024 when compared to the six months ended June 30, 2023. Furthermore, there was a $109 thousand increase in SG&A when comparing the six months ended June 30, 2024 to the six months ended June 30, 2023 resulting from the reversal of out-of-period costs incurred during the six months ended June 30, 2023 associated with carrying mobile hardware assets, reversed due to the cancellation of the related mobile hardware subscription.

The increases in SG&A were offset by notable reductions in SG&A for the six months ended June 30, 2024 including a total reduction of $540 thousand in professional fees, management consulting and training, and office rent as direct result of the Company's recent non-personnel cost cutting initiative.

In both periods, SG&A expenses were primarily comprised of payroll and other compensation expenses to our Company's workforce.

Depreciation and amortization


	For the six months ended June 30,
	2024		2023		$ Change		% Change
Depreciation and amortization	$	365,996	$	406,454	$	(40,458)	(9.95)	%

Depreciation and amortization (“D&A”) decreased by $40 thousand, or 9.95% for the six months ended June 30, 2024, compared to the six months ended June 30, 2023. The primary driver for the decrease in D&A relates to the Company selling mobile hardware in April 2023. As a result of the sale, there is $0 expense for mobile hardware depreciation during the six months ended June 30, 2024 and $30 thousand of expense for mobile hardware depreciation during the six months ended June 30, 2023.

Operating loss


	For the six months ended June 30,
	2024		2023		$ Change		% Change
Operating loss	$	(5,474,624)	$	(4,961,842)	$	(512,782)	10.33	%

The Company’s Operating loss increased by $513 thousand or 10.33% for the six months ended June 30, 2024, compared to the six months ended June 30, 2023. The increase in Operating loss was mostly related to the increase of $667 thousand or 11.35% rise in operating expenses as a result of bolstering our sales resources and bringing in-house technical positions which led to increases in our SG&A expenses that outpaced Net revenue growth.

Interest expense, net


	For the six months ended June 30,
	2024		2023		$ Change		% Change
Interest expense, net	$	(35,322)	$	(19,994)	$	(15,328)	76.66	%

Interest expense, net increased by $15 thousand, or 76.66% for the six months ended June 30, 2024, compared to the six months ended June 30, 2023.The increase in interest expense is primarily due to an increase of $9 thousand as a result of the Malta loan interest rate increasing from 4.5% for the six months ended June 30, 2023 to 6.5% for the six months ended June 30, 2024. Additionally, the Company recorded $4 thousand in interest expense during the six months ended June 30, 2024 for interest accrued on Malta's tax obligations. Interest earned decreased by $148 to $167 for the six months ended June 30, 2024 from $315 for the six months ended June 30, 2023.

Change in fair value of warrant liability


	For the six months ended June 30,
	2024		2023		$ Change		% Change
Change in fair value of warrant liability	$	4,868	$	5,615	$	(747)	(13.30)	%

The Company recognized a gain in Change in fair value of warrant liability during the six months ended June 30, 2024 of $5 thousand compared to a gain of $6 thousand during the six months ended June 30, 2023. This change is based on the fair value assessment and adjustment for one warrant liability as described in Note 3 to the unaudited condensed consolidated financial statements provided under Item 1 of this report.

Other income


	For the six months ended June 30,
	2024		2023		$ Change		% Change
Other income	$	229,102	$	261,547	$	(32,445)	(12.41)	%

Other income decreased by $32 thousand for the six months ended June 30, 2024, compared to the six months ended June 30, 2023. The decrease is primarily due to a $213 thousand gain on the sale of certain mobile hardware assets during the six months ended June 30, 2023, which was a one-time event and did not recur during the six months ended June 30, 2024. This decrease was offset by a $187 thousand gain from a settlement of a mobile hardware bill that was outstanding as of June 30, 2023, which we negotiated for a lower payment, and paid during the six months ended June 30, 2024.

Other expense


	For the six months ended June 30,
	2024		2023		$ Change		% Change
Other expense	$	(6,704)	$	(3,144)	$	(3,560)	113.23	%

Other expense decreased by $4 thousand for the six months ended June 30, 2024, compared to the six months ended June 30, 2023. The Company incurred $6 thousand in unrealized loss on foreign currency translation expense for the six months ended June 30, 2024, for intercompany transactions between the parent company, T Stamp Inc., and its subsidiaries, Trust Stamp Rwanda Limited with currencies denominated in United States Dollars and Rwandan Franc, respectively.

Liquidity and Capital Resources

As of June 30, 2024, the Company had approximately $660 thousand cash in its banking accounts. The Company is generating revenues, but has not yet generated profits, with a net loss for the six months ended June 30, 2024 of $5.28 million, Net operating cash outflows of $3.76 million for the same period, and an accumulated deficit of $56.13 million as of June 30, 2024. The Company is not currently generating sufficient amounts of cash to meet its requirements for the next 12 months. The Company anticipates that it will need to raise capital from equity and/or debt financings within the next six (6) months in order to fund its operations.

Subsequent Investment and Pro Forma Balance Sheet

The following table sets forth our consolidated cash and cash equivalents and capitalization as of June 30, 2024 on an actual basis and as adjusted basis to reflect (i) cash received on July 25, 2024 upon the repayment of the first $500,000 promissory note; and (ii) receivable for the second and third promissory notes totaling $1,500,000.


		June 30, 2024		June 30, 2024 (Pro Forma As Adjusted, Reflecting Cash received on July 25, 2024 from repayment of the first $500,000 promissory note, and receivables for the second and third promissory notes totaling $1,500,000)
ASSETS
Cash and cash equivalents	$	659,533	$	1,159,533
Accounts receivable (includes unbilled receivables of $4,440 and $143,219 as of June 30, 2024 and December 31, 2023, respectively)		517,380		517,380
Related party receivables		24,921		24,921
Prepaid expenses and other current assets		726,612		726,612
Promissory Note Receivable		—		1,500,000
Total Long-term Assets		3,264,912		3,264,912
Total Assets		5,193,358		7,193,358

LIABILITIES AND STOCKHOLDERS’ EQUITY
Total Current Liabilities		3,002,534		3,002,534
Warrant liabilities		251,668		251,668
Non-convertible notes payable, plus accrued interest		953,799		953,799
Long-term operating lease liabilities		73,520		73,520
Total Liabilities		4,281,521		4,281,521

Stockholders’ Equity:
Common stock		113,841		159,818
Additional paid-in capital		56,591,713		58,545,736
Accumulated other comprehensive income		175,059		175,059
Accumulated deficit		(56,130,215)		(56,130,215)
Total T Stamp Inc. Stockholders’ Equity		750,398		2,750,398
Non-controlling interest		161,439		161,439
Total Stockholders’ Equity		911,837		2,911,837
Total Liabilities and Stockholders’ Equity	$	5,193,358	$	7,193,358

Going Concern

The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company is a business that has not yet generated profits, with a Net loss for the six months ended June 30, 2024 of $5.28 million, Net operating cash outflows of $3.76 million for the same period, and an Accumulated deficit of $56.13 million as of June 30, 2024.

The Company’s ability to continue as a going concern in the next twelve months, following the date the unaudited condensed consolidated financial statements were available to be issued, is dependent upon its ability to produce revenues and/or obtain financing sufficient to meet current and future obligations and deploy such to produce profitable operating results. Management has evaluated these conditions and plans to generate revenue and raise capital as needed to satisfy its capital needs. While the negotiation of significant additional revenue is well advanced, it has not reached a stage that

allows it to be factored into a going concern evaluation. In addition, although the Company has previously been successful in raising capital as needed and has already made plans to do so as well as restructuring expenses to meet the Company’s cash needs, no assurance can be given that the Company will be successful in its capital raising efforts. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period.

Cash Flows

The following table summarizes our cash flows for the six months ended June 30, 2024 and 2023:


	For the six months ended June 30,
	2024		2023
Net cash flows from operating activities	$	(3,756,928)	$	(3,581,369)
Net cash flows from investing activities	$	(363,086)	$	(17,249)
Net cash flows from financing activities	$	1,633,487	$	7,415,347

Operating Activities

Net cash flows from operating activities increased by 4.90% from $3.58 million during the six months ended June 30, 2023, compared to $3.76 million during the six months ended June 30, 2024. Of the $5.28 million net loss for the six months ended June 30, 2024, there were various cash and non-cash adjustments that were added back to the Net loss to arrive at $3.76 million cash used for operating activities for the six months ended June 30, 2024.

Those adjustments included the add back of $605 thousand related to stock-based compensation mainly due to the timing of stock-based compensation awards. There was a $466 thousand increase in stock-based compensation during the six months ended June 30, 2024 when compared to the six months ended June 30, 2023 due to the timing of stock-based compensation awards. Additionally, there is an add back of $171 thousand in Deferred revenue mainly comprised of an annual license fee billing of $345 thousand that will be recognized over the current year in alignment with the service period. Cash and noncash add backs also included $366 thousand for non-cash Depreciation and amortization, $169 thousand for cash received on Accounts receivable, $100 thousand for Prepaid expenses, and $239 thousand from the pay down of accruals.

The add backs were offset by reductions in certain cash and noncash adjustments including $162 thousand for the noncash settlement of mobile hardware liabilities.

Investing Activities

Net cash used in investing activities during the six months ended June 30, 2024 was $363 thousand, compared to net cash of $17 thousand used in the six months ended June 30, 2023. Cash used in investing activities during the six months ended June 30, 2024 related primarily to continued investments in technologies intended to be capitalized and monetized over time. In addition, the Company continued to prioritize intellectual property, which produced three (3) new pending patent applications and five (5) issued patents with the United States Patent and Trademark Office during the six months ended June 30, 2024.

Financing Activities

During the six months ended June 30, 2024, Net cash flows from financing activities was $1.63 million, compared to Net cash flows from financing activities of $7.42 million for the six months ended June 30, 2023. During the six months ended June 30, 2024, the Company raised $1.69 million in net proceeds from a securities purchase agreement with an institutional investor for the issuance of Class A Common Stock, pre-funded warrants, and common stock warrants. See Note 3 to the unaudited condensed consolidated financial statements provided under Item 1 of this report for more details. In addition, there was a $57 thousand in tax withholding payments for net issuances on employee equity compensation issued during the six months ended June 30, 2024.

Critical Accounting Estimates

Our unaudited condensed consolidated financial statements are prepared in accordance with GAAP. The preparation of these unaudited condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses, as well as related disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. There have been no material changes in the critical accounting estimates policies from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2023.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We are a smaller reporting company, as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended, and are not required to provide the information required under this item.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

We are required to maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Management necessarily applied judgment in assessing the costs and benefits of such controls and procedures, which, by their nature, can provide only reasonable assurance regarding our control objectives.

As of June 30, 2024, we carried out an evaluation, under the supervision and with the participation of management, including the Chief Executive Officer along with the Chief Financial Officer, of the effectiveness, design and operation of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)). Based upon the foregoing, the Chief Executive Officer along with the Chief Financial Officer concluded that our disclosure controls and procedures were effective. In addition, based on such evaluation we have identified no changes in our internal control over financial reporting that occurred during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Management’s Report on Internal Controls Over Financial Reporting

As a publicly traded company, we are required to comply with the SEC’s rules implementing Section 302 and 404 of the Sarbanes-Oxley Act, which require management to certify financial and other information in our quarterly and annual reports and provide an annual management report on the effectiveness of controls over financial reporting.

Our management is responsible for establishing and maintaining an adequate system of internal control over financial reporting, as defined in the Exchange Act Rule 13a-15(f). Management conducted an assessment of our internal control over financial reporting based on the framework established in 2013 by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework.

Based on our evaluation, management concluded that our internal control over financial reporting was effective as of June 30, 2024.

Change in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the six months ended June 30, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

From time to time, the Company may be involved in a variety of legal matters that arise in the normal course of business. The Company is not currently involved in any litigation, and its management is not aware of any pending or threatened legal actions relating to its intellectual property, conduct of its business activities, or otherwise. See Part I, “Item 1A. Risk Factors,” of our Annual Report on Form 10-K for the year ended December 31, 2023 for a summary of risks our Company may face in relation to litigation against our Company.

Item 1A. Risk Factors.

Not applicable.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

During the six months ended June 30, 2024, the Company made the following sales of securities in transactions not registered under the Securities Act.

–On April 3, 2024, the Company sold to a certain institutional investor 499,990 shares of Class A Common Stock and pre-funded warrants to purchase 1,500,010 shares of Class A Common Stock of the Company (the “Warrant A”) for a total purchase price of $1,936,000. Also, as additional consideration for the purchase, the Company issued the investor a stock purchase warrant for the purchase of 2,000,000 shares of the Company’s Class A Common Stock (“Warrant B”), and a stock purchase warrant for the purchase of 1,600,000 shares of the Company’s Class A Common Stock (“Warrant C”), (Warrant A, Warrant B and Warrant C shall collectively be referred to herein as the “Warrants”). The shares of Class A Common Stock and Warrants were offered and sold pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D promulgated thereunder. The Company used the proceeds for general working capital.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

Item 1.01 Entry into a Material Definitive Agreement.

License Agreement - Boumarang

On August 6, 2024, the Company entered into a License Agreement (the “Agreement”) with Boumarang Inc. (“Boumarang”), a developer, manufacturer, and seller of hydrogen-powered UAV and USV drones.

Pursuant to the Agreement, the Company agreed to grant a non-exclusive license to Boumarang to exploit certain of the Company’s patents for the purpose of producing, selling, marketing, and distributing drones. As consideration for the grant of the non-exclusive license, Boumarang agreed to pay the Company a non-refundable license fee of $5,000,000 in the form of a prepaid warrant issued by Boumarang to the Company for 5,000,000 shares of common stock of Boumarang at $1.00 per share (the “Prepaid Warrant”).

The Prepaid Warrant may be exercised in whole or in part at any time prior to the tenth annual anniversary of the issuance date of the Prepaid Warrant. No additional exercise price must be paid by the Company to exercise any portion of the Prepaid Warrant. The Prepaid Warrant also provides that the Company will receive any dividends declared by Boumarang that it would have been entitled to had the Prepaid Warrant been fully exercised, even if the Prepaid Warrant has not been exercised as of such time the distribution is made. Boumarang agreed to reserve a number a sufficient number of shares at all times to allow the Company to fully exercise the Prepaid Warrant. The Prepaid Warrant has certain anti-dilution protections, whereby the number of shares issuable upon the exercise of the Prepaid Warrant will proportionately adjust in the case of a stock-split or stock dividend of Boumarang’s common stock.

The Company has no additional obligation to perform any service or return any portion of the license fee, notwithstanding any failure by Boumarang to develop any products exploiting the patents. Boumarang agreed to indemnify, defend, and hold harmless the Company and its affiliates from any liability or expense arising from product liability claims or any claims related to Boumarang’s use of the Company’s patent rights under the Agreement. This includes claims made by employees, subcontractors, sublicensees, agents of the Boumarang, and the general public. The Agreement also stipulates that the Boumarang will make best efforts to include the Company and its affiliates as additional insured parties on any applicable product liability insurance policies. Further, Boumarang is required to mark all products in accordance with applicable patent marking laws. The Agreement restricts the use of the name of the Company in advertising or product sales without prior written approval.

The effective date of the agreement was August 6, 2024, and on same date, Boumarang issued the Company the Prepaid Warrant.

The foregoing descriptions of the Agreement and Prepaid Warrant are not complete, and are qualified by reference to the copies of the Agreement and Prepaid Warrant filed as Exhibit 10.29 and 4.17 to this Quarterly Report on Form 10-Q, and are incorporated by reference herein.

Item 2.01 Completion of Acquisition or Disposition of Assets.

The applicable information set forth under Item 1.01 above with respect to the acquisition of the Company of the Prepaid Warrant is incorporated by reference herein.

Item 6. Exhibits.


Exhibit No.						Exhibit Description
3.1						Third Amended and Restated Certificate of Incorporation (incorporated by reference to the Company’s Form 8-K filed with the SEC on July 7, 2023).

3.2						Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K filed with the SEC on December 12, 2022).

4.1						Warrant issued to the Armistice Capital Master Fund Ltd. dated September 14, 2022 (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on September 15, 2022).

4.2						Form of Warrant dated November 9, 2016 ($5,000 per share) (incorporated by reference to Exhibit 3.9 to the Company’s Form DOS filed with the SEC on December 30, 2019).

4.3						Form of Warrant dated November 9, 2016 ($1,000,000) (incorporated by reference to Exhibit 3.10 to the Company’s Form DOS filed with the SEC on December 30, 2019).

4.4						Form of Warrant dated September 30, 2016 (incorporated by reference to Exhibit 3.11 to the Company’s Form DOS filed with the SEC on December 30, 2019).

4.5						Form of Warrant dated December 16, 2016 (incorporated by reference to Exhibit 3.12 to the Company’s Form DOS filed with the SEC on December 30, 2019).

4.6						Warrant issued by the Company to Reach® Ventures 2017 LP (incorporated by reference to Exhibit 3.14 to the Company’s Form 1-A filed with the SEC on March 12. 2020).

4.7						Warrant issued by the Company to Second Century Ventures, LLC (incorporated by reference to Exhibit 3.15 to the Company’s Form 1-A filed with the SEC on March 12. 2020).

4.8						Form of Private Placement Warrant (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed with the SEC on April 18, 2023).

4.9						Form of Private Placement Warrant (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed with the SEC on June 5, 2023).

4.10						Form of New Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on December 21, 2023).

4.11						Warrant A issued to the investor dated April 1, 2024 (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed by the Company on April 4, 2024).

4.12						Warrant B issued to the investor dated April 1, 2024 (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed by the Company on April 4, 2024).

4.13						Warrant C issued to the investor dated April 1, 2024 (incorporated by reference to Exhibit 4.3 to the Current Report on Form 8-K filed by the Company on April 4, 2024).
4.14						Form of Promissory Note due and payable on July 31, 2024 ($500,000) (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on July 18, 2024).

4.15						Form of Promissory Note due and payable on August 31, 2024 ($500,000) (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed with the SEC on July 18, 2024).
4.16						Form of Promissory Note due and payable within three days of an effective resale registration statement ($1,000,000) (incorporated by reference to Exhibit 4.3 to the Company’s Current Report on Form 8-K filed with the SEC on July 18, 2024).
4.17*						Prepaid Warrant issued by Boumarang Inc. to the Company
10.1						Emergent Agreement dated June 11, 2020 (incorporated by reference to Exhibit 6.11 to the Company’s Form 1-SA for the six months ended June 30, 2020 filed with the SEC on September 28, 2020).

10.2						Executive Employment Agreements of Gareth Genner and Andrew Gowasack, effective as of December 8, 2020 (incorporated by reference to Exhibit 6.13 to the Company’s Form 1-K for the year ended December 31, 2020 filed with the SEC on April 30, 2021).

10.3						Malta Enterprise Letter dated July 8, 2020 sent to the Company (Repayable Advance of €800,000) (incorporated by reference to Exhibit 6.14 to the Company’s Form 1-A/A filed with the SEC on January 12, 2022).


10.4						Purchase Order executed September 23, 2021 issued by U.S. Immigration and Customs Enforcement to the Company (as Contractor) (incorporated by reference to Exhibit 6.15 to the Company’s Form 1-A/A filed with the SEC on January 12, 2022).

10.5						Letter of Appointment effective December 1, 2021 sent by the Company to Berta Pappenheim (as non-executive director appointee) (incorporated by reference to Exhibit 6.16 to the Company’s Form 1-A/A filed with the SEC on January 12, 2022).

10.6						Letter of Appointment effective December 1, 2021 sent by the Company to Kristin Stafford (as non-executive director appointee) (incorporated by reference to Exhibit 6.17 to the Company’s Form 1-A/A filed with the SEC on January 12, 2022).

10.7						Warrant Agency Agreement between the Company and Colonial Stock Transfer Company, Inc. dated August 20, 2021. (incorporated by reference to Exhibit 6.18 to the Company’s Form 1-A/A filed with the SEC on January 12, 2022).

10.8						Mutual Channel Agreement dated November 15, 2020 between the Company and Vital4Data, Inc. (incorporated by reference to Exhibit 6.19 to the Company’s Form 1-A/A filed with the SEC on January 12, 2022).

10.9						Warrant to Purchase Common Stock between the Company and Second Century Ventures, LLC dated April 22, 2020 (incorporated by reference to Exhibit 6.9 to the Company’s Form 1-A/A filed with the SEC on April 30, 2020).

10.10						Settlement Agreement dated July 1, 2019 between Emergent Technology Holdings, LP and the Company . (Incorporated by reference to Exhibit 6.1 to the Company’s Form 1-A filed with the SEC on March 12, 2020).

10.11						Amendment dated April 15, 2022 to Purchase Order executed September 23, 2021 issued by U.S. Immigration and Customs Enforcement to the Company (as Contractor) (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on April 21, 2022).

10.12						Amendment dated July 15, 2022 to Purchase Order executed September 23, 2021 issued by U.S. Immigration and Customs Enforcement to the Company (as Contractor) (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on July 21, 2022).

10.13						Securities Purchase Agreement, dated September 11, 2022 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on September 15, 2022).

10.14						Registration Rights Agreement, dated September 11, 2022 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on September 15, 2022).

10.15						Form of Lock-Up Agreement (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the SEC on September 15, 2022).

10.16						Placement Agent Agreement dated September 11, 2022 (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed with the SEC on September 15, 2022).

10.17						Executive Employment Agreement of Alex Valdes, effective as of December 8, 2020 (incorporated by reference to Exhibit 6.12 to the Company’s Form 1-K for the year ended December 31, 2020 filed with the SEC on April 30, 2021).

10.18						Executive Employment Agreement of Andrew Scott Francis, effective as of December 8, 2020 (incorporated by reference to Exhibit 6.13 to the Company’s offering statement on Form 1-A filed with the SEC on November 19, 2021).

10.19						Form of Securities Purchase Agreement by and between the Company and a certain institutional investor dated April 14, 2023 (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on April 18, 2023).
10.20						Form of Securities Purchase Agreement by and between the Company and a certain institutional investor dated June 1, 2023 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on June 5, 2023).
10.21						Warrant Amendment by and between the Company and a certain institutional investor dated June 1, 2023 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on June 5, 2023).
10.22						Form of Warrant Exercise Agreement, dated December 21, 2023 by and between T Stamp Inc. and the Institutional Investor (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on December 21, 2023).

10.23						Securities Purchase Agreement dated April 1, 2024 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by the Company on April 4, 2024).



10.24						Registration Rights Agreement dated April 1, 2024 (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed by the Company on April 4, 2024).

10.25						Placement Agent Agreement dated April 1, 2024 (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed by the Company on April 4, 2024)
10.26						Securities Purchase Agreement dated July 13, 2024 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on July 18, 2024).

10.27						Registration Rights Agreement dated July 13, 2024 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on July 18, 2024).
10.28						Voting Limitation Agreement Registration dated July 13, 2024 (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the SEC on July 18, 2024).
10.29*						License Agreement between the Company and Boumarang Inc. dated July August 6, 2024
31.1*						Certification of the principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*						Certification of the principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*						Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS*						XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH*						Inline XBRL Taxonomy Extension Schema

101.PRE*						Inline XBRL Taxonomy Extension Presentation Linkbase

101.CAL*						Inline XBRL Taxonomy Extension Calculation Linkbase

101.LAB*						Inline XBRL Taxonomy Extension Label Linkbase

101.DEF*						Inline XBRL Taxonomy Extension Definition Linkbase

104						Cover Page Interactive Data File—the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

_________________________

* Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


T STAMP INC.

/s/ Gareth Genner
Gareth Genner, Chief Executive Officer
Trust Stamp

The following persons in the capacities and on the dates indicated have signed this report.


/s/ Gareth Genner
Gareth Genner, Principal Executive Officer, Chief Executive Officer, Director
Date: August 13, 2024

/s/ Alex Valdes
Alex Valdes, Principal Financial Officer, Principal Accounting Officer
Date: August 13, 2024

/s/ Andrew Gowasack
Andrew Gowasack, President, Director
Date: August 13, 2024

/s/ William McClintock
William McClintock, Director
Date: August 13, 2024

/s/ Charles Potts
Charles Potts, Director
Date: August 13, 2024

/s/ Joshua Allen
Joshua Allen, Director
Date: August 13, 2024

/s/ Kristin Stafford
Kristin Stafford, Director
Date: August 13, 2024

/s/ Berta Pappenheim
Berta Pappenheim, Director
Date: August 13, 2024

Exhibit 4.17

COMMON STOCK PURCHASE WARRANT

Boumarang Inc.

Warrant Shares: 5,000,000 shares of Common Stock subject to adjustment as set forth herein.

Issuance Date: August 6, 2024

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, T Stamp Inc. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issuance Date as set forth above and on or prior to the tenth annual anniversary of the Issuance Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Boumarang Inc., (the “Company”), 5,000,000 (five million) shares of Common Stock, par value $0.0001 per share (the “Common Stock”) of the Company (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of the Common Stock has been prepaid in full by the grant of a patent license valued at $5,000,000, entered between the parties on this date; therefore, no additional consideration is payable to exercise the Warrant. For the avoidance of doubt, the Exercise Price shall be $0.00 per share of Common Stock under this Warrant.

1.Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time before the Termination Date by delivery of written notice to the Company by email to admin@boumarang.com. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.

2.Notwithstanding anything herein to the contrary (although the Holder may surrender the Warrant to, and receive a replacement Warrant from, the Company), the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date the final Notice of Exercise is delivered to the Company.

3.Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall lower the outstanding number of Warrant Shares purchasable hereunder by an amount equal to the applicable number of Warrant Shares purchased.

4.The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to a Notice of Exercise within one (1) Trading Day of delivery of such notice.

5.By accepting this Warrant, the Holder and any assignee acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.

6.Certificates for shares purchased hereunder shall be transmitted by the Company’s then- engaged transfer agent (the “Transfer Agent”) to the Holder by crediting the account of the Holder’s broker with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such system and there is an effective registration statement permitting the issuance of the Warrant Shares to, or resale of the Warrant Shares, by the Holder and otherwise by physical delivery to the address specified by the Holder in the Notice of Exercise by the date that is two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (such date, the “Warrant Share Delivery Date”). The Warrant Shares shall be deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes as of the date the Warrant has been exercised, with payment to the Company of the Exercise Price and all taxes required to be paid by the Holder, if any, prior to the issuance of such shares, having been paid.

7.In the event that the Company fails for any reason to effect delivery of the Warrant Shares by the Warrant Share Delivery Date, the Holder may revoke all or part of the relevant Warrant exercise by delivery of a notice to such effect to the Company, whereupon the Company and the Holder shall each be restored to their respective positions immediately prior to the exercise of the relevant portion of this Warrant.

8.If this Warrant has been exercised in part, the Company shall, upon surrender of this Warrant certificate, at the request of the Holder, deliver to the Holder a new Warrant evidencing the Holder's rights to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.

9.Closing of Books. The Company will not close its shareholder books or records in any manner that prevents the timely exercise of this Warrant, pursuant to the terms hereof.

10.Adjustments for Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for the avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of

shares, then both the Exercise Price and the number of shares of Common Stock issuable upon the Exercise of this Warrant shall each be appropriately and proportionally adjusted to reflect any stock dividend, stock split, a combination of shares, reclassification, recapitalization or other similar event affecting the number of outstanding shares of Common Stock (or such other stock or securities).

11.Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin-off, reclassification, corporate rearrangement, scheme of arrangement, or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution.

12.Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant to the Company or its designated agent via email together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be canceled. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

13.Subject to compliance with all applicable securities laws, this Warrant may be divided or combined with other Warrants upon presentation hereof to theCompany via email, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney and the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or

exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

14.The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder and for all other purposes, absent actual notice to the contrary.

15.The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction, or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

16.The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares and will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value; (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant; and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

17.This Agreement shall be solely and exclusively construed and enforced in accordance with, and all questions concerning its construction, validity, interpretation, and performance shall be governed solely and exclusively by the laws of the State of Delaware without giving effect to any choice of law or conflict of law provision or rule that would cause the application of the laws of any jurisdiction other than Delaware.

18.The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will have restrictions upon resale imposed by state and federal securities laws.

19.No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights,

powers, or remedies. Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

20.Notices. Any notice, request, or other document required or permitted to be given or delivered hereunder shall be delivered by email:

If to the Company, to: admin@boumarang.com

If to the holder to ggenner@truststamp.net with a copy to legal@truststamp.net

21.Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holders of Warrant Shares.

22.Other than as specifically set forth herein, this Warrant may be modified or amended, or the provisions hereof waived only with the Company's and the Holder's written consent.

23.Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

24.This Warrant may be executed in multiple counterparts, each of which shall be deemed an original and all of which, taken together, shall be but a single instrument.

25.The Company represents and warrants that:

a.The authorized share capital of the Company is 100,000,000 shares of Common Stock par value of $0.0001 per share

b.No Common Stock has been issued at less than $1.00 per share

c.The Company is currently conducting a seed funding round and has received commitments for Common Stock at $1.00 per share

d.Within 60 days of the Issuance Date and on each anniversary thereof, the Company will provide the Holder with a 409A fair market valuation of its Common Stock

and based upon professional expertise, believes that the valuation will be not less than $1.00 per share

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the Issuance Date.

Boumarang Inc.

By:

Name: Imran Firoz Title: Interim CEO

Agreed and accepted: T Stamp Inc.

By:

Gareth N. Genner

Chief Executive Officer

Exhibit 10.29

LICENSE AGREEMENT

This License Agreement is entered into and made effective as of this 6th day of August 2024 by and between T Stamp Inc. dba Trust Stamp, a company incorporated under the laws of Delaware having its head office in Atlanta, Georgia, USA and hereafter called ‘Trust Stamp,’ and Boumarang Inc. hereafter called “the Licensee.”

RECITALS

A.Trust Stamp is engaged in developing and producing software based in part on patents set forth in Exhibit A hereto, hereinafter referred to as the ‘Patents.’

B.The Licensee is engaged in the business of the development, manufacturing, sale, and marketing of hydrogen- powered UAV and USV (“Drones” or “Products”)

C.Trust Stamp is willing to broaden the market for its technology by granting the Licensee the non-exclusive right to exploit the Patents to produce, sell, market, and distribute Drones, and the Licensee wishes to acquire such a non- exclusive license.

AGREEMENT

NOW, THEREFORE, in consideration of the mutual covenants and conditions set forth herein, Trust Stamp and Licensee hereby agree as follows:

1.1 Trust Stamp hereby grants to the Licensee a non-exclusive license to exploit Trust Stamp Patent Rights as specified in Exhibit A for the sole purpose of producing, selling, marketing, and distributing Drones.

1.2. The parties agree that this license grant shall not affect Trust Stamp's rights to develop, manufacture, market, and sell any product either by itself or through its distribution agents.

1.3 In consideration for the non-exclusive license granted pursuant to Section 1.1 hereof, the Licensee shall pay to Trust Stamp a non-refundable License Fee upon execution of this Agreement in the form of a pre-paid warrant to acquire 5,000,000 shares of common stock in the Licensee valued at $1.00 per share. The License Fee described in this Section is the consideration for the grant of the License hereunder, and Trust Stamp shall have no additional obligation to perform any service or return any portion of such License Fee, notwithstanding any failure by the Licensee to develop any Products exploiting the Patents.

2.1 The Licensee shall be responsible for obtaining all necessary governmental approvals for the development, production, distribution, sale, and use of any Products using the licensed patent rights at the Licensee’s expense. The Licensee shall have sole responsibility for any warning labels, packaging, and instructions as to the use of Products and for the quality control of any Products and must not provide any warranty or representations regarding the Licensed Patents.

2.2 Licensee hereby agrees to indemnify, defend, and hold harmless Trust Stamp and any and all co-owners of Trust Stamp Patent Rights, and any parent, subsidiary, or other affiliated entity and their trustees, officers, employees, scientists, and agents from and against any liability or expense arising from any product liability claim asserted by any party or any claims arising from the use of any Trust Stamp Patent Rights pursuant to this Agreement. Such indemnity and defense obligation shall apply to any product liability or other claims, including, without limitation, personal injury, death, or property damage, made by employees, subcontractors, sublicensees, or agents of the Licensee, as well as any member of the general public. The Licensee shall use its best efforts to have Trust Stamp, and any and all co-owners of Trust Stamp Technology or Trust Stamp Patent Rights, and any parent, subsidiary, or other affiliated entity and their trustees, officers, employees, scientists, and agents named as additional insured parties

on any product liability insurance policies maintained by the Licensee, its Affiliates and sublicensees applicable to Products.

3.1 Patent Marking. To the extent required by applicable law, Licensee shall mark all Products or their containers in accordance with the applicable patent marking laws.

3.2 The use of the name “Trust Stamp,” or any variation thereof in connection with the advertising or sale of Products is not permitted without Trust Stamp’s prior written approval.

4.1 Trust Stamp hereby represents, warrants, and covenants that (i) it is the sole owner of the Trust Stamp Patent Rights and that it has the exclusive right to grant a license on the Patents; (ii) it has not received written notification that legal proceedings have been commenced, or are expected to be commenced, in which there may be assertions of infringement by Trust Stamp, of the patents, trademarks or copyrights of any third party (ii) it has full right and power to enter into this Agreement.

4.2 Trust Stamp makes no other warranties concerning Trust Stamp patent rights, including without limitation any express or implied warranty as to merchantability or fitness for a particular purpose or that any patent is or will be free from infringement.

5.1 Trust Stamp and any and all co-owners of Trust Stamp Patent Rights retain full ownership and title to Trust Stamp Patent Rights licensed hereunder.

6.1 The parties agree that during the term of this Agreement, and for a period of three (3) years after this Agreement terminates, a party receiving Confidential Information of the other party will (i) maintain in confidence such Confidential Information to the same extent such party maintains its own proprietary industrial information; (ii) not disclose such Confidential Information to any third party without prior written consent of the other party; and (iii) not use such Confidential Information for any purpose except those permitted by this Agreement.

7.1 Any and all assignments of this Agreement or any rights granted hereunder by the Licensee are void except (i) to an Affiliate of Licensee; (ii) in connection with the transfer or sale of all or substantially all of the Licensee’s assets or business or in the event of its merger, consolidation, change in control or similar transaction; or (iii) as expressly permitted hereunder, without the prior written consent of Trust Stamp, such consent not be unreasonably withheld.

8.1. Subject to the limitations on assignment herein, this Agreement shall be binding upon and inure to the benefit of any successors in interest and assigns of Trust Stamp and the Licensee. Any such successor or assignee of the Licensee’s interest shall expressly assume in writing the performance of all the terms and conditions of this Agreement to be performed by the Licensee.

9.1 The relationship between Trust Stamp and the Licensee is that of independent contractors. Trust Stamp and the Licensee are not joint venturers, partners, principal and agent, master and servant, employer or employee, and have no other relationship other than independent contracting parties. Trust Stamp and the Licensee shall have no power to bind or obligate each other in any manner other than as is expressly set forth in this Agreement.

10.1 This Agreement merges and supersedes all prior Agreements between the parties hereto. Any controversy or claim arising out of or relating to this Agreement, or the breach thereof shall be settled by, governed by, and construed in accordance with the laws of the State of New York, United States, and the courts of New York State shall have exclusive jurisdiction in respect of any dispute arising hereunder.

11.1 This Agreement sets forth the entire agreement and understanding between the parties regarding its subject matter. No amendments or modifications shall be made to this Agreement except by a written document signed by both parties.

12.1 Should any one or more of the provisions of this Agreement be held invalid or unenforceable by a court of competent jurisdiction, it shall be considered severed from this Agreement and shall not serve to invalidate the remaining provisions thereof. The parties shall make a good faith effort to replace any invalid or unenforceable provision with a valid and enforceable one such that the objectives contemplated by them when entering this Agreement may be realized.

Executed for T Stamp Inc. dba Trust Stamp

Gareth N. Genner

Chief Executive Officer

Executed for The Licensee

Name: Imran Firoz Position: Interim CEO

Exhibit 31.1

CERTIFICATIONS

I, Gareth Genner, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 of T Stamp Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 13, 2024


/s/ Gareth Genner
Gareth Genner
Chief Executive Officer (Principal Executive Officer)

Exhibit 31.2

CERTIFICATIONS

I, Alex Valdes, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 of T Stamp Inc.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 13, 2024


/s/ Alex Valdes
Alex Valdes
Chief Financial Officer
(Principal Financial Officer)

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of T Stamp Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2024 as filed with the Securities and Exchange Commission (the “Report”), I, Gareth Genner, Chief Executive Officer of the Company, and I, Alex Valdes, Chief Financial Officer of the Company, certify that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: August 13, 2024


/s/ Gareth Genner
Chief Executive Officer
(Principal Executive Officer)

/s/ Alex Valdes
Chief Financial Officer
(Principal Financial Officer)

Cover - shares	6 Months Ended
Cover - shares	Jun. 30, 2024	Aug. 12, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2024
Document Transition Report	false
Entity File Number	001-41252
Entity Registrant Name	T Stamp Inc
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	81-3777260
Entity Address, Address Line One	3017 Bolling Way NE, Floor 2
Entity Address, City or Town	Atlanta
Entity Address, State or Province	GA
Entity Address, Postal Zip Code	30305
City Area Code	404
Local Phone Number	806-9906
Title of 12(b) Security	Class A Common Stock, $0.01 par value per share
Trading Symbol	IDAI
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		16,780,931
Entity Central Index Key	0001718939
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Amendment Flag	false
Current Fiscal Year End Date	--12-31

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 659,533	$ 3,140,747
Accounts receivable, net (includes unbilled receivables of $4,440 and $143,219 as of June 30, 2024 and December 31, 2023, respectively)	517,380	686,327
Related party receivables	24,921	44,087
Prepaid expenses and other current assets	726,612	826,781
Total Current Assets	1,928,446	4,697,942
Capitalized internal-use software, net	1,509,180	1,472,374
Goodwill	1,248,664	1,248,664
Intangible assets, net	192,619	223,690
Property and equipment, net	43,512	56,436
Operating lease right-of-use assets	229,370	164,740
Other assets	41,567	29,468
Total Assets	5,193,358	7,893,314
Current Liabilities:
Accounts payable	1,104,638	1,232,118
Related party payables	53,087	82,101
Accrued expenses	1,539,378	1,143,890
Deferred revenue	182,000	10,800
Income tax payable	0	1,975
Short-term operating lease liabilities	123,431	81,236
Short-term financial liabilities	0	162,130
Total Current Liabilities	3,002,534	2,714,250
Warrant liabilities	251,668	256,536
Notes payable, including accrued interest of $28,808 and $40,317, as of June 30, 2024 and December 31, 2023, respectively	953,799	953,877
Long-term operating lease liabilities	73,520	53,771
Total Liabilities	4,281,521	3,978,434
Commitments, Note 10
Stockholders’ Equity:
Common stock $0.01 par value, 50,000,000 shares authorized, 11,384,139 and 9,198,089 shares issued, and 11,384,139 and 9,143,355 outstanding at June 30, 2024 and December 31, 2023, respectively	113,841	91,434
Treasury stock, at cost: 0 and 54,734 shares held as of June 30, 2024 and December 31, 2023, respectively	0	0
Additional paid-in capital	56,591,713	54,375,622
Accumulated other comprehensive income	175,059	139,670
Accumulated deficit	(56,130,215)	(50,853,285)
Total T Stamp Inc. Stockholders’ Equity	750,398	3,753,441
Non-controlling interest	161,439	161,439
Total Stockholders’ Equity	911,837	3,914,880
Total Liabilities and Stockholders’ Equity	$ 5,193,358	$ 7,893,314

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Unbilled receivables	$ 4,440	$ 143,219
Non-convertible notes payable, current accrued interest	$ 28,808	$ 40,317
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	11,384,139	9,198,089
Common stock, shares outstanding (in shares)	11,384,139	9,143,355
Treasury stock, at cost, shares held (in shares)	0	54,734

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Net revenue	$ 500,395	$ 460,804	$ 1,074,071	$ 919,438
Operating Expenses:
Cost of services (exclusive of depreciation and amortization shown separately below)	247,435	203,928	542,033	420,887
Research and development	564,736	574,397	1,016,578	1,206,766
Selling, general, and administrative	2,132,395	1,877,616	4,624,088	3,847,173
Depreciation and amortization	181,195	187,272	365,996	406,454
Total Operating Expenses	3,125,761	2,843,213	6,548,695	5,881,280
Operating Loss	(2,625,366)	(2,382,409)	(5,474,624)	(4,961,842)
Non-Operating Income (Expense):
Interest expense, net	(16,773)	(9,793)	(35,322)	(19,994)
Change in fair value of warrant liability	2,408	6,955	4,868	5,615
Other income	41,739	217,605	234,852	261,547
Other expense	(369)	(2,726)	(6,704)	(3,144)
Total Other Income (Expense), Net	27,005	212,041	197,694	244,024
Net Loss before Taxes	(2,598,361)	(2,170,368)	(5,276,930)	(4,717,818)
Income tax expense	0	0	0	0
Net loss before non-controlling interest	(2,598,361)	(2,170,368)	(5,276,930)	(4,717,818)
Net loss attributable to non-controlling interest	0	0	0	0
Net loss attributable to T Stamp Inc.	$ (2,598,361)	$ (2,170,368)	$ (5,276,930)	$ (4,717,818)
Basic net loss per share attributable to T Stamp Inc. (in dollars per share)	$ (0.21)	$ (0.32)	$ (0.47)	$ (0.80)
Diluted net loss per share attributable to T Stamp Inc. (in dollars per share)	$ (0.21)	$ (0.32)	$ (0.47)	$ (0.80)
Weighted-average shares used to compute basic net loss per share (in shares)	12,227,476	6,757,320	11,169,735	5,897,089
Weighted-average shares used to compute diluted net loss per share (in shares)	12,227,476	6,757,320	11,169,735	5,897,089

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Statement of Comprehensive Income [Abstract]
Net loss including non-controlling interest	$ (2,598,361)	$ (2,170,368)	$ (5,276,930)	$ (4,717,818)
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	3,698	(7,604)	35,389	(49,046)
Total Other Comprehensive Income (Loss)	3,698	(7,604)	35,389	(49,046)
Comprehensive loss	(2,594,663)	(2,177,972)	(5,241,541)	(4,766,864)
Comprehensive loss attributable to non-controlling interest	0	0	0	0
Comprehensive loss attributable to T Stamp Inc.	$ (2,594,663)	$ (2,177,972)	$ (5,241,541)	$ (4,766,864)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)	Total	Common Stock	Additional Paid-In Capital	Treasury Stock	Stockholders’ Notes Receivable	Accumulated Other Comprehensive Income	Accumulated Deficit	Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2022		4,854,302
Beginning balance at Dec. 31, 2022	$ 625,144	$ 48,543	$ 39,496,183		$ (18,547)	$ 237,252	$ (39,299,726)	$ 161,439
Beginning balance (in shares) at Dec. 31, 2022				56,513
Beginning balance at Dec. 31, 2022				$ 0
Increase (Decrease) in Stockholders' Equity
Exercise of prefunded warrants to common stock (in shares)		1,553,250
Exercise of prefunded warrants to common stock	1,554	$ 15,533	(13,979)
Exercise of options to common stock (in shares)		1,740
Exercise of options to common stock	2,000	$ 17	1,983
Issuance of common stock, prefunded warrants, and common stock warrants, net of fees (in shares)		1,312,468
Issuance of common stock, prefunded warrants, and common stock warrants, net of fees	7,464,312	$ 13,124	7,451,188
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary (in shares)		245,725		(39,692)
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary	(22,804)	$ 2,457	(25,261)
Reverse stock split rounding (in shares)		4,759
Reverse stock split rounding	0	$ 48	(48)
Repayment of shareholders loan through in-kind services	18,547				18,547
Stock-based compensation	157,311		157,311
Currency translation adjustment	(49,046)					(49,046)
Net loss attributable to T Stamp Inc.	(4,717,818)						(4,717,818)
Ending balance (in shares) at Jun. 30, 2023		7,972,244
Ending balance at Jun. 30, 2023	3,479,200	$ 79,722	47,067,377		0	188,206	(44,017,544)	161,439
Ending balance (in shares) at Jun. 30, 2023				16,821
Ending balance at Jun. 30, 2023				$ 0
Beginning balance (in shares) at Dec. 31, 2022		4,854,302
Beginning balance at Dec. 31, 2022	$ 625,144	$ 48,543	39,496,183		(18,547)	237,252	(39,299,726)	161,439
Beginning balance (in shares) at Dec. 31, 2022				56,513
Beginning balance at Dec. 31, 2022				$ 0
Increase (Decrease) in Stockholders' Equity
Exercise of options to common stock (in shares)	1,230
Ending balance (in shares) at Dec. 31, 2023		9,143,355
Ending balance at Dec. 31, 2023	$ 3,914,880	$ 91,434	54,375,622			139,670	(50,853,285)	161,439
Ending balance (in shares) at Dec. 31, 2023	54,734			54,734
Ending balance at Dec. 31, 2023	$ 0			$ 0
Beginning balance (in shares) at Mar. 31, 2023		5,121,607
Beginning balance at Mar. 31, 2023	(1,958,970)	$ 51,216	39,479,741			195,810	(41,847,176)	161,439
Beginning balance (in shares) at Mar. 31, 2023				0
Beginning balance at Mar. 31, 2023				$ 0
Increase (Decrease) in Stockholders' Equity
Exercise of prefunded warrants to common stock (in shares)		1,553,250
Exercise of prefunded warrants to common stock	1,554	$ 15,533	(13,979)
Exercise of options to common stock (in shares)		1,740
Exercise of options to common stock	0	$ 17	(17)
Issuance of common stock, prefunded warrants, and common stock warrants, net of fees (in shares)		1,312,468
Issuance of common stock, prefunded warrants, and common stock warrants, net of fees	7,464,312	$ 13,124	7,451,188
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary (in shares)		(16,821)
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary	52,539	$ (168)	52,707	$ 16,821
Stock-based compensation	97,737		97,737
Currency translation adjustment	(7,604)					(7,604)
Net loss attributable to T Stamp Inc.	(2,170,368)						(2,170,368)
Ending balance (in shares) at Jun. 30, 2023		7,972,244
Ending balance at Jun. 30, 2023	3,479,200	$ 79,722	47,067,377		$ 0	188,206	(44,017,544)	161,439
Ending balance (in shares) at Jun. 30, 2023				16,821
Ending balance at Jun. 30, 2023				$ 0
Beginning balance (in shares) at Dec. 31, 2023		9,143,355
Beginning balance at Dec. 31, 2023	$ 3,914,880	$ 91,434	54,375,622			139,670	(50,853,285)	161,439
Beginning balance (in shares) at Dec. 31, 2023	54,734			54,734
Beginning balance at Dec. 31, 2023	$ 0			$ 0
Increase (Decrease) in Stockholders' Equity
Exercise of options to common stock (in shares)	0
Ending balance (in shares) at Mar. 31, 2024		10,099,672
Ending balance at Mar. 31, 2024	$ 1,543,391	$ 100,997	54,641,448			171,361	(53,531,854)	161,439
Ending balance (in shares) at Mar. 31, 2024				0
Ending balance at Mar. 31, 2024				$ 0
Beginning balance (in shares) at Dec. 31, 2023		9,143,355
Beginning balance at Dec. 31, 2023	$ 3,914,880	$ 91,434	54,375,622			139,670	(50,853,285)	161,439
Beginning balance (in shares) at Dec. 31, 2023	54,734			54,734
Beginning balance at Dec. 31, 2023	$ 0			$ 0
Increase (Decrease) in Stockholders' Equity
Exercise of prefunded warrants to common stock (in shares)		1,424,100
Exercise of prefunded warrants to common stock	$ 0	$ 14,241	(14,241)
Exercise of options to common stock (in shares)	0
Issuance of common stock, prefunded warrants, and common stock warrants, net of fees (in shares)		499,990
Issuance of common stock, prefunded warrants, and common stock warrants, net of fees	$ 1,690,480	$ 5,000	1,685,480
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary (in shares)		316,694		(54,734)
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary	(56,993)	$ 3,166	(60,159)
Stock-based compensation	605,011		605,011
Currency translation adjustment	35,389					35,389
Net loss attributable to T Stamp Inc.	(5,276,930)						(5,276,930)
Ending balance (in shares) at Jun. 30, 2024		11,384,139
Ending balance at Jun. 30, 2024	$ 911,837	$ 113,841	56,591,713			175,059	(56,130,215)	161,439
Ending balance (in shares) at Jun. 30, 2024	0			0
Ending balance at Jun. 30, 2024	$ 0			$ 0
Beginning balance (in shares) at Mar. 31, 2024		10,099,672
Beginning balance at Mar. 31, 2024	1,543,391	$ 100,997	54,641,448			171,361	(53,531,854)	161,439
Beginning balance (in shares) at Mar. 31, 2024				0
Beginning balance at Mar. 31, 2024				$ 0
Increase (Decrease) in Stockholders' Equity
Exercise of prefunded warrants to common stock (in shares)		542,100
Exercise of prefunded warrants to common stock	$ 0	$ 5,421	(5,421)
Exercise of options to common stock (in shares)	0
Issuance of common stock, prefunded warrants, and common stock warrants, net of fees (in shares)		499,990
Issuance of common stock, prefunded warrants, and common stock warrants, net of fees	$ 1,690,480	$ 5,000	1,685,480
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary (in shares)		242,377
Issuance of common stock in relation to vested restricted stock units, to wholly owned subsidiary	(34,496)	$ 2,423	(36,919)
Stock-based compensation	307,125		307,125
Currency translation adjustment	3,698					3,698
Net loss attributable to T Stamp Inc.	(2,598,361)						(2,598,361)
Ending balance (in shares) at Jun. 30, 2024		11,384,139
Ending balance at Jun. 30, 2024	$ 911,837	$ 113,841	$ 56,591,713			$ 175,059	$ (56,130,215)	$ 161,439
Ending balance (in shares) at Jun. 30, 2024	0			0
Ending balance at Jun. 30, 2024	$ 0			$ 0

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net loss attributable to T Stamp Inc.	$ (5,276,930)	$ (4,717,818)
Net loss attributable to non-controlling interest	0	0
Adjustments to reconcile net loss to cash flows used in operating activities:
Depreciation and amortization	365,996	406,454
Stock-based compensation	605,011	157,311
Change in fair value of warrant liability	(4,868)	(5,615)
Repayment of shareholder loan through in-kind services	0	18,547
Impairment of assets	1,112	16,819
Gain on sale of property and equipment	0	(216,189)
Non-cash interest	28,808	19,904
Non-cash lease expense	78,964	109,879
Non-cash write off of mobile hardware	(162,130)	(15,775)
Loss on retirement of equipment	2,955	17,589
Changes in assets and liabilities:
Accounts receivable	168,947	521,685
Related party receivables	19,166	(1,551)
Prepaid expenses and other current assets	100,169	83,041
Other assets	(12,099)	(9,063)
Accounts payable	(127,480)	(171,183)
Accrued expense	395,488	(437,365)
Related party payables	(29,014)	(134,824)
Deferred revenue	171,200	887,218
Income tax payable	(1,975)	(5,616)
Operating lease liabilities	(80,248)	(104,817)
Net cash flows from operating activities	(3,756,928)	(3,581,369)
Cash flows from investing activities:
Proceeds from sale of property, plant and equipment	0	377,360
Capitalized internally developed software costs	(315,192)	(356,892)
Patent application costs	(38,810)	(37,717)
Purchases of property and equipment	(9,084)	0
Net cash flows from investing activities	(363,086)	(17,249)
Cash flows from financing activities:
Proceeds from exercise of warrants to common stock	0	1,554
Proceeds from exercise of options to common stock	0	2,000
Proceeds from common stock, prefunded warrants, and common stock warrants, net of fees	1,690,480	7,464,312
Forfeited common stock shares to satisfy taxes	(56,993)	(22,804)
Principal payments on financial liabilities	0	(29,715)
Net cash flows from financing activities	1,633,487	7,415,347
Effect of foreign currency translation on cash	5,313	(35,809)
Net change in cash and cash equivalents	(2,481,214)	3,780,920
Cash and cash equivalents, beginning of period	3,140,747	1,254,494
Cash and cash equivalents, end of period	659,533	5,035,414
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	2,356	570
Supplemental disclosure of non-cash activities:
Adjustment to operating lease right-of-use assets related to renewed leases	143,594	82,185
Adjustment to operating lease operating lease liabilities related to renewed leases	142,192	83,298
Adjustment to operating lease right-of-use assets related to terminated leases	0	82,095
Adjustment to operating lease liabilities related to terminated leases	0	77,648
Prepaid rent expense reclassified upon termination of leases	$ 0	$ 5,335

Description of Business, Summary of Significant Accounting Policies, and Going Concern

6 Months Ended

Jun. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description of Business, Summary of Significant Accounting Policies, and Going Concern

•Banking/FinTech

•KYC/AML Compliance

•Humanitarian and Development Services

•Government and Law Enforcement, including Alternative to Detention programs

•Cryptocurrency and Digital Assets

•Biometrically Secured Email and Digital Communications

•P2P Transactions, Social Media, and Sharing Economy

•Real Estate, Travel, and Healthcare

Further, we continue to consolidate Tstamp Incentive Holdings (“TSIH”) which we consider to be a variable interest entity.

Disaggregation of Revenue


	For the three months ended June 30,				For the six months ended June 30,
	2024		2023		2024		2023
Professional services (over time)	$	414,145	$	385,804	$	901,571	$	769,438
License fees (over time)	86,250		75,000		172,500		150,000
Total Revenue	$	500,395	$	460,804	$	1,074,071	$	919,438

Borrowings

6 Months Ended

Jun. 30, 2024

Debt Disclosure [Abstract]

Borrowings

Promissory Notes Payable


	June 30, 2024		December 31, 2023
Malta loan receipt 3 – June 3, 2022	$	491,680	$	507,035
Malta loan receipt 2 – August 10, 2021	303,582		313,063
Malta loan receipt 1 – February 9, 2021	62,325		64,271
Interest added to principal	67,404		29,191
Total principal outstanding	924,991		913,560
Plus: accrued interest	28,808		40,317
Total promissory notes payable	$	953,799	$	953,877

Warrants

6 Months Ended

Jun. 30, 2024

Warrants and Rights Note Disclosure [Abstract]

Warrants

Liability Classified Warrants


	Warrants ($)
Balance as of January 1, 2023	$	261,569
Additional warrants issued	—
Change in fair value	(5,033)
Balance as of December 31, 2023	$	256,536
Additional warrants issued	—
Change in fair value	(4,868)
Balance as of June 30, 2024	$	251,668

The following assumptions were used to calculate the fair value of the warrant liability during the six months ended June 30, 2024:


Fair Value of Warrants	$0.26 — $0.64
Exercise price	$0.43 — $0.49
Risk free interest rate	4.38%— 4.50%
Expected dividend yield	—	%
Expected volatility	79.25% — 79.59%
Expected term	3 years

Equity Classified Warrants


Warrant Issuance Date	Strike Price		June 30, 2024	December 31, 2023
November 9, 2016	$	3.12	80,128	80,128
January 23, 2020	$	8.00	186,442	186,442
January 23, 2020	$	8.00	524,599	524,599
April 18, 2023	$	1.34	—	775,330
June 5, 2023	$	1.34	1,173,030	1,279,700
December 21, 2023	$	1.34	3,600,000	3,600,000
April 3, 2024	$	—	957,910	—
April 3, 2024	$	0.97	2,000,000	—
April 3, 2024	$	1.06	1,600,000	—
Total warrants outstanding			10,122,109	6,446,199

November 9, 2016

January 23, 2020

The warrants to purchase the remaining 524,599 shares of the Company’s Class A Common Stock remain outstanding as of June 30, 2024.

April 18, 2023

All warrants related to this investment have been exercised and are no longer outstanding as of June 30, 2024.

June 5, 2023

On December 21, 2023, the Company entered into an Inducement Agreement with Armistice Capital Master Fund Ltd. Pursuant to the terms of the Inducement Agreement, the exercise price for the common stock purchase warrants to purchase the remaining 1,279,700 shares of Class A Common Stock of the Company was reduced to $1.34 for a total purchase price of $1,714,798.

On December 21, 2023, the institutional investor exercised 106,670 warrants to purchase shares of Class A Common Stock of the Company at a price of $1.34 per warrant for total proceeds of $142,938.

The common stock purchase warrants to purchase 1,173,030 shares of the Company’s Class A Common Stock remain outstanding as of June 30, 2024.

December 21, 2023

All 3,600,000 of the New Warrants remain outstanding as of June 30, 2024.

April 3, 2024

As of June 30, 2024, 957,910 warrants of Warrant A, 2,000,000 warrants of Warrant B, and 1,600,000 warrants of Warrant C remain outstanding.

Balance Sheet Components

6 Months Ended

Jun. 30, 2024

Balance Sheet Components

Balance Sheet Components

Prepaid expenses and other current assets

Prepaid expenses and other current assets as of June 30, 2024 and December 31, 2023 consisted of the following:


	June 30, 2024		December 31, 2023
Prepaid operating expenses	$	270,332	$	216,875
Rent deposit	30,333		28,400
Value added tax receivable	49,455		116,095
Tax credit receivable (short-term)	25,045		102,151
Miscellaneous receivable	351,447		363,260
Prepaid expenses and other current assets	$	726,612	$	826,781

Capitalized internal-use software, net

Capitalized internal-use software, net as of as of June 30, 2024 and December 31, 2023 consisted of the following:


	Useful Lives	June 30, 2024		December 31, 2023
Internally developed software	5 Years	$	4,215,099	$	3,901,801
Less: Accumulated depreciation		(2,705,919)		(2,429,427)
Capitalized internal-use software, net		$	1,509,180	$	1,472,374

Property and equipment, net

Property and equipment, net as of as of June 30, 2024 and December 31, 2023 consisted of the following:


	Useful Lives	June 30, 2024		December 31, 2023
Computer equipment	3-4 Years	$	146,596	$	152,014
Furniture and fixtures	10 Years	33,937		28,052
Property and equipment, gross		180,533		180,066
Less: Accumulated depreciation		(137,021)		(123,630)
Property and equipment, net		$	43,512	$	56,436

Accrued expenses

Accrued expenses as of June 30, 2024 and December 31, 2023 consisted of the following:


	June 30, 2024		December 31, 2023
Compensation payable	$	552,133	$	377,403
Commission liability	20,454		26,863
Accrued employee taxes	909,171		624,525
Other accrued liabilities	57,620		115,099
Accrued expenses	$	1,539,378	$	1,143,890

Goodwill and Intangible Assets, Net

6 Months Ended

Jun. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets, Net

There were no changes in the carrying amount of Goodwill for the six months ended June 30, 2024.

Intangible assets, net as of June 30, 2024 and December 31, 2023 consisted of the following:


	Useful Lives	June 30, 2024		December 31, 2023
Patent application costs	3 Years	$	522,845	$	484,035
Trade name and trademarks	3 Years	68,312		70,446
Intangible assets, gross		591,157		554,481
Less: Accumulated amortization		(398,538)		(330,791)
Intangible assets, net		$	192,619	$	223,690

The Company added 5 new issued patents during the six months ended June 30, 2024. The patents issued during the six months ended June 30, 2024 increased our total number of patents to 22 and include:

Estimated future amortization expense of Intangible assets, net is as follows:


Years Ending December 31,	Amount
2024	$	60,076
2025	87,980
2026	41,505
2027	3,058
Total future amortization	$	192,619

Net Loss per Share Attributable to Common Stockholders

6 Months Ended

Jun. 30, 2024

Earnings Per Share [Abstract]

Net Loss per Share Attributable to Common Stockholders

The following table presents the calculation of basic and diluted net loss per share:


	For the three months ended June 30,				For the six months ended June 30,
	2024		2023		2024		2023
Numerator:
Net loss attributable to common stockholders	$	(2,598,361)	$	(2,170,368)	$	(5,276,930)	$	(4,717,818)

Denominator:
Weighted average shares used in computing net loss per share attributable to common stockholders	12,227,476		6,757,320		11,169,735		5,897,089

Net loss per share attributable to common stockholders	$	(0.21)	$	(0.32)	$	(0.47)	$	(0.80)


	As of June 30,
	2024	2023
Options, RSUs, and grants	1,323,580	642,927
Warrants	12,817,277	5,017,180
Total	14,140,857	5,660,107

Stock Awards and Stock-Based Compensation

6 Months Ended

Jun. 30, 2024

Share-Based Payment Arrangement [Abstract]

Stock Awards and Stock-Based Compensation

Stock Options

The following table summarizes stock option activity for the three and six months ended June 30, 2024:


	Options Outstanding	Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (years)	Aggregate Intrinsic Value
Balance as of January 1, 2023	387,109	$	6.40	1.45	$	—
Options granted	11,890	2.28
Options exercised	(1,230)	3.25
Options canceled and forfeited	(4,186)	5.73
Balance as of December 31, 2023	393,583	6.27		1.95	—
Options granted	3,825	1.57
Options exercised	—	—
Options canceled and forfeited	(1,425)	4.21
Balance as of March 31, 2024	395,983	6.24		1.72	—
Options granted	4,375	1.37
Options exercised	—	—
Options canceled and forfeited	(510)	3.92
Balance as of June 30, 2024	399,848	$	6.19	1.49	$	—
Options vested and exercisable as of June 30, 2024	399,848	$	6.19	1.49	$	—


	Options Outstanding	Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (years)	Aggregate Intrinsic Value
Balance as of January 1, 2024	393,583	$	6.27	1.95	$	—
Options granted	8,200	1.46
Options exercised	—	0
Options canceled and forfeited	(1,935)	4.13
Balance as of June 30, 2024	399,848	$	6.19	1.49	—
Options vested and exercisable as of June 30, 2024	399,848	$	6.19	1.49	$	—

The following assumptions were used to calculate the fair value of options granted during the six months ended June 30, 2024:


Fair value of Class A Common Stock	$0.17 — 0.72
Exercise price	$1.32 — 1.64
Risk free interest rate	4.11 — 4.71%
Expected dividend yield	0.00	%
Expected volatility	77.54 — 79.80%
Expected term	3 Years

As of June 30, 2024, the Company had 399,848 stock options outstanding of which all are fully vested options.

Stock Grants

RSU

During the six months ended June 30, 2024 the Company issued 54,734 of Class A Common Stock to employees that were designated for employee stock awards and were previously recorded as treasury stock.

A summary of outstanding RSU activity as of June 30, 2024 is as follows:


			RSU Outstanding Number of Shares
Balance as of January 1, 2023			292,564
Granted			410,516
Vested (issued)			(159,776)
Forfeited			(97,202)
Balance as of December 31, 2023			446,102
Granted			812,050
Vested (issued)			(318,812)
Forfeited			(75,878)
Balance as of June 30, 2024			863,462

Stock-based compensation expense

Our consolidated statements of operations include stock-based compensation expense as follows:


	For the three months ended June 30,				For the six months ended June 30,
	2024		2023		2024		2023
Cost of services	$	—	$	161	$	262	$	656
Research and development	6,094		12,766		14,210		31,620
Selling, general, and administrative	301,031		84,810		590,539		125,035
Total stock-based compensation expense	$	307,125	$	97,737	$	605,011	$	157,311

Related Party Transactions	6 Months Ended
Related Party Transactions	Jun. 30, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Related party payables of $53 thousand and $82 thousand as of June 30, 2024 and December 31, 2023, respectively, primarily relate to amounts owed to 10Clouds, the Company’s contractor for software development and investor in the Company, and smaller amounts payable to members of management as expense reimbursements. Total costs incurred in relation to 10Clouds for the three months ended June 30, 2024 and 2023, totaled approximately $7 thousand and $242 thousand, respectively. Total costs incurred in relation to 10Clouds for the six months ended June 30, 2024 and 2023, totaled approximately $111 thousand and $535 thousand, respectively. Mutual Channel Agreement On November 15, 2020, the Company entered into a Mutual Channel Agreement with Vital4Data, Inc., a company at which one of our Directors serves as Chief Executive Officer. Pursuant to the agreement, the Company engaged Vita4Data, Inc. as a non-exclusive sales representative for the Company’s products and services. Vital4Data, Inc. is entitled to compensation in the form of commissions, receiving a 20% of commission-eligible on net revenue from sales generated by Vital4Data, Inc. in the first year of the contract term, which is reduced to 10% in the second year, and 5% in the third year. The Company has not earned or expensed any commissions pursuant to the Vital4Data, Inc. agreement to date. As of June 30, 2024 and December 31, 2023, the Vital4Data, Inc. commission due was $0.

Malta Grant	6 Months Ended
Malta Grant	Jun. 30, 2024
Malta Grant
Malta Grant	Malta Grant During July 2020 the Company entered into an agreement with the Republic of Malta that would provide for a grant of up to €200 thousand or $251 thousand as reimbursement for operating expenses over the first twelve months following Trust Stamp Malta’s incorporation in the Republic of Malta. The Company must provide an initial capital amount of €50 thousand or $62 thousand, which is matched with a €50 thousand or $62 thousand grant. The remaining €150 thousand or $190 thousand are provided as reimbursement of operating expenses twelve months following incorporation. U.S. GAAP does not provide authoritative guidance regarding the receipt of economic benefits from government entities in return for compliance with certain conditions. Therefore, based on ASC 105-10-05-2, non-authoritative accounting guidance from other sources was considered by analogy in determining the appropriate accounting treatment, the Company elected to apply International Accounting Standards 20 – Accounting for Government Grants and Disclosure of Government Assistance and recognizes the expected reimbursements from the Republic of Malta as deferred income. As reimbursable operating expenses are incurred, a receivable is recognized (reflected within “Prepaid expenses and other current assets” in the consolidated balance sheets) and income is recognized in a similar systematic basis over the same periods in the consolidated statements of operations. During the six months ended June 30, 2023, the Company incurred $0 in expenses that are reimbursable under the grant. As of June 30, 2024, all amounts provided for under this grant were received. On January 25, 2022, the Company entered into an additional agreement with the government of Malta for a grant of up to €100 thousand or $107 thousand, in terms of the ‘Investment Aid to produce the COVID-19 Relevant Product’ program, to support the proposed investment. The estimated value of the grant is €137 thousand or $146 thousand, at an aid intensity of 75% to cover eligible wage costs incurred after February 1, 2022 in relation to new employees engaged specifically for the implementation of the project. On September 22, 2022, the Company entered into an amendment agreement that enables the Company to submit eligible employee expenses for reimbursement by October 31, 2022. The grant was approved in January 2022, however, the request for payment was not approved and management abandoned the agreement. Hence, during the six months ended June 30, 2024 and 2023, the Company incurred $0, respectively, in expenses that are reimbursable under the grant. As of June 30, 2024, no amounts provided under this grant were received.

Leases and Commitments

6 Months Ended

Jun. 30, 2024

Leases and Commitments

Leases and Commitments


Lease term and discount rate	June 30, 2024
Weighted average remaining lease term	2.01 years
Weighted average discount rate	5.0	%

Balance sheet information related to leases as of as of June 30, 2024 and December 31, 2023 was as follows:


	June 30, 2024		December 31, 2023
Operating lease right-of-use assets
Operating lease right-of-use assets	$	229,370	$	164,740

Operating lease liabilities
Short-term operating lease liabilities	$	123,431	$	81,236
Long-term operating lease liabilities	73,520		53,771
Total operating lease liabilities	$	196,951	$	135,007

Future maturities of ASC 842 lease liabilities as of June 30, 2024 are as follows:


Years Ending December 31,	Principal Payments		Imputed Interest Payments		Total Payments
2024	$	71,229	$	4,184	$	75,413
2025	86,673		3,608		90,281
2026	22,390		1,130		23,520
2027	8,493		602		9,095
2028	8,166		171		8,337
Total future maturities	$	196,951	$	9,695	$	206,646


	For the three months ended June 30,				For the six months ended June 30,
	2024		2023		2024		2023
Operating lease expense – fixed payments	$	37,976	$	46,402	$	77,853	$	129,436
Short term lease expense	12,284		15,620		24,220		37,552
Total lease expense	$	50,260	$	62,022	$	102,073	$	166,988

Supplemental cash flows information related to leases was as follow:


	For the six months ended June 30,
	2024		2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	(80,248)	$	(104,817)

During the six months ended June 30, 2024, the Company did not incur variable lease expense.

Subsequent Events	6 Months Ended
Subsequent Events	Jun. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Promissory Note Agreement — On July 9, 2024, the Company entered into a subordinated secured promissory note with Agile Lending, LLC as lead lender (“Agile”) and Agile Capital Funding, LLC as collateral agent, which provides for a term loan to the Company of $453,600 with the principal amount of $315,000 and interest of $138,600. Commencing July 18, 2024, the Company is required to make weekly payments of $16,200 until the due date, January 23, 2025. The loan may be prepaid subject to a prepayment fee. An administrative agent fee of $15,000 was paid on the loan. In connection with the loan, Agile was issued a subordinated secured promissory note, dated July 9, 2024, in the principal amount of $315,000 which note is secured by all of the Borrower’s assets, including receivables. Boumarang License Agreement — On August 6, 2024, the Company entered into a License Agreement (the “Agreement”) with Boumarang Inc. (“Boumarang”), a developer, manufacturer, and seller of hydrogen-powered UAV and USV drones. Pursuant to the Agreement, the Company agreed to grant a non-exclusive license to Boumarang to exploit certain of the Company’s patents for the purpose of producing, selling, marketing, and distributing drones. As consideration for the grant of the non-exclusive license, Boumarang agreed to pay the Company a non-refundable license fee of $5,000,000 in the form of a prepaid warrant issued by Boumarang to the Company for 5,000,000 shares of common stock of Boumarang at $1.00 per share (the “Prepaid Warrant”). Boumarang Subscription Agreement — On August 6, 2024, Trust Stamp executed a Subscription Agreement with Boumarang to participate in a Regulation D offering being conducted by Boumarang, subscribing for 100,000 shares of Boumarang's common stock at a price per share of $1.00. The Company made the $100,000 subscription payment on August 6, 2024.

Description of Business, Summary of Significant Accounting Policies, and Going Concern (Policies)	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	Description of Business — T Stamp Inc. was incorporated in the State of Delaware on April 11, 2016. T Stamp Inc. and its subsidiaries (“Trust Stamp”, “we”, “us”, “our” or the “Company”) develops and markets artificial intelligence-powered software solutions for enterprise and government partners and peer-to-peer markets. Trust Stamp develops proprietary artificial intelligence-powered solutions, researching and leveraging machine learning, artificial intelligence, biometric science, cryptography, and data mining, to deliver insightful identity and trust predictions that identify and defend against fraudulent identity attacks, protect sensitive user information, and extend the reach of digital services through global accessibility. We utilize the power and agility of technologies such as GPU processing, edge-computing, neural networks, and large language models to process and protect data faster and more effectively than has ever previously been possible in order to deliver results at a disruptively low cost for usage across multiple industries, including: •Banking/FinTech •KYC/AML Compliance •Humanitarian and Development Services •Government and Law Enforcement, including Alternative to Detention programs •Cryptocurrency and Digital Assets •Biometrically Secured Email and Digital Communications •P2P Transactions, Social Media, and Sharing Economy •Real Estate, Travel, and Healthcare As our portfolio of intellectual property and solutions has developed, we have started to seek applications for our technology outside our traditional focus on identity and trust. We anticipate licensing our technology in numerous fields, typically through established partners who will integrate our technology into field-specific applications.
Reverse Split	Reverse Split — On February 15, 2023 our Board of Directors approved and, as of February 20, 2023, the holders of a majority of our voting capital stock approved an amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation and approved to effect a reverse split of our issued and outstanding shares of Class A Common Stock at a ratio of one share for every five shares currently held, rounded up to the nearest whole share – whereby every five (5) outstanding shares of Class A Common Stock was combined and became one (1) share of Class A Common Stock, rounding up to the nearest whole number of shares (the “Reverse Split”). All share and per share amounts have been updated to reflect the Reverse Split in these unaudited condensed consolidated financial statements. The Reverse Split was effective for trading on the market opening of Nasdaq on March 23, 2023. The Reverse Stock Split effective March 23, 2023, was ratified by the Company’s stockholders by written consent pursuant to a definitive proxy statement filed with the Securities and Exchange Commission on April 13, 2023. Written consent from the majority of stockholders was received as of May 13, 2023.
Going Concern	Going Concern — The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company is a business that has not yet generated profits, with a net loss during the six months ended June 30, 2024 of $5.28 million, negative net operating cash outflows of $3.76 million for the same period, working capital of negative $1.07 million and an accumulated deficit of $56.13 million as of June 30, 2024. The Company’s ability to continue as a going concern in the next twelve months following the date the unaudited condensed consolidated financial statements were available to be issued is dependent upon its ability to produce revenues and/or obtain financing sufficient to meet current and future obligations and deploy such to produce profitable operating results. Management has evaluated these conditions and plans to generate revenue and raise capital as needed to satisfy the Company’s capital needs. While the negotiation of significant additional revenue is well advanced, it has not reached a stage that allows it to be factored into a going concern evaluation. In addition, although the Company has previously been successful in raising capital as needed and has already made plans to do so as well as restructuring expenses to meet the Company’s cash needs, no assurance can be given that the Company will be successful in its capital raising efforts. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period. On July 13, 2024, T Stamp Inc. entered into a Securities Purchase Agreement (the “SPA”) with a certain investor (the “Purchaser”). Pursuant to the terms of the SPA, the Purchaser agreed, at the closing of the SPA (the “Closing”) and upon the terms and subject to the conditions set forth in the SPA, to purchase from the Company 4,597,701 shares of Class A Common Stock, par value $0.01 of the Company (the “Class A Common Stock”) at $0.435 per share, which was equal to the closing price of the Company’s Class A Common Stock on the Nasdaq Stock Market on July 11, 2024. The total purchase price for the shares was agreed to be paid pursuant to three promissory notes issued by the Purchaser to the Company comprised of (i) a $500,000 promissory note payable on July 31, 2024, which was paid on July 25, 2024; (ii) a $500,000 promissory note payable on August 31, 2024; and (iii) a $1,000,000 promissory note payable within three (3) trading days of an effective resale registration statement as contemplated by the Registration Rights Agreement. The Company filed a resale registration statement on Form S-3 for this purpose on July 18, 2024 (File No.: 333-280884), which is currently under review by the Commission. As of the date of this Quarterly Report on Form 10-Q, the resale registration statement is not yet effective. None of the promissory notes accrue interest, and each may be repaid before their respective due dates. On July 13, 2024 (the “Closing Date”), the Closing of the SPA occurred, and the Company issued 4,597,701 shares of Class A Common Stock to the Purchaser at $0.435 in exchange for the three promissory notes described above, totaling $2,000,000 in combined principal. The Closing of the SPA was subject to a number of customary closing conditions, including, but not limited to, the Company’s entry into a Registration Rights Agreement, the execution of which were conditions to the Closing of the SPA. Additionally, as part of the Closing of the SPA, the Purchaser executed a Voting Limitation Agreement.
Basis of Presentation	Basis of Presentation — The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with US Generally Accepted Accounting Principles (“US GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The accompanying unaudited condensed consolidated financial statements have been prepared on a basis which assumes that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.
Basis of Consolidation	Basis of Consolidation — The accompanying unaudited condensed consolidated financial statements reflect the activity of the Company and its subsidiaries, Trusted Mail Inc. (“Trusted Mail”), Finnovation LLC (“Finnovation”), Trust Stamp Malta Limited (“Trust Stamp Malta”), AIID Payments Limited, Biometric Innovations Limited (“Biometrics”), Trust Stamp Rwanda Limited, Metapresence Limited, Trust Stamp Denmark ApS, Quantum Foundation, TSI GovTech Corporation, Global Server Management Inc., Cheltenham AI LTD, and Trust Stamp Nigeria Limited. All significant intercompany transactions and accounts have been eliminated. Further, we continue to consolidate Tstamp Incentive Holdings (“TSIH”) which we consider to be a variable interest entity. In the opinion of management, these condensed consolidated financial statements reflect all adjustments necessary (which adjustments are of a normal and recurring nature) for the fair presentation of the Company's financial position as of June 30, 2024 and December 31, 2023, and the results of operations for the three and six months ended June 30, 2024 and 2023. The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of results expected for the full year. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with GAAP have been omitted pursuant to the rules and regulations of the SEC. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes to consolidated financial statements in the Company's Annual Report on Form 10-K for the year ended December 31, 2023. The accounting policies employed are substantially the same as those shown in note 1 of the notes to consolidated financial statements included therein.
Variable Interest Entity	Variable Interest Entity — On April 9, 2019, management created a new entity, TSIH. Furthermore, on April 25, 2019, the Company issued 320,513 shares of Class A Common Stock to TSIH, for the purpose of providing a pool of shares of Class A Common Stock of the Company that the Company’s Board of Directors (the “Board”) could use for employee stock awards and were recorded initially as Treasury stock. Since establishing TSIH, 264,000 shares were transferred to various employees as a stock award that were earned and outstanding. On February 15, 2023, Trust Stamp issued 206,033 shares of Class A Common Stock to TSIH to be used to satisfy vested employee stock awards. As of June 30, 2024, no shares of Class A Common Stock are held by TSIH as all shares have been issued pursuant to employee Restricted Stock Units. The Company does not own any of the shares of Class A Common Stock of the Company held by TSIH. The Company considers this entity to be a variable interest entity (“VIE”) because it is thinly capitalized and holds no cash. Because the Company does not own shares in TSIH, management believes that this gives the Company a variable interest. Further, management of the Company also acts as management of TSIH and is the decision-maker as management grants shares held by TSIH to employees of the Company. As this VIE owns only shares in the Company and no other liabilities or assets, the Company is the primary beneficiary of TSIH and will consolidate the VIE.
Major Customers and Concentration of Risks	Major Customers and Concentration of Risks — Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of Cash and cash equivalents, and Accounts receivable. We maintain our Cash and cash equivalents with high-quality financial institutions, mainly in the United States; the composition of which are regularly monitored by us. The Federal Deposit Insurance Corporation covers $250,000 for substantially all depository accounts. The Company from time to time may have amounts on deposit in excess of the insured limits. As of June 30, 2024 and December 31, 2023, the Company had $206,821 and $2,620,765 in U.S. bank accounts, respectively, which exceeded these insured amounts. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts. For Accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit and maintain reserves for potential credit losses based upon the expected collectability of Accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of credit worthiness and applying other credit risk monitoring procedures. Three customers represented 95.42% or 48.95%, 38.80%, and 7.67% of the balance of total Accounts receivable as of June 30, 2024 and three customers represented 91.11% or 53.55%, 30.43%, and 7.13% of the balance of total Accounts receivable as of December 31, 2023. The Company seeks to mitigate its credit risk with respect to Accounts receivable by contracting with large commercial customers and government agencies, and regularly monitoring the aging of Accounts receivable balances. As of June 30, 2024 and December 31, 2023, the Company had not experienced any significant losses on its Accounts receivable. During the three months ended June 30, 2024, the Company sold to primarily three customers which made up approximately 96.21% of total Net revenue, and consisted of 67.33%, 17.38%, and 11.50% from an S&P 500 Bank, Mastercard and Triton, respectively. Additionally, during the three months ended June 30, 2023, the Company sold to primarily three customers which made up approximately 90.67% of total Net revenue, and consisted of 48.97%, 31.33%, and 10.37% from an S&P 500 Bank, Mastercard, and Triton, respectively. During the six months ended June 30, 2024, the Company sold to primarily three customers which made up approximately 95.37% of total Net revenue, and consisted of 62.39%, 22.72%, and 10.26% from an S&P 500 Bank, Mastercard and Triton, respectively. Additionally, during the six months ended June 30, 2023, the Company sold to primarily four customers which made up approximately 92.73% of total Net revenue, and consisted of 44.57%, 28.21%, 10.22%, and 9.73% from an S&P 500 Bank, Mastercard, FIS, and Triton, respectively.
Property and Equipment, Net	Property and Equipment, Net — Property and equipment, net is stated at cost less accumulated depreciation. Depreciation is recognized using the straight-line method over the estimated useful lives of the respective assets. Maintenance and repairs that do not improve or extend the useful lives of the assets are expensed when incurred, whereas additions and major improvements are capitalized. Upon sale or retirement of assets, the cost and related accumulated depreciation are derecognized from the consolidated balance sheet and any resulting gain or loss is recorded in the consolidated statements of operations in the period realized.
Accounting for Impairment of Long-Lived Assets	Accounting for Impairment of Long-Lived Assets — Long-lived assets with finite lives include Property and equipment, net, Capitalized internal-use software, Operating lease right-of-use assets, and Intangible assets, net subject to amortization. The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of assets held and used is measured by comparison of the carrying amount of an asset or an asset group to estimated undiscounted future net cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset exceeds these estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the assets exceeds the fair value of the asset or asset group. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell. As of June 30, 2024, the Company determined that $1 thousand of Capitalized internal-use software were impaired. The impaired Capitalized internal-use software was expensed to Research and development during the six months ended June 30, 2024. As of December 31, 2023, the Company determined that $19 thousand of Capitalized internal-use software and $12 thousand of Intangible assets was impaired. The impaired Capitalized internal-use software was expensed to Research and development during the year ended December 31, 2023.
Goodwill	Goodwill — Goodwill is accounted for in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 350, Intangibles—Goodwill and Other. The Company allocates the cost of an acquired business to the assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. The excess of the purchase consideration transferred over the fair value of the net assets acquired, including other Intangible assets, net, is recorded as Goodwill. Goodwill is tested for impairment at the reporting unit level at least quarterly or more frequently when events or circumstances occur that indicate that it is more likely than not that an impairment has occurred. In assessing Goodwill for impairment, the Company first assesses qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. In the qualitative assessment, the Company considers factors including economic conditions, industry and market conditions and developments, overall financial performance and other relevant entity-specific events in determining whether it is more likely than not that the fair value of the reporting unit is less than the carrying amount. Should the Company conclude that it is more likely than not that the recorded Goodwill amounts have been impaired, the Company would perform the impairment test. Goodwill impairment exists when a reporting unit’s carrying value exceeds its fair value. Significant judgment is applied when Goodwill is assessed for impairment. There were no impairment charges to Goodwill as of June 30, 2024 and December 31, 2023.
Remaining Performance Obligations	Remaining Performance Obligations — The Company’s arrangements with its customers often have terms that span over multiple years. However, the Company generally allows its customers to terminate contracts for convenience prior to the end of the stated term with less than twelve months’ notice. Revenue allocated to remaining performance obligations represents non-cancelable contracted revenue that has not yet been recognized, which includes deferred revenue and, in certain instances, amounts that will be invoiced. The Company has elected the practical expedient allowing the Company to not disclose remaining performance obligations for contracts with original terms of twelve months or less. Cancellable contracted revenue, which includes customer deposit liabilities, is not considered a remaining performance obligation. As of June 30, 2024 and December 31, 2023, the Company did not have any related performance obligations for contracts with terms exceeding twelve months.
Recent Accounting Pronouncements Not Yet Adopted	Recent Accounting Pronouncements Not Yet Adopted — In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) – Improvements to Income Tax Disclosures. ASU 2023-09 requires enhancements and further transparency to certain income tax disclosures, most notably the tax rate reconciliation and income taxes paid. This ASU is effective for fiscal years beginning after December 15, 2024 on a prospective basis and retrospective application is permitted. The Company is currently evaluating the impacts of the new standard but does not expect a material impact to its unaudited condensed consolidated financial statements or related disclosures. In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. The amendments in this ASU clarify that an entity should measure the fair value of an equity security subject to contractual sale restriction the same way it measures an identical equity security that is not subject to such a restriction. The FASB said the contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, should not affect its fair value. The ASU is effective for public entities for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect this guidance to have a material impact to its unaudited condensed consolidated financial statements or related disclosures.

Description of Business, Summary of Significant Accounting Policies, and Going Concern (Tables)

6 Months Ended

Jun. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Disaggregation of Revenue

Disaggregation of Revenue


	For the three months ended June 30,				For the six months ended June 30,
	2024		2023		2024		2023
Professional services (over time)	$	414,145	$	385,804	$	901,571	$	769,438
License fees (over time)	86,250		75,000		172,500		150,000
Total Revenue	$	500,395	$	460,804	$	1,074,071	$	919,438

Borrowings (Tables)

6 Months Ended

Jun. 30, 2024

Debt Disclosure [Abstract]

Summary of Non-Convertible Promissory Notes Payable


	June 30, 2024		December 31, 2023
Malta loan receipt 3 – June 3, 2022	$	491,680	$	507,035
Malta loan receipt 2 – August 10, 2021	303,582		313,063
Malta loan receipt 1 – February 9, 2021	62,325		64,271
Interest added to principal	67,404		29,191
Total principal outstanding	924,991		913,560
Plus: accrued interest	28,808		40,317
Total promissory notes payable	$	953,799	$	953,877

Warrants (Tables)

6 Months Ended

Jun. 30, 2024

Warrants and Rights Note Disclosure [Abstract]

Schedule of Changes in Warrant Liability


	Warrants ($)
Balance as of January 1, 2023	$	261,569
Additional warrants issued	—
Change in fair value	(5,033)
Balance as of December 31, 2023	$	256,536
Additional warrants issued	—
Change in fair value	(4,868)
Balance as of June 30, 2024	$	251,668

Schedule of Fair Value of Warrants Liabilities

The following assumptions were used to calculate the fair value of the warrant liability during the six months ended June 30, 2024:


Fair Value of Warrants	$0.26 — $0.64
Exercise price	$0.43 — $0.49
Risk free interest rate	4.38%— 4.50%
Expected dividend yield	—	%
Expected volatility	79.25% — 79.59%
Expected term	3 years

Schedule of Warrant Issuance Date


Warrant Issuance Date	Strike Price		June 30, 2024	December 31, 2023
November 9, 2016	$	3.12	80,128	80,128
January 23, 2020	$	8.00	186,442	186,442
January 23, 2020	$	8.00	524,599	524,599
April 18, 2023	$	1.34	—	775,330
June 5, 2023	$	1.34	1,173,030	1,279,700
December 21, 2023	$	1.34	3,600,000	3,600,000
April 3, 2024	$	—	957,910	—
April 3, 2024	$	0.97	2,000,000	—
April 3, 2024	$	1.06	1,600,000	—
Total warrants outstanding			10,122,109	6,446,199

Balance Sheet Components (Tables)

6 Months Ended

Jun. 30, 2024

Balance Sheet Components

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets as of June 30, 2024 and December 31, 2023 consisted of the following:


	June 30, 2024		December 31, 2023
Prepaid operating expenses	$	270,332	$	216,875
Rent deposit	30,333		28,400
Value added tax receivable	49,455		116,095
Tax credit receivable (short-term)	25,045		102,151
Miscellaneous receivable	351,447		363,260
Prepaid expenses and other current assets	$	726,612	$	826,781

Schedule of Capitalized Internal-Use Software, Net

Capitalized internal-use software, net as of as of June 30, 2024 and December 31, 2023 consisted of the following:


	Useful Lives	June 30, 2024		December 31, 2023
Internally developed software	5 Years	$	4,215,099	$	3,901,801
Less: Accumulated depreciation		(2,705,919)		(2,429,427)
Capitalized internal-use software, net		$	1,509,180	$	1,472,374

Schedule of Property and Equipment, Net

Property and equipment, net as of as of June 30, 2024 and December 31, 2023 consisted of the following:


	Useful Lives	June 30, 2024		December 31, 2023
Computer equipment	3-4 Years	$	146,596	$	152,014
Furniture and fixtures	10 Years	33,937		28,052
Property and equipment, gross		180,533		180,066
Less: Accumulated depreciation		(137,021)		(123,630)
Property and equipment, net		$	43,512	$	56,436

Schedule of Accrued Expenses

Accrued expenses as of June 30, 2024 and December 31, 2023 consisted of the following:


	June 30, 2024		December 31, 2023
Compensation payable	$	552,133	$	377,403
Commission liability	20,454		26,863
Accrued employee taxes	909,171		624,525
Other accrued liabilities	57,620		115,099
Accrued expenses	$	1,539,378	$	1,143,890

Goodwill and Intangible Assets, Net (Tables)

6 Months Ended

Jun. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets, Net

Intangible assets, net as of June 30, 2024 and December 31, 2023 consisted of the following:


	Useful Lives	June 30, 2024		December 31, 2023
Patent application costs	3 Years	$	522,845	$	484,035
Trade name and trademarks	3 Years	68,312		70,446
Intangible assets, gross		591,157		554,481
Less: Accumulated amortization		(398,538)		(330,791)
Intangible assets, net		$	192,619	$	223,690

Schedule of Estimated Future Amortization Expense of Intangible Assets, Net

Estimated future amortization expense of Intangible assets, net is as follows:


Years Ending December 31,	Amount
2024	$	60,076
2025	87,980
2026	41,505
2027	3,058
Total future amortization	$	192,619

Net Loss per Share Attributable to Common Stockholders (Tables)

6 Months Ended

Jun. 30, 2024

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Loss Per Share Attributable to Common Stockholders

The following table presents the calculation of basic and diluted net loss per share:


	For the three months ended June 30,				For the six months ended June 30,
	2024		2023		2024		2023
Numerator:
Net loss attributable to common stockholders	$	(2,598,361)	$	(2,170,368)	$	(5,276,930)	$	(4,717,818)

Denominator:
Weighted average shares used in computing net loss per share attributable to common stockholders	12,227,476		6,757,320		11,169,735		5,897,089

Net loss per share attributable to common stockholders	$	(0.21)	$	(0.32)	$	(0.47)	$	(0.80)

Schedule of Anti-Dilutive Securities Excluded From Computation of Diluted Net Loss Per Share


	As of June 30,
	2024	2023
Options, RSUs, and grants	1,323,580	642,927
Warrants	12,817,277	5,017,180
Total	14,140,857	5,660,107

Stock Awards and Stock-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Stock Options Activity

The following table summarizes stock option activity for the three and six months ended June 30, 2024:


	Options Outstanding	Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (years)	Aggregate Intrinsic Value
Balance as of January 1, 2023	387,109	$	6.40	1.45	$	—
Options granted	11,890	2.28
Options exercised	(1,230)	3.25
Options canceled and forfeited	(4,186)	5.73
Balance as of December 31, 2023	393,583	6.27		1.95	—
Options granted	3,825	1.57
Options exercised	—	—
Options canceled and forfeited	(1,425)	4.21
Balance as of March 31, 2024	395,983	6.24		1.72	—
Options granted	4,375	1.37
Options exercised	—	—
Options canceled and forfeited	(510)	3.92
Balance as of June 30, 2024	399,848	$	6.19	1.49	$	—
Options vested and exercisable as of June 30, 2024	399,848	$	6.19	1.49	$	—


	Options Outstanding	Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (years)	Aggregate Intrinsic Value
Balance as of January 1, 2024	393,583	$	6.27	1.95	$	—
Options granted	8,200	1.46
Options exercised	—	0
Options canceled and forfeited	(1,935)	4.13
Balance as of June 30, 2024	399,848	$	6.19	1.49	—
Options vested and exercisable as of June 30, 2024	399,848	$	6.19	1.49	$	—

Schedule of Stock Options Valuation Assumptions

The following assumptions were used to calculate the fair value of options granted during the six months ended June 30, 2024:


Fair value of Class A Common Stock	$0.17 — 0.72
Exercise price	$1.32 — 1.64
Risk free interest rate	4.11 — 4.71%
Expected dividend yield	0.00	%
Expected volatility	77.54 — 79.80%
Expected term	3 Years

Schedule of Outstanding RSU Activity

A summary of outstanding RSU activity as of June 30, 2024 is as follows:


			RSU Outstanding Number of Shares
Balance as of January 1, 2023			292,564
Granted			410,516
Vested (issued)			(159,776)
Forfeited			(97,202)
Balance as of December 31, 2023			446,102
Granted			812,050
Vested (issued)			(318,812)
Forfeited			(75,878)
Balance as of June 30, 2024			863,462

Schedule of Stock-Based Compensation Expense

Our consolidated statements of operations include stock-based compensation expense as follows:


	For the three months ended June 30,				For the six months ended June 30,
	2024		2023		2024		2023
Cost of services	$	—	$	161	$	262	$	656
Research and development	6,094		12,766		14,210		31,620
Selling, general, and administrative	301,031		84,810		590,539		125,035
Total stock-based compensation expense	$	307,125	$	97,737	$	605,011	$	157,311

Leases and Commitments (Tables)

6 Months Ended

Jun. 30, 2024

Leases and Commitments

Summary of Lease Term and Discount Rate


Lease term and discount rate	June 30, 2024
Weighted average remaining lease term	2.01 years
Weighted average discount rate	5.0	%

Summary of Balance Sheet Information Related to Leases

Balance sheet information related to leases as of as of June 30, 2024 and December 31, 2023 was as follows:


	June 30, 2024		December 31, 2023
Operating lease right-of-use assets
Operating lease right-of-use assets	$	229,370	$	164,740

Operating lease liabilities
Short-term operating lease liabilities	$	123,431	$	81,236
Long-term operating lease liabilities	73,520		53,771
Total operating lease liabilities	$	196,951	$	135,007

Summary of Future Maturities of ASC 842 Lease Liabilities

Future maturities of ASC 842 lease liabilities as of June 30, 2024 are as follows:


Years Ending December 31,	Principal Payments		Imputed Interest Payments		Total Payments
2024	$	71,229	$	4,184	$	75,413
2025	86,673		3,608		90,281
2026	22,390		1,130		23,520
2027	8,493		602		9,095
2028	8,166		171		8,337
Total future maturities	$	196,951	$	9,695	$	206,646

Summary of Total Lease Expense, Under ASC 842, was Included in Selling, General, and Administrative Expenses in Consolidated Statement of Operations


	For the three months ended June 30,				For the six months ended June 30,
	2024		2023		2024		2023
Operating lease expense – fixed payments	$	37,976	$	46,402	$	77,853	$	129,436
Short term lease expense	12,284		15,620		24,220		37,552
Total lease expense	$	50,260	$	62,022	$	102,073	$	166,988

Summary of Supplemental Cash Flows Information Related to Leases

Supplemental cash flows information related to leases was as follow:


	For the six months ended June 30,
	2024		2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	(80,248)	$	(104,817)

Description of Business, Summary of Significant Accounting Policies, and Going Concern - Narrative (Details)					3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 13, 2024 USD ($) $ / shares shares	Apr. 03, 2024 USD ($) $ / shares shares	Mar. 23, 2023	Apr. 25, 2019 shares	Jun. 30, 2024 USD ($) $ / shares shares	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($) $ / shares shares	Jun. 30, 2023 USD ($)	Dec. 31, 2023 USD ($) $ / shares shares	Jun. 05, 2023 $ / shares shares	Apr. 18, 2023 $ / shares shares	Feb. 15, 2023 shares	Dec. 31, 2022 USD ($)	Jun. 30, 2020 shares	Jan. 31, 2020 shares	Nov. 09, 2016 shares
Disaggregation of Revenue
Stock split			0.2
Common stock, shares authorized (in shares) \| shares					50,000,000		50,000,000		50,000,000
Net loss attributable to T Stamp Inc. \| $					$ 2,598,361	$ 2,170,368	$ 5,276,930	$ 4,717,818
Operating cash outflows \| $							3,756,928	3,581,369
Working capital \| $					(1,070,000.00)		(1,070,000.00)
Accumulated deficit \| $					$ 56,130,215		$ 56,130,215		$ 50,853,285
Common stock, par value (in dollars per share) \| $ / shares					$ 0.01		$ 0.01		$ 0.01
Number of warrants exercised for issuance of shares (in shares) \| shares					10,122,109		10,122,109		6,446,199					6,418
Treasury stock, at cost, shares held (in shares) \| shares					0		0		54,734
Common stock, shares issued (in shares) \| shares					11,384,139		11,384,139		9,198,089
Cash and cash equivalents \| $					$ 659,533	$ 5,035,414	$ 659,533	$ 5,035,414	$ 3,140,747				$ 1,254,494
Impairment on finite-lived assets \| $							$ 1,000		12,000
Impaired capitalized internal-use software \| $									$ 19,000
Impairment, intangible asset, finite-lived, statement of income or comprehensive income									Research and development
Subsequent Event \| Promissory Note Payable July 31, 2024
Disaggregation of Revenue
Promissory note payable \| $	$ 500,000
Subsequent Event \| Promissory Note Payable August 31, 2024
Disaggregation of Revenue
Promissory note payable \| $	500,000
Subsequent Event \| Promissory Note Payable
Disaggregation of Revenue
Promissory note payable \| $	$ 1,000,000
Top Three Customers \| Accounts receivable \| Customer Concentration Risk
Disaggregation of Revenue
Concentration risk (as a percent)							95.42%		91.11%
Top Three Customers \| Sales revenue net \| Customer Concentration Risk
Disaggregation of Revenue
Concentration risk (as a percent)					96.21%	90.67%	95.37%
Customer One \| Accounts receivable \| Customer Concentration Risk
Disaggregation of Revenue
Concentration risk (as a percent)							48.95%		53.55%
Customer Two \| Accounts receivable \| Customer Concentration Risk
Disaggregation of Revenue
Concentration risk (as a percent)							38.80%		30.43%
Customer Three \| Accounts receivable \| Customer Concentration Risk
Disaggregation of Revenue
Concentration risk (as a percent)							7.67%		7.13%
S And P 500 Bank \| Sales revenue net \| Customer Concentration Risk
Disaggregation of Revenue
Concentration risk (as a percent)					67.33%	48.97%	62.39%	44.57%
Mastercard \| Sales revenue net \| Customer Concentration Risk
Disaggregation of Revenue
Concentration risk (as a percent)					17.38%	31.33%	22.72%	28.21%
Triton \| Sales revenue net \| Customer Concentration Risk
Disaggregation of Revenue
Concentration risk (as a percent)					11.50%	10.37%	10.26%	9.73%
Top Four Customers \| Sales revenue net \| Customer Concentration Risk
Disaggregation of Revenue
Concentration risk (as a percent)								92.73%
FIS \| Sales revenue net \| Customer Concentration Risk
Disaggregation of Revenue
Concentration risk (as a percent)								10.22%
Bank Time Deposits
Disaggregation of Revenue
Cash and cash equivalents \| $					$ 206,821		$ 206,821		$ 2,620,765
Common Class A
Disaggregation of Revenue
Number of warrants exercised for issuance of shares (in shares) \| shares															932,111	80,128
Treasury stock, at cost, shares held (in shares) \| shares				320,513
Common stock, shares issued (in shares) \| shares												206,033
Common stock, shares held (in shares) \| shares					0		0
Common Class A \| Various employees
Disaggregation of Revenue
Number of shares transferred (in shares) \| shares				264,000
Securities purchase agreement
Disaggregation of Revenue
Common stock, par value (in dollars per share) \| $ / shares										$ 2.30	$ 3.30
Number of warrants exercised for issuance of shares (in shares) \| shares										543,300	1,009,950
Private Placement \| Securities purchase agreement
Disaggregation of Revenue
Sale of stock, number of shares issued in transaction (in shares) \| shares		499,990
Sale of stock, consideration received per transaction \| $		$ 1,936,000
Payments of stock issuance costs \| $		245,520
Sale of stock, consideration received on transaction \| $		$ 1,690,480
Private Placement \| Securities purchase agreement \| Subsequent Event
Disaggregation of Revenue
Sale of stock, number of shares issued in transaction (in shares) \| shares	4,597,701
Sale of stock, consideration received per transaction \| $	$ 2,000,000
Private Placement \| Securities purchase agreement \| Warrant A
Disaggregation of Revenue
Sale of stock, price per share (in dollars per share) \| $ / shares		$ 0.968
Number of warrants exercised for issuance of shares (in shares) \| shares		1,500,010			957,910		957,910
Private Placement \| Securities purchase agreement \| Warrant B
Disaggregation of Revenue
Sale of stock, price per share (in dollars per share) \| $ / shares		$ 0.968
Number of warrants exercised for issuance of shares (in shares) \| shares		2,000,000
Private Placement \| Securities purchase agreement \| Warrant C
Disaggregation of Revenue
Sale of stock, price per share (in dollars per share) \| $ / shares		$ 1.06
Number of warrants exercised for issuance of shares (in shares) \| shares		1,600,000
Private Placement \| Securities purchase agreement \| Common Class A
Disaggregation of Revenue
Common stock, par value (in dollars per share) \| $ / shares		$ 0.01
Private Placement \| Securities purchase agreement \| Common Class A \| Subsequent Event
Disaggregation of Revenue
Common stock, par value (in dollars per share) \| $ / shares	$ 0.01
Sale of stock, price per share (in dollars per share) \| $ / shares	$ 0.435

Description of Business, Summary of Significant Accounting Policies, and Going Concern - Schedule of Disaggregation of Revenue (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disaggregation of Revenue
Total Revenue	$ 500,395	$ 460,804	$ 1,074,071	$ 919,438
Professional services (over time)
Disaggregation of Revenue
Total Revenue	414,145	385,804	901,571	769,438
License fees (over time)
Disaggregation of Revenue
Total Revenue	$ 86,250	$ 75,000	$ 172,500	$ 150,000

Borrowings - Summary of Non-Convertible Promissory Notes Payable (Details) - Non-Convertible Promissory Notes Payable - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Borrowings
Total principal outstanding	$ 924,991	$ 913,560
Interest added to principal	67,404	29,191
Plus: accrued interest	28,808	40,317
Total promissory notes payable	953,799	953,877
Malta loan receipt 3
Borrowings
Total principal outstanding	491,680	507,035
Malta loan receipt 2
Borrowings
Total principal outstanding	303,582	313,063
Malta loan receipt 1
Borrowings
Total principal outstanding	$ 62,325	$ 64,271

Borrowings - Narrative (Details) € in Thousands, $ in Thousands		1 Months Ended	6 Months Ended
	Jul. 08, 2020 EUR (€)	May 31, 2020	Jun. 30, 2024 USD ($)	Jun. 30, 2023	Jul. 08, 2020 USD ($)
Borrowings
Minimum base rate for interest		1.00%
Fixed interest rate percentage		1.00%
Loans from Maltese government \| Trust Stamp Malta Limited
Borrowings
Potential repayable advance	€ 800				$ 858
Percentage of payroll cost covered by advance	75.00%
Term of payroll costs covered by advance	24 months
Employment term for receiving advances	36 months
Proceeds from loan from Maltese government			$ 858
Spread on variable rate		2.00%
Loan interest rate			6.50%	4.50%
Loans from Maltese government \| Trust Stamp Malta Limited \| Minimum
Borrowings
Percentage of pre-tax profits per annum to be repaid		10.00%
Loans from Maltese government \| Trust Stamp Malta Limited \| Maximum
Borrowings
Percentage of pre-tax profits per annum to be repaid		15.00%

Warrants - Schedule of Changes in Warrant Liability (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Change In Financial Instruments [Roll Forward]
Balance, beginning of period	$ 256,536
Balance, end of period	251,668	$ 256,536
Fair Value, Inputs, Level 3
Change In Financial Instruments [Roll Forward]
Balance, beginning of period	256,536	261,569
Additional warrants issued	0	0
Change in fair value	(4,868)	(5,033)
Balance, end of period	$ 251,668	$ 256,536

Warrants - Narrative (Details) - USD ($)														1 Months Ended			6 Months Ended
Warrants - Narrative (Details) - USD ($)	Jul. 13, 2024	Jun. 30, 2024	May 24, 2024	Apr. 03, 2024	Dec. 21, 2023	Jun. 23, 2023	Jun. 12, 2023	Jun. 05, 2023	Jun. 01, 2023	Apr. 18, 2023	Apr. 14, 2023	Dec. 21, 2021	Dec. 16, 2016	Aug. 13, 2024	Dec. 31, 2023	Jan. 31, 2020	Jun. 30, 2024	Jun. 30, 2023	Feb. 27, 2024	Feb. 07, 2024	Feb. 15, 2023	Jun. 30, 2020	Nov. 09, 2016
Warrants
Maximum number of warrants issued to purchase common stock in future		$ 1,000,000.00															$ 1,000,000.00
Percentage of discount of future issuance of preferred stock																	20.00%
Fair value of warrants		$ 250,000											$ 50,000				$ 250,000
Number of warrants exercised for issuance of shares (in shares)		10,122,109													6,446,199		10,122,109					6,418
Warrant liabilities		$ 251,668													$ 256,536		$ 251,668
Change in fair value of warrant liability																	$ (5,000)
Common stock, par value (in dollars per share)		$ 0.01													$ 0.01		$ 0.01
Shares issued upon exercise of warrants (in shares)					1,573,330				1,279,700
Proceeds from common stock, prefunded warrants, and common stock warrants, net of fees																	$ 1,690,480	$ 7,464,312
Common stock, shares issued (in shares)		11,384,139													9,198,089		11,384,139
April 18, 2023
Warrants
Number of warrants exercised for issuance of shares (in shares)		0													775,330		0
Exercise price of warrants (in dollars per share)		$ 1.34															$ 1.34
Warrants, held in abeyance (in shares)															775,330
Pre Funded Warrants
Warrants
Exercise price of warrants (in dollars per share)			$ 0.000			$ 0.001	$ 0.001
Shares issued upon exercise of warrants (in shares)						221,000	322,300
Proceeds from common stock, prefunded warrants, and common stock warrants, net of fees			$ 0			$ 221	$ 322
Warrants exercised (in shares)			542,100			221,000	322,300
Pre Funded Warrants \| Subsequent Event
Warrants
Exercise price of warrants (in dollars per share)														$ 0.000
Proceeds from common stock, prefunded warrants, and common stock warrants, net of fees														$ 0
Warrants exercised (in shares)														799,091
December 21, 2023
Warrants
Number of warrants exercised for issuance of shares (in shares)		3,600,000													3,600,000		3,600,000
Exercise price of warrants (in dollars per share)		$ 1.34															$ 1.34
Warrants exercised (in shares)					106,670
June 5, 2023
Warrants
Number of warrants exercised for issuance of shares (in shares)		1,173,030													1,279,700		1,173,030
Exercise price of warrants (in dollars per share)		$ 1.34															$ 1.34
Institutional Investor
Warrants
Warrants exercised (in shares)															106,670
Notice to Exercise \| April 18, 2023
Warrants
Number of warrants exercised for issuance of shares (in shares)															798,000
Securities purchase agreement
Warrants
Number of warrants exercised for issuance of shares (in shares)								543,300		1,009,950
Number of shares agreed to issue and sell (in shares)								736,400		563,380
Common stock, par value (in dollars per share)								$ 2.30		$ 3.30
Shares issued upon exercise of warrants (in shares)								736,400		1,573,330
Proceeds from common stock, prefunded warrants, and common stock warrants, net of fees								$ 1,693,720		$ 1,859,154
Proceeds from warrant exercises								1,249,047		3,332,835
Proceeds from offering after deducting placement fee and legal expense								2,686,773		4,778,550
Placement fee								205,994		363,439
Legal expense								$ 50,000		$ 50,000
Securities purchase agreement \| Registered direct offering
Warrants
Exercise price of warrants (in dollars per share)									$ 0.001		$ 0.001
Number of shares agreed to issue and sell (in shares)									736,400		563,380
Common stock, par value (in dollars per share)					$ 0.01				$ 0.01		$ 0.01
Share issue price (in dollars per share)					2.30				$ 2.30		$ 3.30
Warrants to purchase shares of common stock agreed to issue and sell (in shares)									543,300		1,009,950
Price per warrant (in dollars per share)					3.30			$ 2.299	$ 2.299		$ 3.299
Securities purchase agreement \| Private Placement
Warrants
Exercise price of warrants (in dollars per share)					$ 2.30				$ 2.30		$ 3.30
Shares issued upon exercise of warrants (in shares)										1,573,330
Sale of stock, number of shares issued in transaction (in shares)				499,990
Sale of stock, consideration received per transaction				$ 1,936,000
Payments of stock issuance costs				245,520
Sale of stock, consideration received on transaction				$ 1,690,480
Securities purchase agreement \| Private Placement \| Subsequent Event
Warrants
Sale of stock, number of shares issued in transaction (in shares)	4,597,701
Sale of stock, consideration received per transaction	$ 2,000,000
Securities purchase agreement \| Private Placement \| April 18, 2023
Warrants
Proceeds from issuance of Common Stock warrants					$ 2,108,262
Common stock, par value (in dollars per share)					$ 1.34
Shares issued upon exercise of warrants (in shares)					1,573,330
Securities purchase agreement \| Private Placement \| December 21, 2023
Warrants
Shares issued upon exercise of warrants (in shares)					1,279,700												1,173,030
Securities purchase agreement \| Private Placement \| June 5, 2023
Warrants
Proceeds from issuance of Common Stock warrants					$ 142,938
Common stock, par value (in dollars per share)					$ 1.34
Securities purchase agreement \| Private Placement \| Warrant A
Warrants
Number of warrants exercised for issuance of shares (in shares)		957,910		1,500,010													957,910
Sale of stock, price per share (in dollars per share)				$ 0.968
Securities purchase agreement \| Private Placement \| Warrant B
Warrants
Number of warrants exercised for issuance of shares (in shares)				2,000,000
Sale of stock, price per share (in dollars per share)				$ 0.968
Securities purchase agreement \| Private Placement \| Warrant C
Warrants
Number of warrants exercised for issuance of shares (in shares)				1,600,000
Sale of stock, price per share (in dollars per share)				$ 1.06
Second Century Ventures, LLC \| January 2020 Warrant Purchase Agreement
Warrants
Proceeds from issuance of Common Stock warrants												$ 3,260,000
Armistice Capital Master Fund Ltd. \| April 18, 2023
Warrants
Exercise price of warrants (in dollars per share)					1.34
Armistice Capital Master Fund Ltd. \| December 21, 2023
Warrants
Exercise price of warrants (in dollars per share)					$ 1.34
Warrants exercised (in shares)					1,800,000
Armistice Capital Master Fund Ltd. \| June 5, 2023
Warrants
Exercise price of warrants (in dollars per share)					$ 1.34
Trusted Mail
Warrants
Cancellation of shares																$ 100,000
Exchange of SAFEs for warrants																$ 125,000
Trusted Mail \| Second Century Ventures, LLC \| January 2020 Warrant Purchase Agreement
Warrants
Proceeds from issuance of Common Stock warrants												$ 3,260,000
Common Class A
Warrants
Proceeds from issuance of Common Stock warrants													$ 50,000
Number of warrants exercised for issuance of shares (in shares)																932,111							80,128
Exercise price of warrants (in dollars per share)																$ 8.00							$ 3.12
Fair value of consideration received from warrants																$ 300,000
Credited value over three years																$ 100,000
Common stock, shares issued (in shares)																					206,033
Common Class A \| April 18, 2023
Warrants
Common stock, shares issued (in shares)																			455,330	320,000
Common Class A \| Securities purchase agreement \| Private Placement
Warrants
Common stock, par value (in dollars per share)				$ 0.01
Common Class A \| Securities purchase agreement \| Private Placement \| Subsequent Event
Warrants
Common stock, par value (in dollars per share)	$ 0.01
Sale of stock, price per share (in dollars per share)	$ 0.435
Common Class A \| Securities purchase agreement \| Private Placement \| December 21, 2023
Warrants
Shares issued upon exercise of warrants (in shares)		3,600,000			3,600,000
Percentage of shares issued					200.00%
Common Class A \| Second Century Ventures, LLC
Warrants
Number of warrants exercised for issuance of shares (in shares)		524,599															524,599
Common Class A \| Second Century Ventures, LLC \| January 2020 Warrant Purchase Agreement
Warrants
Number of warrants exercised for issuance of shares (in shares)												407,512
Exercise price of warrants (in dollars per share)												$ 8.00
Common Class A \| Armistice Capital Master Fund Ltd. \| April 18, 2023
Warrants
Maximum number of warrants issued to purchase common stock in future					$ 2,108,262
Common Class A \| Armistice Capital Master Fund Ltd. \| December 21, 2023
Warrants
Number of warrants exercised for issuance of shares (in shares)					120,000
Common Class A \| Armistice Capital Master Fund Ltd. \| June 5, 2023
Warrants
Maximum number of warrants issued to purchase common stock in future					$ 1,714,798
Common Class A \| Armistice Capital Master Fund Ltd. \| Notice to Exercise \| December 21, 2023
Warrants
Number of warrants exercised for issuance of shares (in shares)					918,000
Common Class A \| Trusted Mail
Warrants
Number of warrants exercised for issuance of shares (in shares)																186,442
Fair Value of Warrant Liability
Warrants
Warrant liabilities		$ 2,000													$ 7,000		$ 2,000
Existing Warrants \| Armistice Capital Master Fund Ltd. \| December 21, 2023
Warrants
Warrants exercised (in shares)					882,000

Warrants - Schedule of Fair Value of Warrants Liabilities (Details)	Jun. 30, 2024 $ / shares yr
Fair Value of Warrants \| Minimum
Warrants
Warrants measurement input	0.26
Fair Value of Warrants \| Maximum
Warrants
Warrants measurement input	0.64
Exercise price \| Minimum
Warrants
Warrants measurement input	0.43
Exercise price \| Maximum
Warrants
Warrants measurement input	0.49
Risk free interest rate \| Minimum
Warrants
Warrants measurement input	0.0438
Risk free interest rate \| Maximum
Warrants
Warrants measurement input	0.0450
Expected dividend yield
Warrants
Warrants measurement input	0
Expected volatility \| Minimum
Warrants
Warrants measurement input	0.7925
Expected volatility \| Maximum
Warrants
Warrants measurement input	0.7959
Expected term
Warrants
Warrants measurement input \| yr	3

Warrants - Schedule of Warrant Issuance Date (Details) - $ / shares	Jun. 30, 2024	Dec. 31, 2023	Jun. 30, 2020
Warrants
Number of warrants exercised for issuance of shares (in shares)	10,122,109	6,446,199	6,418
November 9, 2016
Warrants
Exercise price of warrants (in dollars per share)	$ 3.12
Number of warrants exercised for issuance of shares (in shares)	80,128	80,128
January 23, 2020
Warrants
Exercise price of warrants (in dollars per share)	$ 8.00
Number of warrants exercised for issuance of shares (in shares)	186,442	186,442
Second Warrant Issuance January 23 2020
Warrants
Exercise price of warrants (in dollars per share)	$ 8.00
Number of warrants exercised for issuance of shares (in shares)	524,599	524,599
April 18, 2023
Warrants
Exercise price of warrants (in dollars per share)	$ 1.34
Number of warrants exercised for issuance of shares (in shares)	0	775,330
June 5, 2023
Warrants
Exercise price of warrants (in dollars per share)	$ 1.34
Number of warrants exercised for issuance of shares (in shares)	1,173,030	1,279,700
December 21, 2023
Warrants
Exercise price of warrants (in dollars per share)	$ 1.34
Number of warrants exercised for issuance of shares (in shares)	3,600,000	3,600,000
April 3, 2024
Warrants
Exercise price of warrants (in dollars per share)	$ 0
Number of warrants exercised for issuance of shares (in shares)	957,910	0
Second Warrant Issuance April 3, 2024
Warrants
Exercise price of warrants (in dollars per share)	$ 0.97
Number of warrants exercised for issuance of shares (in shares)	2,000,000	0
Third Warrant Issuance April 3, 2024
Warrants
Exercise price of warrants (in dollars per share)	$ 1.06
Number of warrants exercised for issuance of shares (in shares)	1,600,000	0

Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Balance Sheet Components
Prepaid operating expenses	$ 270,332	$ 216,875
Rent deposit	30,333	28,400
Value added tax receivable	49,455	116,095
Tax credit receivable (short-term)	25,045	102,151
Miscellaneous receivable	351,447	363,260
Prepaid expenses and other current assets	$ 726,612	$ 826,781

Balance Sheet Components - Schedule of Capitalized Internal-Use Software, Net (Details) - USD ($)	6 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Balance Sheet Components
Useful Lives	5 years
Internally developed software	$ 4,215,099	$ 3,901,801
Less: Accumulated depreciation	(2,705,919)	(2,429,427)
Capitalized internal-use software, net	$ 1,509,180	$ 1,472,374

Balance Sheet Components - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Balance Sheet Components
Amortization of capitalized Internal-use Software	$ 139	$ 138	$ 278	$ 279
Impairment on finite-lived assets			1		$ 12
Impairment, intangible asset, finite-lived, statement of income or comprehensive income					Research and development
Depreciation	$ 9	$ 11	$ 19	$ 53

Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Property and Equipment, Net
Property and equipment, gross	$ 180,533	$ 180,066
Less: Accumulated depreciation	(137,021)	(123,630)
Property and equipment, net	43,512	56,436
Computer equipment
Property and Equipment, Net
Property and equipment, gross	$ 146,596	152,014
Computer equipment \| Minimum
Property and Equipment, Net
Useful Lives	3 years
Computer equipment \| Maximum
Property and Equipment, Net
Useful Lives	4 years
Furniture and fixtures
Property and Equipment, Net
Useful Lives	10 years
Property and equipment, gross	$ 33,937	$ 28,052

Balance Sheet Components - Schedule of Accrued Expenses (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Balance Sheet Components
Compensation payable	$ 552,133	$ 377,403
Commission liability	20,454	26,863
Accrued employee taxes	909,171	624,525
Other accrued liabilities	57,620	115,099
Accrued expenses	$ 1,539,378	$ 1,143,890

Goodwill and Intangible Assets, Net - Schedule of Intangible Assets, Net (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Intangible assets
Intangible assets, gross	$ 591,157	$ 554,481
Less: Accumulated amortization	(398,538)	(330,791)
Intangible assets, net	$ 192,619	223,690
Patent application costs
Intangible assets
Useful Lives	3 years
Intangible assets, gross	$ 522,845	484,035
Trade name and trademarks
Intangible assets
Useful Lives	3 years
Intangible assets, gross	$ 68,312	$ 70,446

Goodwill and Intangible Assets, Net - Narrative (Details) $ in Thousands				3 Months Ended		6 Months Ended
	Mar. 19, 2024 trademark	Jan. 30, 2024 trademark	Jan. 02, 2024 trademark	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($) patent	Jun. 30, 2023 USD ($)
Intangible assets
Number of intangible assets added \| patent						22
Amortization expense \| $				$ 33	$ 38	$ 70	$ 75
Patent application costs
Intangible assets
Number of intangible assets added	1	1	1			5

Goodwill and Intangible Assets, Net - Schedule of Estimated Future Amortization Expense of Intangible Assets, Net (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Estimated future amortization expense of intangible assets
2024	$ 60,076
2025	87,980
2026	41,505
2027	3,058
Total	$ 192,619	$ 223,690

Net Loss per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Loss Per Share Attributable to Common Stockholders (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Numerator:
Net loss attributable to common stockholders	$ (2,598,361)	$ (2,170,368)	$ (5,276,930)	$ (4,717,818)
Denominator:
Weighted average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	12,227,476	6,757,320	11,169,735	5,897,089
Weighted average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	12,227,476	6,757,320	11,169,735	5,897,089
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.21)	$ (0.32)	$ (0.47)	$ (0.80)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.21)	$ (0.32)	$ (0.47)	$ (0.80)

Net Loss per Share Attributable to Common Stockholders - Schedule of Dilutive Securities Excluded From Computation of Diluted Net Loss Per Share (Details) - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Net Loss per Share Attributable to Common Stockholders
Total	$ 14,140,857	$ 5,660,107
Options, RSUs, and grants
Net Loss per Share Attributable to Common Stockholders
Total	1,323,580	642,927
Warrants
Net Loss per Share Attributable to Common Stockholders
Total	$ 12,817,277	$ 5,017,180

Stock Awards and Stock-Based Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Mar. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Aggregate intrinsic value of options exercised	$ 0	$ 0	$ 0	$ 0
Weighted average grant-date fair value of options granted per share			$ 0.43	$ 1.48
Weighted average grant-date fair value of options granted amount	$ 4	7	$ 4	$ 7
Stock options outstanding (in shares)	399,848		399,848		395,983	393,583	387,109
Treasury Stock
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Treasury stock issued (in shares)			54,734	39,692
Share-Based Payment Arrangement, Option
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock options outstanding (in shares)	399,848		399,848
Restricted stock units, outstanding (in shares)	60,270		60,270
Stock not yet issued (in shares)	45,502		45,502
Stock granted not yet vested (in shares)			14,768
Unrecognized stock-based compensation related to common stock grants			$ 7
Restricted Stock Units (RSUs)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Restricted stock units, outstanding (in shares)	863,462		863,462
Stock not yet issued (in shares)	37,175		37,175
Stock granted but not yet vested (in shares)			826,287
Unrecognized stock compensation related to the RSUs			$ 584
Management \| Grants
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock based awards granted	$ 9	0	18	$ 0
Management \| Share-Based Payment Arrangement, Option
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock based awards granted	0	0	0	0
Management \| Restricted Stock Units (RSUs)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock based awards granted	1	6	2	9
Various employees \| Grants
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock based awards granted	8	21	20	47
Various employees \| Share-Based Payment Arrangement, Option
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock based awards granted	1	3	4	7
Various employees \| Restricted Stock Units (RSUs)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock based awards granted	$ 288	$ 68	$ 562	$ 95

Stock Awards and Stock-Based Compensation - Schedule of Stock Options Activity (Details) - USD ($)	3 Months Ended		6 Months Ended	12 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Options Outstanding
Beginning balance (in shares)	395,983	393,583	393,583	387,109
Options granted (in shares)	4,375	3,825	8,200	11,890
Options exercised (in shares)	0	0	0	(1,230)
Options canceled and forfeited (in shares)	(510)	(1,425)	(1,935)	(4,186)
Ending balance (in shares)	399,848	395,983	399,848	393,583	387,109
Options vested and exercisable (in shares)	399,848		399,848
Weighted Average Exercise Price Per Share
Beginning balance (in dollars per share)	$ 6.24	$ 6.27	$ 6.27	$ 6.40
Options granted (in dollars per share)	1.37	1.57	1.46	2.28
Options exercised (in dollars per share)	0	0	0	3.25
Options canceled and forfeited (in dollars per share)	3.92	4.21	4.13	5.73
Ending balance (in dollars per share)	6.19	$ 6.24	6.19	$ 6.27	$ 6.40
Options vested and exercisable (in dollars per share)	$ 6.19		$ 6.19
Weighted Average Remaining Contractual Life (years)
Outstanding	1 year 5 months 26 days	1 year 8 months 19 days	1 year 5 months 26 days	1 year 11 months 12 days	1 year 5 months 12 days
Options vested and exercisable			1 year 5 months 26 days
Aggregate Intrinsic Value
Outstanding	$ 0	$ 0	$ 0	$ 0	$ 0
Options vested and exercisable	$ 0		$ 0

Stock Awards and Stock-Based Compensation - Schedule of Stock Options Valuation Assumptions (Details) - Share-Based Payment Arrangement, Option	6 Months Ended
	Jun. 30, 2024 $ / shares
Stock Awards and Stock-Based Compensation
Expected dividend yield	0.00%
Expected term	3 years
Minimum
Stock Awards and Stock-Based Compensation
Fair value of Class A Shares of Common Stock (in dollars per share)	$ 0.17
Exercise Price (in dollars per share)	$ 1.32
Risk free interest rate	4.11%
Expected volatility	77.54%
Maximum
Stock Awards and Stock-Based Compensation
Fair value of Class A Shares of Common Stock (in dollars per share)	$ 0.72
Exercise Price (in dollars per share)	$ 1.64
Risk free interest rate	4.71%
Expected volatility	79.80%

Stock Awards and Stock-Based Compensation - Schedule of Outstanding RSU Activity (Details) - Restricted Stock Units (RSUs) - shares	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
RSU Outstanding Number of Shares
Balance at the beginning (in shares)	446,102	292,564
Granted (in shares)	812,050	410,516
Vested (issued) (in shares)	(318,812)	(159,776)
Forfeited (in shares)	(75,878)	(97,202)
Balance at the end (in shares)	863,462	446,102

Stock Awards and Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Stock Awards and Stock-Based Compensation
Total stock-based compensation expense	$ 307,125	$ 97,737	$ 605,011	$ 157,311
Cost of services
Stock Awards and Stock-Based Compensation
Total stock-based compensation expense	0	161	262	656
Research and development
Stock Awards and Stock-Based Compensation
Total stock-based compensation expense	6,094	12,766	14,210	31,620
Selling, general, and administrative
Stock Awards and Stock-Based Compensation
Total stock-based compensation expense	$ 301,031	$ 84,810	$ 590,539	$ 125,035

Related Party Transactions (Details) - USD ($)		3 Months Ended		6 Months Ended
Related Party Transactions (Details) - USD ($)	Nov. 15, 2020	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Related Party Transactions
Related party receivables		$ 24,921		$ 24,921		$ 44,087
Related Party
Related Party Transactions
Related party receivables		53,000		53,000		82,000
Related party cost		7,000	$ 242,000	111,000	$ 535,000
Percentage of commission received, first year	20.00%
Percentage of commission received, second year	10.00%
Percentage of commission received, third year	5.00%
Payment of commission		$ 0		$ 0		$ 0

Malta Grant (Details) - Malta Grant Agreement € in Thousands		6 Months Ended
	Jan. 25, 2022 EUR (€)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Jan. 25, 2022 USD ($)	Jul. 31, 2020 EUR (€)	Jul. 31, 2020 USD ($)
Malta Grant
Maximum amount grant	€ 100			$ 107,000	€ 200	$ 251,000
Requirement of initial capital amount					50	62,000
Reimbursement of grant for initial capital amount					50	62,000
Remaining reimbursement amount of grant for operating expenses incurred up to 12 Months from incorporation					€ 150	$ 190,000
Expenses incurred for grant		$ 0	$ 0
Estimated amount of grant	€ 137			$ 146,000
Percentage of aid intensity to cover eligible wage cost	75.00%
Amounts received from grants		$ 0

Leases and Commitments - Narrative (Details)		6 Months Ended
Leases and Commitments - Narrative (Details)	Mar. 03, 2023	Jun. 30, 2024 USD ($) office lease	Dec. 31, 2023 USD ($)
Leases and Commitments
Minimum lease commitments related to month-to-month lease arrangements		$ 0
Number of leases terminated \| lease		1
Number of offices terminated \| office		1
Short-term financial liabilities		$ 0	$ 162,130
Termination notice term	30 days
Minimum
Leases and Commitments
Remaining lease term		1 year
Maximum
Leases and Commitments
Remaining lease term		5 years

Leases and Commitments - Summary of Lease Term and Discount Rate (Details)	Jun. 30, 2024
Leases and Commitments
Weighted average remaining lease term	2 years 3 days
Weighted average discount rate	5.00%

Leases and Commitments - Summary of Balance Sheet Information Related to Leases (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Balance sheet information related to leases
Operating lease right-of-use assets	$ 229,370	$ 164,740
Operating lease liabilities
Short-term operating lease liabilities	123,431	81,236
Long-term operating lease liabilities	73,520	53,771
Total operating lease liabilities	$ 196,951	$ 135,007

Leases and Commitments - Summary of Future Maturities of ASC 842 Lease Liabilities (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Principal Payments
2024	$ 71,229
2025	86,673
2026	22,390
2027	8,493
2028	8,166
Total operating lease liabilities	196,951	$ 135,007
Imputed Interest Payments
2024	4,184
2025	3,608
2026	1,130
2027	602
2028	171
Total future maturities	9,695
Total Payments
2024	75,413
2025	90,281
2026	23,520
2027	9,095
2028	8,337
Total future maturities	$ 206,646

Leases and Commitments - Summary of Total Lease Expense, Under ASC 842, was Included in Selling, General, and Administrative Expenses in Consolidated Statement of Operations (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Total lease expense
Operating lease expense – fixed payments	$ 37,976	$ 46,402	$ 77,853	$ 129,436
Short term lease expense	12,284	15,620	24,220	37,552
Total lease expense	$ 50,260	$ 62,022	102,073	166,988
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases			$ (80,248)	$ (104,817)

Subsequent Events (Details) - USD ($)	Aug. 06, 2024	Jul. 18, 2024	Jul. 09, 2024	Jun. 30, 2024	Dec. 31, 2023	Jun. 30, 2020	Dec. 16, 2016
Subsequent Events
Fair value of warrants				$ 250,000			$ 50,000
Number of warrants exercised for issuance of shares (in shares)				10,122,109	6,446,199	6,418
Subsequent Event
Subsequent Events
Subscription payment	$ 100,000
Subsequent Event \| Boumerang Inc
Subsequent Events
Sale of stock, number of shares issued in transaction (in shares)	100,000
Sale of stock, price per share (in dollars per share)	$ 1.00
Subsequent Event \| Boumerang Inc \| Prepaid Warrant
Subsequent Events
Fair value of warrants	$ 5,000,000
Number of warrants exercised for issuance of shares (in shares)	5,000,000
Exercise price of warrants (in dollars per share)	$ 1.00
Secured Debt \| Subsequent Event
Subsequent Events
Face amount			$ 453,600
Principal amount			315,000
Interest amount			138,600
Weekly payments		$ 16,200
Administrative agent fee			15,000
Secured Debt \| Subsequent Event \| Agile Lending, LLC
Subsequent Events
Face amount			$ 315,000

Grafico Azioni T Stamp (NASDAQ:IDAI)
Storico
Da Feb 2025 a Mar 2025

Grafico Azioni T Stamp (NASDAQ:IDAI)
Storico
Da Mar 2024 a Mar 2025

Dati di Mercato

Notizie

Utensili

Mercato

Scoprire

Caratteristiche principali

Follow Feed

Flusso di Opzioni

Monitor

IDAI T Stamp Inc

Notizie T Stamp Inc - IDAI

La tua Cronologia

Azienda

Attività

Popular

Ottieni l'app

Più Attivi

Toplist

Dati di Mercato

Notizie

Utensili

Mercato

Scoprire

Caratteristiche principali

Follow Feed

Flusso di Opzioni

Monitor

IDAI T Stamp Inc

Notizie T Stamp Inc - IDAI

La tua Cronologia

Azienda

Attività

Popular

Ottieni l'app

Rimuovi gli annunci